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ABSTRACT 
  
 
  
While nanotechnologies are expected to bring substantial benefits across many sectors 
and contribute to competitiveness, there is a growing body of scientific data indicating 
that there are reasonable grounds for concern that particular nanomaterials might lead to 
potential risks and damaging effects on health and the environment. 
My aim is to examine how the European Union is shaping a regulatory regime for 
nanomaterials: the regulatory option chosen, the actual legislation applicable and its 
effectiveness (with special focus on REACH regulatory gaps), the position taken by the 
different actors in this process and the expected legal developments in the short term. 
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INTRODUCTION 
  
 
This  is  the  regulators'  dilemma:  while  nanotechnologies  are  expected  to  bring 
substantial benefits across many sectors (chemistry, material sciences, health, transport, 
communication or energy) and contribute to competitiveness, innovation and job 
creation, there is a growing body of scientific data (inconclusive and preliminary) 
indicating that there are reasonable grounds for concern that particular nanomaterials 
might lead to potential risks and consequently damaging effects on human health and 
the  environment.  It  is  within  this  framework  of  scientific  uncertainty,  risk  and 
precaution on one side, and innovation and competitiveness on the other, that regulatory 
authorities have to develop a legal framework for nanotechnologies. 
 
 
My aim in this research paper in to examine how the European Union is shaping a legal 
framework for nanomaterials: the regulatory option chosen, the actual legislation 
applicable and its effectiveness, what position has taken the different actors in this 
process and where we stand in the quest for a regulatory regime for nanomaterials. 
 
In Part I we present the basic framework that may allow us to enter in the complexities 
of nanomaterials regulation: what are nanomaterials and which are the properties that 
make them so different from other substances, which are the health, safety and 
environmental threats that may pose and which are the actual and future applications 
that we may expect and that have created so many expectations. 
 
 
In Part II we focus on the development of the European Union policy and regulation on 
nanomaterials. We have structured this Part in three main Sections. 
  
Section I present the main regulatory options open to regulators and asses in which of 
them can be categorized the European Union regulatory strategy from a conceptual 
point of view. In addition we focus on the interplay of the Precautionary Principle (as 
developed by the European Courts) in the shaping of the European strategy. 
 
 
Section II present the European “nano-regulation” from two different angles. The first 
one (Section II.A) deals with the current legislation affecting nanomaterials. We will see 
5 
that the overall assessment from the Commission is that it covers “in principle” risks 
arising from the use of nanomaterials. 
  
Based  on  this  basic  assessment  we  present  in  Section  II.B the  different 
Communications, Recommendations, Resolutions and proposals taken by the different 
actors at play, with special attention to the European Parliament Resolution that 
considered, on the contrary, that “current (…) rules are about as effective in addressing 
nanotechnology as trying to catch plankton with a cod fishing net” (Carl Schlyter 
-rapporteur of the European Parliament Resolution-). From a methodological point of 
view, we have decided to present in chronological order the different contributions to 
the regulatory debate, as it allows a comprehensive overlook (as all official documents 
are presented), it give a real sense of “regulatory process” and each contribution can be 
individually assessed. 
 
 
In Section II.C we present the new regulatory developments that are in the pipeline, 
with special focus on the (second) assessment from the Commission on the regulatory 
aspects of nanomaterials (including those related with REACH) and the debate around 
the compulsory and harmonized reporting scheme for nanomaterials. 
 
 
We finally close this Section (at II.D) by presenting a personal assessment of the 
European Union regulatory regime for nanomaterials and propose the basic pillars for 
the development of a consistent regulatory regime. 
 
 
Part III is devoted to a case study. Our objective was to choose one of the regulations 
previously identified affecting nanomaterials and check whether it covers risks 
associated with nanomaterials. We have chosen REACH (Regulation 1907/2006) for 
being a comprehensive new system of (total) harmonization for the regulation of 
industrial  chemicals  throughout  Europe,  because  its  approval  process  may  be  an 
example if a nano specific regulation have to be designed and because “constitutes a 
cornerstone for addressing health, safety and environmental risks in relation with 
nanomaterials” (Commission staff working paper accompanying document to the 
Regulatory aspects of nanomaterials COM(2008)366final). 
 
 
The  case  study  identify  several  nanomaterials  regulatory  gaps  within  REACH, 
6 
confirming  that  REACH  is  ill-equipped  for  regulating  the  risk  associated  with 
nanomaterials. 
  
Finally, Part IV present our main conclusions. 
   
I  would  like  to  thank  Prof.  Blanca  Vilà  and  Dr  Montserrat  Pi  for  facilitating  all 
necessary conditions that have allowed me to conduct this research. 
 
 
I would like to express my sincere gratitude to my advisor Dr Isabel Pont for her 
support. For many years she has been accessible and willing to help. 
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PART I: INTRODUCTION TO NANOTECHNOLOGY AND NANOMATERIALS 
 
1.- CONCEPT, HISTORY, PROPERTIES AND APPLICATIONS 
 
 
CONCEPT 
  
 
Nanotechnology is an umbrella term that covers a set of technologies that enables the 
manipulation, study or exploitation of very small (typically less than 100 nanometres1) 
structures and systems2, and, in doing so, contributes to novel materials, devices and 
products (whether at micro or macro scale) that have qualitatively different properties3. 
  
From this broad definition there are two elements that needs to be underlined and 
clarified as they are fundamental to the proper understanding of the regulatory 
challenges  that  we  will  be  analysing,  namely:  “set  of  technologies”  and  “novel 
materials with qualitative different properties”. 
 
 
Nanotechnology it is not a technology on its own right, but a set of enabling 
technologies that will allow one or more elements of a material, product or process to 
1 The word “nano” is originating from the Greek word meaning “dwarf”. In science and technology a nanometre is 
a unit of spatial measurement that equals one billionth (10-9) (= 0.000000001), thus, a nanometre (nm) is one 
billionth of a metre. 
2 The focus on nanotechnology debate is on applications and products using “engineered” or “manufactured” nano 
particles (those produced intentionally for specific purposes and with defined chemical composition and size 
distribution). Engineered nanomaterials have to be distinguished from “natural” nano particles (those that occur 
in the environment -volcanic dust, lunar dust, mineral composites) and “incidental” nano particles (those that 
occur as the result of man made industrial processes -diesel exhaust, could combustion, welding fumes). Natural 
and incidental nano particles may have irregular or regular shape, while engineered nano particles most often 
have regular shapes, such as tubes, spheres or rings. Bell, T.E. (2006) <<Understanding Risk Assessment of 
Nanotechnology>>. At http:// www.nano.gov/Understanding_Risk_Assessment.pdf (Accessed December 2010). 
3 The European Commission definition of nanotechnology: <<Nanotechnology refers to science and technology at 
the nanoscale of atoms and molecules, and to the scientific principles and new properties that can be understood 
and mastered when operating in this domain. Such properties can then be observed and exploited at the micro- or 
macro-scale, for example, for the development of materials and devices with novel functions and performance>>. 
<<European Commission Communication from the Commission – Towards a European strategy for 
nanotechnology>>. COM(2004)338 Final. At 4; 
“Nanotechnology” has been defined by The International Standards Organization (ISO) Technical Committee 
(TC) 229 as <<the application of scientific knowledge to manipulate and control matter in the nano-scale to 
make  use  of  size  and  structure-dependent  properties  and  phenomena  distinct  from  those  associated  with 
individual atoms or molecules or with bulk materials>>. Technical Committee (TC) 229 of the international 
Organisation for Standardisation (ISO) is the main TC responsible for standardisation work related to 
nanotechnologies. Within the European Standardisation Committee (CEN), Technical committee (TC) 352 deals 
with  nanotechnologies.  Many  of  the  members  of  CEN/TC  352  also  participate  in  ISO/TC  229/JWG  1 
Terminology and Nomenclature. A number of nano-related definitions have already been published by ISO in 
Technical  Specifications  (TS),  which  can  be  freely  consulted  via  the  on-line  ISO  Concept  Database 
(http://cdb.iso.org/); ISO TS 80004-1 Nanotechnologies – Vocabulary- Part 1: Core Terms; ISO TS 80004-2 
Nanotechnologies – Terminology and definitions for nano-objects – nanoparticle, nanofibre and nanoplate; ISO 
TS 80004-3 Nanotechnologies – Vocabulary – Part 3: Carbon nano-objects. 
See also the OECD Working Party on Nanotechnology (WPN) at 
http://www.oecd.org/site/0,3407,en_21571361_41212117_1_1_1_1_1,00.html. (Accessed October 2010). The 
WPN was stablish in 2007 with the aim to “advice upon emerging policy issues of science, technology and 
innovation related to the responsible development of nanotechnology”. 
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be done differently, in this sense, nanotechnology is known as a Key Enabling 
Technology (KET) or General Purpose Technology (GPT)4. The consequence is that it 
is not confined to one industry or market, but offers a broad technology platform in 
applications to all industry sectors and scientific disciplines (it transcends the 
conventional boundaries between physics, chemistry, biology, mathematics, electronics, 
and medicine, so being inherently multidisciplinary). It is classified by the size of the 
material being developed and used, not by the process being used or product being 
produced. From a regulatory point of view, it is important to take into considerations 
what kind of limitations (and complexities) pose this characteristic when designing a 
possible overarching regulatory regime. 
 
 
The second element to be clarified is that the properties of materials at the nanoscale 
can have some unexpected differences from their behaviour in larger bulk forms5 that 
makes for new application opportunities6. The different behaviour is also paramount for 
understanding the difficulties for a regulatory design. Bulk or conventional substances 
has the same phsycochemical characteristics, being the difference, basically, the weight. 
This is the reason why “volume” is, in most regulations (for instance REACH), the 
basic element that is taken into consideration for thresholds setting. This logic do not 
work for nanosubstances, just because the phsycochemical characteristics may change, 
so applying current regulatory logic will inevitably lead to regulatory gaps. 
  
It is basically due to these characteristics that, from a scientific and legal perspective, 
the conceptual definition of “nanotechnology” is of very limited importance since its 
practical use is only occasional7, being “nanomaterial” the one with real implications. 
  
4 Shea, C.M., Roger G., Elmslie B. (2011) <<Nanotechnology as general-purpose technology: empirical evidence 
and implications>> Technology Analysis & Strategic Management. 23(2) Feb. 2011, 175 – 192. At 177. 
5 For instance, in its natural bulk form, gold is inert. However, at a particle size of 2-5 nm, gold becomes highly 
reactive. The chemical composition of these two materials is identical: it is the different physical size of bulk 
materials and nanoparticles that accounts for their very different chemical properties. 
6 The two reasons for this change in behaviour are: increased relative surface area (producing increased chemical 
reactivity) and   increasing dominance of quantum effects (with effects on the material’s optical, magnetic, or 
electrical properties). Hunt, W. H.  Jr. (2004) <<Nanomaterials: Nomenclature, Novelty, and Necessity>> JOM 
Oct.   2004.   Hypertext-Enhanced  Available   at   http://www.tms.org/pubs/journals/JOM/0410/Hunt-0410.html 
(Accessed October 2010). 
7 For  example when  evaluating  whether  project  applications  in  a  “nano”  specific  area  can  be  regarded  as 
nanotechnology or not, or when making estimates of the importance of the “nanotechnology” market. It is 
believed that the term “nanotechnology” will sooner or later cease to exist as researchers and developers study 
and use materials due to their functionality rather than their size.  Lövestam, G. ,  Rauscher, H. ,  Roebben, G., 
Klüttgen, B. S., Gibson, N., Putaud , JP., Stamm, H. (2010) <<Considerations on a Definition of Nanomaterials 
for  regulatory  Purposes>>.  JRC  Reference  Reports.  June  2010.   EUR  24403   EN.  Available  at  http: 
//ec.europa.eu/dgs/jrc/downloads/jrc_reference_report_201007_nanomaterials.pdf. (Accessed December 2010). 
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At international level, the ISO Technical Committee 229 defined “nanomaterial” as 
 
<<material with any external dimension in the nanoscale or having internal structure or 
surface in the nanoscale>>8. 
 
 
At EU level, the efforts by the European Commission to release a legal definition of 
“nanomaterial” for regulatory purposes started in 2009 with the European Parliament 
request “for the introduction of a comprehensive science-based definition of 
nanomaterials”9, that was followed in September 2010 by a draft Recommendation10, 
that finally crystallised in the Recommendation of 18.10.2011 on the definition of 
nanomaterial11 that “should be used as a reference for determining whether a material 
should be considered as a “nanomaterial” for legislative and policy purposes in the 
Union”. 
  
In broad terms, according with the Recommendation, “nanomaterial” is defined as a 
natural, incidental or manufactured material containing particles, in an unbound state or 
as an aggregate or as an agglomerate and where, for 50 % or more of the particles in the 
number size distribution, one or more external dimensions is in the size range 1 nm - 
100 nm. 
   
In specific cases and where warranted by concerns for the environment, health, safety or 
competitiveness the number size distribution threshold of 50 % may be replaced by a 
threshold between 1 and 50 %. 
 
 
In addition, fullerenes, graphene flakes and single wall carbon nanotubes with one or 
more external dimensions below 1 nm should be considered as nanomaterials. 
 
 
Given the complexity of the concept just outlined we remit in full to Part II Section B.8) 
 
of this research paper where the Commission Recommendation is further analysed. 
 
 
8      ISO/TS 80004-1:2010. Available at https//cdb.iso.org. (Accessed January 2011). 
9 PA_T6(2009) 0328. The EP called for the introduction of a comprehensive science-based definition as part of 
nano-specific amendments to relevant horizontal and sectoral legislation. Also the Belgian Presidency of the 
Council called for the adoption of a definition. See Part II B.6) and C.2) of this research paper. 
10  In September 2010 the Commission released a draft Recommendation that for the first time defined the term 
“nanomaterial” with the objective of becoming an “overarching, broadly applicable reference term for any Union 
communication or legislation addressing nanomaterials”. Commission Recommendation of […] on the definition 
of the term “nanomaterial” C(20..) yyy final. Available at 
http://ec.europa.eu/environment/consultations/nanomaterials.htm (Accessed Nov. 2010). 
11    Recommendation 2011/696/UE OJ L275/38 of 20.10.2011 
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FIGURE 2-1 
Length scale showing the nanometre in context 
This diagram places the nanoscale in context One nanometre (nm) is equal to one-billionth (1,000,000,000) 
if a metre, 1(}9m. Most structurcs if nanomaterials which are if interest are between 1 and 100 nm in one or more 
dimensions. For example, carbon Buck(yballs (figure 2-111) are about  lttm in diameter. 
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 HISTORY 
  
 
From a historical perspective12 it is generally stated that the “authoritative founding 
myth”13 of (engineered) nanotechnology did not occur until 1959, when Richard 
Feynman, presented a talk to the American Physical Society entitled There’s Plenty of 
Room at the Bottom14. 
 
The following milestone was in  1974,  when Norio Taniguchi introduced the  term 
 
‘nanotechnology’15, but the real breakthrough was with the invention of the scanning 
tunnelling microscope (STM) in 198116, and subsequently, the invention of the atomic 
force microscope (AFM) in 198617. 
 
 
The discovery of novel materials on the nanoscale began with the Buckminsterfullerene 
(also called the buckyball) in 198518. In 1991, a new step was achieved with the 
discovery of the carbon nanotubes by Sumio Iijima. From there, and at increased pace, 
   
12   It has been said that the agreed conventional history of nanotechnology is used to push the importance of 
nanotechnology to policy makers and is invoked to direct scientists and engineers toward production, something 
different from the understanding of ‘pure’ science.   Shew, A. (2008) <<Nanotech’s History: An Interesting, 
Interdisciplinary, Ideological Split>> Bulletin of Science, Technology & Society. 28 (5): 390 – 399.  Available at 
http://www.eric.ed.gov/ERICWebPortal/search/detailmini.jsp? 
_nfpb=true&_&ERICExtSearch_SearchValue_0=EJ809246&ERICExtSearch_SearchType_0=no&accno=EJ809 
246. (Accessed Oct. 2010); Allhoff, F. (2010) “Unit I What is Nanotechnology?”at WILEY-BLACKWELL 
<<What is Nanotechnology and why does it matter? From Science to Ethics>>. Pgs. 1 – 70. 
13   Keiper, A. (2009)   <<Happy Birthday, Nanotechnology?>>. The New Atlantis. A Journal  of Technology & 
Society.  Available  at   http://futurisms.thenewatlantis.com/2009/12/happy-birthday-nanotechnology.html 
(Accessed October 2010) 
14  Feynman, R. (1959) <<There’s Plenty of Room at the Bottom. An Invitation to Enter a New Field of Science>> 
Lecture given at the annual meeting of the American Physical Society, California Institute of Technology, 
December  29,  1959.  http://www.zyvex.com/nanotech/feynman.html (Accessed  October  2010);  Toumey,  C. 
(2009)  <<Feynman and nanotechnology – anniversary reflections>>. Available at 
http://www.nanowerk.com/spotlight/spotid=13169.php (Accessed October 2010); Christopher Toumey (2005) 
<<Apostolic Succession: Does nanotechnology descends from Richard Feynman's 1959 talk?>> Engineering & 
Science. LXVIII (1-2): 12- Available at  http://pr.caltech.edu/periodicals/EandS/articles/LXVIII1_2/Feynman.pdf 
(accessed October 2010); Eric Drexler <<There's Plenty of Room at the Bottom” (Richard Feynman, Pasadena, 
29  December  1959>>.  Available  at  http://metamodern.com/2009/12/29/theres-plenty-of-room-at-the-bottom 
%E2%80%9D-feynman-1959/ (accessed October 2010). 
15  Taniguchi, defined “Nanotechnology” for the first time in 1974: <<Nano-technology’ mainly consists of the 
processing of separation, consolidation and deformation of the materials by one atom or one molecule. Needless 
to say, the measurement and control techniques assure the preciseness and fineness of 1 nm play a very important 
role in this technology.>>. 
16  Gerd Binnig and Heinrich Rohrer (IBM Zurich Laboratories). With this technology, individual atoms could be 
clearly identified for the first time. Despite its limitations, this breakthrough was essential for the development 
of nanotechnology because what had been previously concepts were now within view and testable. 
17  Some of the STM limitations were eliminated through the 1986 invention of the Atomic Force Microscope. 
Using  contact  to  create an  image, this  microscope could  image non-conducting  materials such  as organic 
molecules. 
18  It consists of an arrangement of 60 carbon atoms. Was created by Harry Kroto, Robert Curl and Richard Smalley. 
The buckyball was so named because of the resemblance to the geodesic domes from the architect Richard 
Buckminster. 
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novel nanoscale material has been reported19. 
   
PROPERTIES 
  
 
As we have already seen, the reason for studying, manipulating and exploiting the 
materials at the nanoscale is that the properties of nanomaterials can have differences 
from their behaviour in larger bulk forms that permits new application opportunities20. 
 
 
The individual molecular and atomic dimensions and interactions determine the 
arrangement, stability, flexibility and function of nano structures (that permits to display 
such different properties). As the AFSSET21 indicates: 
<<Les propriétés des nanomatériaux varient notamment selon leur composition chimique, leur taille, leur 
surface spécifique, l’état de surface, ou encore la forme du nano-objet considéré. De plus, chaque 
nanomatériaux peut être doté d’une réactivité ou d’un comportement différent selon la formulation et la 
matrice du produit fini qui le contient>>. 
  
So  the complexity when dealing with nanomaterials is  that  the  indicated different 
and/or unique properties are based on a number of key physicochemical characteristics 
22 and on the formulation and the matrix of the finished product where it is contained. 
 
 
19   See http://www.nanowerk.com. Nanomaterial database with currently 2700 nanoparticles from 167 suppliers. 
(Accessed May 2011). 
20   Could be different chemical, biological, electronic, magnetic, optical (photon) mechanical or structural properties 
depending on each substance, formulation and matrix of the finished product where it is contained. For instance, 
the colour of gold shows different hues of red, blue, and green at the nano-scale; zinc oxide, which is usually 
opaque and thus used to block ultraviolet rays, turns transparent; and aluminium, which is stable in bulk, 
becomes explosive. The uses of these novel particles are manifold: different shades of gold may produce new 
types of precious jewels; transparent versions of zinc dioxide are already being used to improve sunscreen, 
making it less visible yet more effective; and aluminium’s explosive properties are expected to bolster rocket 
propulsion. Hunt, W. H.  Jr. (2004). 
21   Agence française de sécurité sanitaire de l'environnement et du travail-AFSSET (2010) <<Évaluation des risques 
liés    aux    nanomatériaux    pour    la    population    générale    et    dans    l'environnement>>.   Available    at 
http://www.afsset.fr/upload/bibliotheque/460552230101468097041324565478/10_03_ED_Les_nanomateriaux_ 
Rapport_compresse.pdf 17.03.2010. (Accessed December 2010). 
22  Key physicochemical characteristics: size, aggregation and agglomeration state, chemical composition; shape; 
solubility; dispersibility; surface area; surface chemistry -for example hidrophobicity- and surface charge. These 
characteristics are the ones facilitating a proper characterisation of nanomaterials and permitting a proper 
comparison of toxicological test results. 
ENRHES project final report states that <<(...) there is now a consensus that thorough and accurate particle 
characterisation is an essential part of assessing the potential toxicity of nanoparticles (...) characterisation of test 
materials is important to ensure that results are reproducible, and also to provide the basis for understanding the 
properties of nanoparticles that determine their biological effects. Some of the key parameters influencing the 
biological activity of nanoparticles remain unknown or to be fully understood at this point>> ENRHES (2010) 
<<Engineered  Nanoparticles:  Review  of  Health  and  Environmental  Safety>>.  Project  webside  address: 
http://nmi.jrc.ec.europa.eu/project/ENRHES.htm. At 315; See also Hansen, S.F., Larsen, B.H., Olsen, S.I., Baun, 
A. (2007) <<Characterisation framework to aid hazard identification of nanomaterials>>. Nanotoxicology.1 iFirst 
Article:    243-250.    Available    at    http://www.dina.kvl.dk/~envirosymp/downloads/readingMaterials/4-Risk- 
Assessment-of-Nanoparticles/Optional-reading/Hazard-identification-of-nanomaterials.pdf     (Accessed      Nov 
2010). 
13 
From a regulatory perspective, a consequence that has to be taken is that the details of 
individual nano particles need to be considered, rather than generalization23. 
  
It is the exploitation of this unique properties (by engineering a substance with 
nanotechnology, that basically can be linked to creating a new chemical) that grant 
nanotechnology the potential of catalysing technological revolution that eventually will 
have large impact (positive or negative) on society (from the live of individuals to 
industry) as we will review on following sections. 
 
 
  
 
  
 
                     
 
OECD (2010), The Impacts of Nanotechnology on Companies: Policy Insights from Case Studies, OECD At. 28 
  
23   Based on this different characterization of nanomaterials and from a scientific perspective, Drezec and Tour 
suggest the following recommendation to regulators: 
a) Use toxicity standards that are understood in other fields of science, such as chemistry or drug development, 
avoiding generalizations; 
b) Help stakeholders identify the highest quality nanotechnology studies; 
c) Consider sectioning “nanotechnology” into a number of narrowly defined fields. Might include: C60 and 
related small fullerenes and other pseudo-zero-dimensional carbon materials; carbon nanotubs and other pseudo- 
one-dimension carbon  materials; graphene and other two-dimensional carbon materials; gold nanoparticles; 
silver nanoparticles, etc. 
For each field to consider features as particle size, surface coating and charges, aggregation state and typical 
trapped impurities, such as exogenous metals and solvents; 
d) To focus on specific materials used and particular products created rather than on an underlying scientific 
regime or  rubric.  Drezec, R.A., Tour,  J.M.  (2010)  <<Is  nanotechnology  too  broad  to  practice?>>  Nature 
Nanotechnology. 5. March 2010. At. 169. 
Engineered nanomaterials can be classified into carbon-based materials (nanotubes, fullerenes), metal-based 
materials (metal oxides and quantum dots), dendrimers (nano-sized polymers built from branched units  of 
unspecified chemistry) and composites (including nanoclays). See Ortiguy, C, Roberge, B., Woods, C., Soucy, B. 
(2010). <<Engineered Nanoparticles: Current Knowledge about Occupational Health and Safety Risks and 
Prevention Measures. Second Ed.>>. Studies and Research Projects. Report R-656. IRSST Institut de Recherche 
Robert-Sauvé en santé et sécurité du travail. Available at  http://www.irsst.qc.ca (Accessed December 2011). 
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APPLICATIONS 
  
Nano materials are used in a wide variety of applications in multiple sectors of the 
economy, including manufacturing, health, energy, textiles, aerospace, construction, 
mining, agriculture, information and communication technologies and even 
environmental remediation applications24. 
 
 
From the existing databases incorporating nanomaterials can be concluded that: 
 
a) Number of nanoproducts in the marketplace is increasing dramatically25; 
 
b) Nanomaterials are playing a minor role and are used to improve existing products in 
terms of quality or functionality (passive naostructures); 
c) Consistent information can not be obtained due to lack of compulsory registration 
and different inventories' methodology and range of registered products26. 
               
24   Engineered nanomaterials can be produced either by milling or lithographic etching of a large sample to obtain 
nanosized particles (an approach often called “top-down”) or by assembling smaller subunits through crystal 
growth or chemical synthesis to grow nanomaterials of the desired size and configuration (“bottom-up”).  Bell, 
T.E. (2006) . 
25   For instance, a three-fold increase has been identified for Europe since 2006, reaching actually 858 consumer 
products: Wijnhoven, S.W.P., Dekkers, S., Kooi, M. Jongeneel, W.P., de Jong. W.H. (2011) <<Nanomaterials in 
consumer products. Update of products on the European market in 2010>>. National Institute for Public Health 
and the Environment. RIVM Report 340370003/2010. Ministry of Health, Welfare and Sport.Available at 
http://www.nanoform.org and http://www.rivm.nl. 
26  Another databases currently available are: a) PEN The Project on Emerging Nanotechnologies. Available at 
http:/www.nanotechproject.org. As  of  March  10,  2010,  the  nanotechnology  consumer  products  inventory 
contains 1317 products; b) ANEC – BEUC inventory of products claiming to contain nanoparticles available on 
the EU market. As of Oct 10, 2010, the nanotechnology consumer products inventory contains 475 products. 
Available at www.anec.org/attachments/ANEC-PT-2010-Nano-017.xls (Accessed May 2011) c) 
http://www.azonano.com/ industry oriented directory with companies, materials and applications database 
(Accessed May 2011); d)   http://www.nanowerk.com. The purpose of the database is to give  an idea of how and 
where in industry nanoscale materials, devices, structures and processes are being used. (Accessed May 2011). 
On the other hand, the real potential of nanomaterials can also be ascertained by the analysis of the European 
Patent Office entries. The EPO introduced in 2009 a tagging system for all nanotechnology patent documents. 
The EPO created a  tag (Y01N) for specifically retrieving information on nanomaterials. The EPO reported that a 
15% yearly increase in nanotechnology patents -what is a higher percentage growth than general EPO 
applications. In 2009 the number of nanotechnology patents was of 99.992 patents. See Nanotechnology and 
patents. European Patent Office EPO. 2009. The EPO tagging system has now been accepted internationally 
under  the  International  Patent  Classification (IPC)  system. The   new  tag  as from January 2011  is  B82Y. 
http://documents.epo.org/projects/babylon/eponet.nsf/0/623ecbb1a0fc13e1c12575ad0035efe6/$file/nanotech_brochure_en.pdf. 
; http://www.epo.org/news-issues/news/2011/20110128.html 
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MONTOVANI, E. <<Hard e Soft Regulation per le Nanotecnologie>>. 4A Conferenza Nazionale del 
Programma NIC – Nanotecnologia nell'industria chimica. 2/XII/2010. AIRI/Nanotec IT, 2010. 
   
From a regulators perspectives, and following a generally agreed nanotechnology 
development forecast27, on the first and second development stages (passive and active 
nanostructures) regulatory focus have to be on solving the issues related with Health, 
Safety and Environmental issue, as by its nature (protecting human health and 
environment) are the most compelling ones. When entering the third and forth stage 
(systems of nanosystems and heterogeneous molecular nanosystems) increased focus 
will be on Ethical, Legal and Social aspects (ELSA) with a set of extremely compelling 
issues that are outside the scope of this report28. 
 
27  Widmer, M., Meili, C., Mantovani, E., Porcari, A. (2009) <<Mapping study on Regulation and Governance of 
Nanotechnologies>>. Published under the FramingNano project as deliverable D1.1 for Work Package 1. 
Available at  http://www.framinhnano.eu/ At. 104. (Accessed Feb. 2011) 
28  Catalogue of Ethical, Legal and Societal Issues (“ELSI”) surrounding nanotechnology: 
a) Regulatory issues 
Once EHS implications are addressed, a myriad of legal issues appears: to regulate privacy, patent law and 
nanotechnology, liability, criminal law, ethical issues, etc. 
b) Public perception and public engagement 
How the public perceives/accepts applications and risks of nanotechnology; how to engage the public in a 
proactive debate on risks and benefits of nanotechnology; the role of scientific and not scientific communication; 
how these elements can influence the governance of nanotechnology development. 
c) Commercialization and governance issues 
Impact of nanotechnology on economy, trade, employment at regional/national or local level; rights to access to 
information (also in relation with the use Intellectual Property Rights); non discrimination in the access to the 
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2.- HEALTH, SAFETY AND ENVIRONMENTAL (HSE) ISSUES 
  
 
If engineered nanomaterials have physical properties different from their bulk 
counterparts, might they also pose new risks to human health in their manufacture, use 
and disposal? 
 
 
As per today, certain health and environmental hazards have been identified for a 
variety of manufactured nanomaterials29, indicating potential toxic effects30. Similarly, 
the occurrence and possible adverse consequences of engineered nanoparticles in the 
environment has already been reported31. 
 
 
Although  from  a  Health,  Safety  and  Environmental  (HSE)  perspective  it  can  be 
assessed that a growing body of scientific evidence suggests that some manufactured 
  
benefits of nanotechnology, including the questions of a nanotechnology divide versus the promises for a 
beneficial use of nanotechnology in the developing world. 
d) Application specific issues (mainly in relationship with nanomedicine and security applications) 
- Ethical and philosophical issues related to non therapeutic human enhancement and novel applications 
exploring man-machine interactions; 
- Increased personal responsibility related to novel diagnostic tools providing predictive information on 
diseases; 
- Protection of personal data, privacy, limits to personal freedom, confidentiality issues raised by novel 
surveillance, military and medical applications of nanotechnology; 
- Use/misuse of novel applications in military, criminal or terrorist activities. 
Widmer, M. et Al (2009) At 108. 
29   From manufactured nanoparticles, the scientific community mainly considers that the safety concerns are related 
with “free”, rather than fixed nanoparticles (when nanoparticles are dispersed into fluid or gaseous media they 
are called unbound or free nanoparticles) although there is clearly potential for the fixed nanoparticles (also) to 
become detached and enter natural ecosystems, especially when products containing them abrade or weather 
during use or when they are disposed of as waste or are recycled (when nanoparticles are dispersed into fluid or 
gaseous media they are called unbound or free nanoparticles). Royal Society and Royal Academy of Engineering 
(RS/RAE) (2004). <<Nanoscience and Nanotechnologies: Opportunities and uncertainties>>. Royal Society 
Policy Document 19/04. (RS/RAE). 
30  Long, non-degradable nanotubes (longer than 20 micrometres) have in several experiments been found to have 
effects similar to hazardous asbestos, causing inflammatory reactions. Experiments also indicate that carbon 
nanotubes could induce a specific form of lung cancer (mesothelioma), which is also observed in relation to 
asbestos exposure. Sanderson, K. (2008) <<Carbon nanotubes: the new asbestos?>> ICON Backgrounder. 
Available at  http://www.nature.com/news/2008/080520/full/news.2008.845.htm; Kulinowski, K. (2009) <<Multi- 
walled Carbon Nanotubes and Meshothelioma>>. ICON Backgrounder. Available at 
http://icon.rice.edu/resources.cfm?doc_id=12299(Accessed May 2011); Aitken, R.J.,  Hankin S.M.,  Ross,  B., 
Tran, C.L., Stone, V., Fernandes, T.F., Donaldson, K., Duffin, R., Chaudhry, Q., Wilkins, T.A., Wilkins, S.A, 
Levy, L.S. Rocks, S.A, Maynard, A. (2009) <<A review of completed and near completed environment, health 
and safety research on nanomaterials and nanotechnology>>.  Defra Project CB0409. Report TM/09/01. March 
2009.  EMERGNANO  -  SAFENANO.  IOM.  March  2009.  (Accessed  February  2011);  Guix,  M.  (2008) 
<<Nanoparticles for cosmetics. How safe is safe?>> Contributions to Science. 4(2): 213 – 217. Institut d'Estudis 
Catalans. Available  http://www.cat-science.cat. (Accessed February 2011). 
31  The EMERGNANO project that identified and assessed 673 projects related with toxicology and ecotoxicology 
of nanomaterials concluded: <<(...) from the results presented (...), three different nanomaterials have been 
identified that give rise to sufficient concern. There is evidence that carbon nanotubes may have an adverse effect 
on human health; and that silver nanoparticles and titanium dioxide nanoparticles are detrimental to the 
environment. In these specific cases, further investigation as to the need to invoke the precautionary principle is 
required, taking into consideration all available data>>.  Aitken, R.J. Et Al. At 157; Nowack, B. (2009) <<The 
behaviour and effects of nanoparticles in the environment>>. Environmental Pollution 157: 1063-1064. 
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nanomaterials <<harbour new and unusual dangers>>32, as per today evidence of 
harmful impacts in “real world” has not been reported and basically the plausibility of 
damage has been based on the extrapolation of evidence from laboratory investigations 
and occupational exposure studies on dust and other substances33. 
 
 
The reasons behind the reported limited knowledge available regarding the potential 
health, safety and environmental impacts of nanotechnology, can be summarized as the 
intrinsic scientific complexity of nanosubstance characterisation (or in broader terms 
risk assessment shortcomings)34 and the comparatively minor investments done in the 
32  The Scientific Committee on Emerging and Newly-Identified Health Risks -SCENIHR- (2007), <<The 
appropriateness of risk assessment methodology in accordance with the Technical Guidance Documents for new 
and existing substances for assessing the risks of nanomaterials>>. Adopted on 21-22 June 2007; Maynard, A.D. 
(2006) <<Nanotechnology: The Next Big Thing, or Much Ado about Nothing?>>. The Annals of Occupational 
Hygiene. 51 (1): 1 – 12. 
33   Royal Commission on Environmental Pollution (RCEP). (2008) <<Novel Materials in the Environment: The 
case of nanotechnology>>. Twenty-seventh Report of the RCEP presented to the UK Parliament in November 
2008. Available at   http://www.rcep.org.uk/reports/27-novel%20materials/27-novelmaterials.htm#supp 
At 2.42. 
34  Risk Assessment: 
- Risk assessment can be defined as a procedure in which the risk posed by inherent hazards involved in 
processes or situations are estimated either quantitatively or qualitatively. EEA (1998) <<Environmental Risk 
Assessment: Approaches, Experiences and Information Sources>>. Environmental Issue Report no. 4. EEA.. 
March  1998.  Available  at  http://www.eea.europa.eu/publications/GH-07-97-595-EN-C2.  (Accessed  January 
2011). At Chapter 1; The  European  Court  of  Justice  has  defined  risk  assessment as  a  “scientific process 
consisting in the identification and characterisation of a hazard, the assessment of exposure to the hazard and the 
characterisation of the risk” Case T-13/99 Pfizer Animal Health v Council. At 156. 
- In the EU, risk assessment methodology is described in the Technical Guidance Document (TGD) on Risk 
Assessment. Institute for Health and Consumer Protection. European Chemicals Bureau. Joint Research Centre. 
European Commission. EUR20418 EN/1. 2003. The guidance given on the TGD is not legally binding. It can be 
used other  methods or approaches  if they are considered to be more appropriated,  provided that they are 
scientifically justified. Those methods, including any assumptions, uncertainties and calculations, should be 
clearly described and justified. See TGD2003 At 1.3. 
- The TGD characterizes risk assessment as consisting in four parts, namely hazard identification, hazard 
characterisation, exposure assessment, risk characterisation. 
- It is generally agreed that Risk Assessment as described in the TGD cannot be directly extrapolated to 
nanomaterials. See European Commission's Scientific Committee on Emerging and Newly Identified Health 
Risks SCENIHR (2007). At 26. 
- In broader terms, risk assessment for nanomaterials precludes going further than identifying hazards -first step 
of risk assessment- and providing some elements of hazard characterisation (dose/response assessment). Hansen, 
S.F.  (2009)  <<Regulation  and  Risk Assessment of  Nanomaterials – Too  Little, Too  Late?>> PhD  Thesis, 
February 2009. Department of Environmental Engineering. Technical University of Denmark. Available at http: 
wwww.env.dtu.dk. (Accessed December 2010). 
- SCENIHR has listed the shortcoming of nanomaterials risk characterisation: 
1. Persistence of nanoparticles in the atmosphere, which will depend on rates of agglomeration and 
disagglomeration, and on degradation; 2. Relevance of routes of exposure to individual circumstances; 3. Metrics 
used for exposure measurements; 4. Mechanisms of translocation to different parts of the body and the possibility 
of degradation after nanoparticles enter the body; 5. Mechanisms of toxicity of nanoparticles; 6. Phenomenon of 
transfer between various environmental media. 
These are not simply uncertainties in the values of some traditional parameters, but rather the uncertainties about 
the potentially unique or significantly modified causal mechanisms themselves. The Scientific Committee on 
Emerging and Newly-Identified Health Risks SCENIHR (2007) At 26. 
- In order to overcome these limitations SCENIHR has proposed to assess the risk of nanomaterials on a case-by- 
case basis, that has been criticised as unworkable. See HANSEN, S.F. (2009). At. 71. 
- Alternative decision making tools for risk assessment has been proposed, like Multi Criteria Decision Analysis 
(MCDA), hazard trigger algorithm or life cycle inventory analysis. See Linkov I, Satterstrom FK, Kiker G, 
Seager TP, Bridges T, Gardner KH, Rogers SH, Belluck DA, Meyer A (2006) <<Multicriteria decision analysis: a 
comprehensive  decision  approach  for  management  of  contaminated  sediments>>.  Risk Anal  26(1):61–78; 
Hansen, S.F. (2010)  <<Multicriteria mapping of stakeholder preferences in regulating nanotechnology>>  J 
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field of nanotechnology- related environment, health and safety (HSE) research when 
compared with the development of technology itself and of consumer applications35. 
 
 
Faced with scientific uncertainty, the regulator's option to postpone action until 
conclusive  scientific  knowledge  is   obtained  do   not   seams  reasonable,  as   the 
development of the technology could be hindered by public opinion over reaction due 
to lack of knowledge, fear36, misleading information and lack of transparency37. 
 
 
From a regulatory perspective, it is commonly agreed that the legislator needs to 
regulate based on inconclusive and preliminary scientific evaluation indicating that 
there are reasonable grounds for concern that particular nanomaterial might lead to 
potential risks and consequently, damaging effects on the environment, or on humans, 
animals or plants health. It is in this context of uncertainty that the Precautionary 
Principle has to be invoked38 as directly applicable, extracting from it a set of legal 
consequences in the regulatory field (and specifically in REACH -European Union's 
  2010.                   Available                   at қججФ
s.  Regulation    
Nanopart Res 12:1959–1970. 
35  HSE research fundings: 
- The imbalance at EU level has been underlined by the Commission Communication from at <<Nanosciences 
and Nanotechnologies: An action plan for Europe 2005-2009. Second Implementation Report 2007-2009>>- 
Commission Staff  Working  Document.  29.10.2009.  SEC(2009)1468.  {COM(2009)607final} At  Chapter  1; 
Milieu / RPA Stakeholders Conference <<Nanomaterials on the Market What Regulators Need to Know>> 
Brussels. 9.10.2009. At 10. Available at http://www.nanomaterialsconf.eu/further-information.html (Accessed 
November 2010). 
It has to be underlined that the Commission has placed a considerable focus on research projects related to HSE 
in the FP07. For a detailed review of projects see European Commission DG Research (2008) <<Workshop on 
research   projects   on   the   safety   of   nanomaterials:   reviewing   the   knowledge   gaps>.   Available   at 
ftp://ftp.cordis.europa.eu/pub/nanotechnology/docs/final_report.pdf. 
- Furthermore, most research programmes are still in the very early stages and it will be a long way down the 
road before comprehensive information is available (lead times of “several decades” could easily be involved) to 
give a clear picture of what risks the different manufactured nanoparticles may pose. Royal Commission on 
Environmental Pollution -RCEP- (2008). 
36  The nanoscale world is so small that we can't directly see or experience it, neither imagine it, so inevitably, fear 
is a natural human reaction in front of the unknown. Based on this added difficulty, it is interesting to note the 
efforts done to “ visualize” this world. This objective links nanotechnology and art in a deeper way than any 
other of the new emerging technologies. One project worth mentioning is the “Visualization Laboratory project”, 
who's goal is  to  create and  study  effective and  innovative visualization techniques  for  understanding  and 
experiencing the nanoscale.  http://www.nisenet.org/viz_lab. 
Fears can also came from science fiction in nanotechnology, see Milborn, C (2002) <<Nanaotechnology in the 
Age of Posthuman Engineering: Science Fiction as Science>> Configurations 10: 261 – 295; Lopez, J (2004) 
<<Bridging the Gaps: Science Fiction in Nanotechnology>> HYLE – International  Journal  for Philosophy of 
Chemistry. 10(2): 129 – 152. 
37   The Commission has repeatedly stressed the need of “identify and resolve safety concerns (real or perceived) at 
the earliest possible stage” See Communication (2004) COM(2004) 338 final At 1.3; Communication from the 
Commission <<Preparing for our future Developing a common strategy for Key enabling technologies in the 
EU>> COM(2009) 512 final 30.09.2009. At 1.8. 
38   In this sense Lin, A. C. <<Size matters: Regulating nanotechnology>>. Harvard Environmental Law Review. 31: 
349 – 408. At 384. 
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1907/2006) that we will analyse further on39. 
   
As we have seen so far, the nanotechnology debate is filled with uncertainty (over 
terminology,  methodologies,  HSE  risk,  risk  assessment,  quantity  and  quality  of 
products in the marketplace, on future developments of nanomaterials, etc.) and it is 
within this framework that regulators needs to set up a balance regulation capable of 
ensuring safety without hindering technological development. 
 
 
On the following sections we will be analysing the EU policy on N & N and consider 
whether those objectives are reached, but it is important to underline once more the 
complexity of such a task: 
 
 
<< (...) appropriate regulation of nanotechnology will be challenging. The term “nanotechnology” 
incorporates a broad, diverse range of materials, technologies, and products, with an even greater 
spectrum of potential risks and benefits. This technology slashes across the jurisdiction of many existing 
regulatory statutes and regulatory agencies, and does so across the globe. Nanotechnology is developing 
at an enormously rapid rate, perhaps surpassing the capability of any potential regulatory framework to 
keep pace. Finally, the risks of nanotechnology remain largely unknown, both because of the multitude of 
variations in the technology and because of the limited applicability of traditional toxicological 
approaches such as structure-activity relationship (SAR) to nanotechnology products.>>40 
                           
39   Remission is made to the Precautionary Principle in Part II. Section 1. 
40   Marchand, G., Abbot, K.W., Sylvester, D.J.  (2009) <<What does the History of Technology Regulation Teach 
Us about Nano oversight?>>. Journal  of Law, Medicine & Ethics. Winter 2009. 724-731. At. 724 Available at 
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1470446. (Accessed February 2011). 
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PART II: NANOMATERIALS REGULATION IN THE EUROPEAN UNION 
  
 
1. REGULATORY OPTIONS AND THE PRECAUTIONARY PRINCIPLE 
  
 
Regulatory regimes are designed (almost by definition) to handle regulatory concerns 
existing at the time of promulgation and, as a consequence, emerging technologies often 
exacerbate or create regulatory gaps41. In other words, regulatory systems are badly 
equipped to respond to new technologies. In fact, it could be seen as logical to expect 
that the emergence of nanotechnology creates regulatory gaps. 
 
 
As the actual regulatory regime (that we will be presenting in the following Section) 
applicable to Nanotechnology and Nanomaterials (N&N) was not designed for 
nanomaterials is, (up to some point) inadequate. Following STOKES (2009)42, there are 
two broad reasons for this inadequacy; 
–       Nanomaterials may escape regulation either because the same materials in 
conventional -bulk- form are themselves outside the remit of legislative control43, or 
where their uses are so new that they fall outside the prescribed definition of a 
“regulated” substance44. 
–        Provisions  fails  to  address  the  fact  that  nanomaterials  can  have  unique 
properties. The legislation is designed from the assumption that an analogy can be made 
between materials in their nano and bulk forms. The reported failure is caused by 
placing inappropriate thresholds45 or inappropriate read-across46. 
 
 
In the following sections we will be presenting firstly, the regulatory option open to 
  
41   Mandel, G. N. (2009) <<Regulating Emerging Technologies>>. Law, Innovation & Technology. 1: 75 – 87. 
Available at  http://papers.ssrn.com. Abstract 13556748. (Accessed April 2011). 
42    Stokes, E. (2009) <<Regulating nanotechnologies: sizing up the options>> Legal Studies, 29 (2): 281 – 304. 
43   This was the case with carbon and graphite for instance. Regulation 987/2008. 
44    This is a problem not specific to nanomaterials but with the completeness of any given legislation. 
45    Inappropriate thresholds: Legislation establishing thresholds can be found in a variety of sectors, from consumer 
products (electrical equipment, foodstuffs or cosmetics by limiting or prohibiting  the content  of potentially 
hazardous substances) to chemicals (REACH minimum threshold) or waste (setting maximum concentrations or 
upper limits to emissions and discharges). 
The problem is that the thresholds have been established taking in consideration the bulk-scale substance only. 
While the safety of a substance (so risk management) is determined by production volume, nanomaterials toxicity 
may better be assessed taking into consideration other characteristics as size, aggregation and agglomeration 
state, chemical composition, shape, solubility, surface area and others. See Part I. Section 1 from this Report. 
46    Inappropriate read-across: Situation in which information on bulk-scale materials is incorrectly extrapolated and 
applied to nanomaterials. This is caused by inappropriate data read-across (suppliers inappropriately choose not 
to assign a classification to nano-scale substance, or assign a classification which fails to convey their potential 
hazardousness or by inappropriate methodological read-across (basically related with the limitations encountered 
by the risk assessment of nanomaterials). 
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regulators and secondly the interplay of the Precautionary Principle. 
   
It is for the regulator to decide the regulatory regime and how to modulate it but, in the 
European Union legal context, we understand that the interpretation given by the 
European Courts to the Precautionary Principle is placing specific obligations to the 
regulators that may guide their regulatory option (or its timely implementation). 
 
 
A) REGULATORY OPTIONS 
  
 
Faced with a “(nano) regulatory deficit” four broad different strategies can be identified: 
  
 
(1) “Wait and see”: Nanomaterials are not new materials. The existing regulatory 
situation is adequate. If scientific evidence indicates the need for modification, the 
regulatory framework will be adapted. 
 
 
(2) Differentiated approach: The Differentiated approach can be defined as a regulatory 
process which uses existing legislative structures to the maximum together with the 
need of reviewing and amending (when appropriate, on a case by case basis and for 
specific nanomaterials and their applications) existing legislation (including the 
development of a specific guidance and standards to support existing regulation) and the 
introduction of supplementary policy. When a high potential risk is identified, the 
precautionary principle has to be invoked47. 
 
 
In any case, this approach have to be supplemented by: 
 
• Support of research initiatives on HSE issues (esp. on exposure, dose-response, 
toxicology, and ecotoxicology); 
• Promotion of risk assessment throughout the life cycle of a nanotechnology 
including conception, R&D, manufacturing, distribution, use, and disposal—not 
only at the macro, ecological level but also within the human body, as in the case 
of drug delivery devices; 
47    European Commission (2004) <<Nanotechnologies: A Preliminary Risk Analysis On The Basis Of A Workshop 
Organized In Brussels On 1–2 March 2004 By The Health And Consumer Protection Directorate General Of The 
European Commission, European Commission (2004) – At. 22. Available at 
http://europa.eu.int/comm/health/ph_risk/events_risk_en.htm (Accessed April 2011); Widmer, M., Meili, C., 
Mantovani, E., Porcari, A. (2010) <<The FramingNano Governance Platform: A New Integrated Approach to the 
Responsible Development of Nanotechnologies>>. Final Report. Available at http://www.framinhnano.eu/ 
(Accessed January 2011). 
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•    Setting-up of a dialogue among all stakeholders; 
 
• International  coordination:  within  recognized  international  bodies,  working 
group on nanotechnology have been set up to coordinate efforts among subjects 
involved in regulation of nanotechnology at different levels. 
 
 
It could be said that the differentiated approach is, at least, a pragmatic solution48 that 
can help in the recasting and adaptation of the actual regulatory framework. In addition, 
its implementation can be more efficient (time and resources wise), and focused to 
address the environmental, health and safety concerns of nanotechnology and its 
application. 
 
 
But because the “differentiated approach” is multi-layered and flexible in design, a 
consistent implementation roadmap is vital. Without it, we will be faced with loose 
measures that could lead to greater legal uncertainty49. 
 
 
The EU regulation strategy is known as the <<safe, integrated and responsible>> 
strategy to nanotechnologies and is based on the so called <<incremental approach>> 
that (at least on its general approach) can be broadly included on the Differentiated 
Approach mainstream. 
 
 
The Commission's <<incremental approach strategy>> can be summarized50 as follows: 
 
48    This pragmatic approach implies that if in the short term the differentiated approach is followed, it does not 
exclude that in the longer term, a new regulatory framework could be set up, after allowing the technology to 
develop while regulators, industry and society continually re-evaluate regulation in light of the evolving scientific 
evidence and of citizen concern. In this sense, Bowman, D., Hodge, G., A., (2007) <<Nanotechnology “Down 
Under”: Getting on Top of Regulatory Matters>>. Nanotechnology Law and Business. 4: 225-235. At 235. 
49    The Royal Commission on Environmental Pollution when defining the key qualities that a governance system 
must comply states: <<4.11 (...) Effective and trustworthy governance arrangements must therefore have al least 
four key qualities. They must be informed, transparent, prospective and adaptive. To achieve these characteristics 
they  also  need  to  be  supported  by  skilled  regulatory  bodies  and  decision-making  processes  that  deliver 
proportionate  outcomes>>.  Royal  Commission  on  Environmental  Pollution  (RCEP)  (2008).  For  the  basic 
meaning of those key qualities see Brown, S. (2009) <<The New Deficit Model>>. Nature Nanotechnology. 4: 
609 – 611. 
50    <<3.4.4. Regulation 
Appropriate and timely regulation in the area of public health, consumer protection and the environment, is 
essential, also to ensure confidence from consumers, workers and investors. Maximum use should be made of 
existing regulation. However, the particular nature of nanotechnologies requires their re-examination and possible 
revision. A proactive approach should be taken. Advancing knowledge in nanosciences through R&D at both 
European and national level should form the basis for further action in this direction. 
Aside from ensuring consistency and avoiding market distortions, harmonised regulation plays a key role in 
minimising risk and ensuring health and environmental protection. Existing regulation relies frequently upon 
parameters  that  may  turn  out  to  be  inappropriate  for  certain  applications  of  nanotechnology,  e.g.  loose 
nanoparticles. For example, thresholds are often defined in terms of production volumes or mass, below which a 
substance may be exempt from regulation. The relevance of such thresholds should be revisited and, when 
appropriate, changed.>> (COM(2004) 338 final. At 3.4.4). <<The Precautionary Principle, as used up to now, 
could be applied in the event that realistic and serious risks are identified>> (COM(2004) 338 final At. 3.5.1). 
23 
a) Appropriate, consistent and timely regulation; 
 
b) Maximum use of existing regulation; 
 
c) Proactive approach by re-examination and reviewing legislation due to the 
especial characteristics of nanomaterials and the updated scientific information; 
d) Ensure free movement of goods by regulatory harmonization. 
 
 
For being able to assess the intensity and extent of the European Union policy and 
regulation towards the Differentiated approach, we previously need to present the 
European Union policy and regulation, task that will be done in the following sections. 
 
 
(3) Nano specific regulation: The existing regulatory situation is not adequate and the 
effort needed for adapting it could surpass the benefits. For this main reason, it may be 
better to set up a mandatory nano-specific regulation. 
 
In this sense, HANSEN (2010) states: 
<<at some point, regulatory agencies worldwide will have to address the question of whether it is not 
more effective to implement a new more authoritative and prescriptive legislative framework compared to 
having to implement a forever-increasing number of smaller and larger adaptations to existing legislation 
while simultaneously trying to overcome the limitations of chemical risk assessment.>>51 
 
 
We consider that in the medium to long term, the recourse to a nano-specific regulation 
may be advisable, but as per today, it is not a solution if our objective is to tackle, as 
soon as possible, the regulatory deficits related with health, safety and environmental 
concerns caused by nanomaterials (HSE). 
 
 
This opinion is based on several factors that have to be taken into consideration, among 
them, the complexity of the proposed task52, the increased regulatory agenda53, and the 
51    HANSEN considers that the new regulatory framework should be based on fundamental principles such as 
protection of health and the environment, promoting green innovation, and having a high level of transparency 
and multi-stakeholder participation. As REACH, the burden of proof should be placed on the industry. Also 
propose a nanoagency. HANSEN, S.F. (2010) <<A global view of regulations affecting nanomaterials>>. WIREs 
Nanomedicine and Nanobiotechnology. 2: 441- 449. At 449; Also see EEB (2009) <<Small scale, big promises, 
divisive messages>>. Position paper on nanotechnologies and nanomaterials. February 2009. At 7. 
52    To design an overarching regulatory framework that implies multiple sectors and products its not only complex 
but also will be time consuming, have to involve all stakeholders, etc. In this sense, it is advisable to analyse in 
detail the legislative process followed with REACH (from the White Paper on European Union Chemical Policy 
to the actual REACH Regulation) that can be considered as a model of new regulatory governance. This is one of 
the reasons for choosing REACH as a Case Study in the context of the present report. 
53    Van Calster points out that in addition to HSE issues the following topics are being incorporated to the regulatory 
agenda: 
- The requirements imposed by modern environmental and consumer protection law on the regulation of new 
technologies.  This  includes  the  precautionary  principle  (while  contested,  this  principle  at  any  rate  applies 
generally in European environmental law), liability for environmental damage, etc.; 
- The public participation principles of international and European environmental law, as exemplified by the 
Aarhus process: access to information, public participation, access to the courts; 
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uncertainty regarding projected applications54. 
   
(4) Moratorium: Until a regulatory framework is created or the existing legislation is 
adapted, a moratorium must be put in place on the release of nanomaterials and the use 
of nanotechnology applications55. The European Commission has explicitly rejected this 
approach: 
<<Despite some calls for a moratorium on nanotechnology research, the Commission is convinced that 
this would be severely counter-productive. Apart from denying society the possible benefits, it may lead 
to the constitution of “technological paradises”, -where research is carried out in zones without regulatory 
frameworks and is open to possible misuse-. Our consequent inability to follow developments and 
intervene under such circumstances could lead to even worse consequences>>56. 
 
 
B) THE PRECAUTIONARY PRINCIPLE 
 
  
From the regulatory option reviewed, we have seen that, perhaps only for pragmatic 
reasons,  most  governments  are  currently  relying  on  existing  regulation  to  cover 
potential  risks  related  to  nanomaterials.  Identifying  the  appropriate  response  to 
uncertain risks is a difficult task for policy-makers and regulators as they have to seek a 
compromise between conflicting interests (innovation, safety, free movement of goods, 
environmental protection, etc.). 
 
 
Within this framework, the Precautionary Principle may guide decision-makers to 
balance those goals, so helping them in the shaping of a proper regulatory regime for 
nanomaterials. 
 
 
In this section we will focus on the interpretation and scope that the European Courts 
have given to  the  Precautionary Principle  and,  from  there,  we  will  advance some 
specific legal consequences that its application may have for the EU nanomaterials 
  
- Other requirements of international environmental governance, such as the plight of developing countries and 
the need to avoid what the Commission calls a “knowledge apartheid”; 
- The application of international trade law, in particular the law of the World Trade Organization. 
Van  Calster,  G.  (2006)  <<Regulating Nanotechnology  in  the  European  Union>>.  Nanotechnology Law & 
Business. 3: 359 – 374. At 369. 
54    Projected applications with the greatest impact are far in the future (remission is made to Part I of this report), and 
it is unclear how to regulate technologies whose feasibility is speculative at this point. 
55    For moratorium see Friends of the Earth Europe (2007) <<Nanotechnology and the current legislation – Position 
Paper>>. 
56    European  Commission (2004)  Communication from the  Commission: <<Towards a  European  Strategy  for 
Nanotechnology>>. COM(2004) 338 final. At. 20 
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regime in general, and for REACH particularly. 
   
The Precautionary Principle is not included in Article 114 of TFEU (which is the legal 
basis of European chemical regulation), but in the field of European environmental 
policy (Article 191.2 of the TFEU) 
 
 
Art 191 TFEU (ex article 174 TEC) 
 
1.- (...) 
 
2.- Union policy on the environment (...) shall be based on the precautionary principle and 
on the principle that preventive action should be taken, that environmental damage should 
as a priority by rectified at source and that polluter should pay>>. 
  
The European Court of Justice has not only broadened its scope but established it as 
 
General Principles of Community Law57. 
   
Although the concept do not have a generally agreed definition58 and no definition is 
  
57    Artegodan GmbH v. Commission (Joined Cases T-74/00, 76/00, 83/00, 84/00, 85/00, 132/00, 137/00 and 141/00) 
[2002] ECR II-4945. 
<<183. Therefore, although the precautionary principle is mentioned in the Treaty only in connection with 
environmental policy, it is broader in scope. It is intended to be applied in order to ensure a high level of 
protection  of  health,  consumer  safety and  the  environment  in  all  the  Community's spheres  of  activity. In 
particular, Article 3(p) EC includes ‘a contribution to the attainment of a high level of health protection’ among 
the policies and activities of the Community. Similarly, Article 153 EC refers to a high level of consumer 
protection and Article 174(2) EC assigns a high level of protection to Community policy on the environment. 
Moreover, the requirements relating to that high level of protection of the environment and human health are 
expressly integrated into the definition and implementation of all Community policies and activities under Article 
6 EC and Article 152(1) EC respectively. 
184. It follows that the precautionary principle can be defined as a general principle of Community law requiring 
the competent authorities to take appropriate measures to prevent specific potential risks to public health, safety 
and the environment, by giving precedence to the requirements related to the protection of those interests over 
economic interests. Since the Community institutions are responsible, in all their spheres of activity, for the 
protection of public health, safety and the environment, the precautionary principle can be regarded as an 
autonomous principle stemming from the above mentioned Treaty provisions.>> 
58    The COMEST Report after reviewing precautionary principles' concept and capturing the key elements to the 
principle, propose a working definition that we consider that embraces the different aspects presents on the 
precautionary principle: 
<<When human activities may lead to morally unacceptable harm that is scientifically plausible but uncertain, 
actions shall be taken to avoid or diminish that harm. 
Morally unacceptable harm refers to harm to humans or the environment that is 
• threatening to human life or health, or 
• serious and effectively irreversible, or 
• inequitable to present or future generations, or 
• imposed without adequate consideration of the human rights of those affected. 
The judgement of plausibility should be grounded in scientific analysis. Analysis should be ongoing so that 
chosen actions are subject to review. 
Uncertainty may apply to, but need not be limited to, causality or the bounds of the possible harm. 
Actions are interventions that are undertaken before harm occurs that seek to avoid or diminish the harm. Actions 
should be chosen that are proportional to the seriousness of the potential harm, with consideration of their 
positive and  negative consequences,  and  with an assessment of the moral implications of both  action and 
inaction. The choice of action should be the result of a participatory process.>> 
UNESCO (2005) <<COMEST Report. The Precautionary Principle>>. World commission on the Ethics of 
Scientific Knowledge and Technology. At. 14. 
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included on the Treaties59, the Commission and the European Courts have given their 
definitions. 
 
 
The  European  Commission  issued  on  2  February  2000  a  Communication  on  the 
 
Precautionary Principle, where the principle was defined60: 
  
 
<<Although the precautionary principle is not explicitly mentioned in the Treaty except in 
the environmental field, its scope is far wider and covers those specific circumstances 
where scientific evidence is insufficient, inconclusive or uncertain and there are indications 
through preliminary objective scientific evaluation that there are reasonable grounds for 
concern that the potentially dangerous effects on the environment, human, animal or plant 
health may be inconsistent with the chosen level of protection.>>61 
 
 
Although the Communication has been criticized as being “so vague and imprecise that 
is only a good guide for arbitrariness or paralysis”62, the basic guidelines for the 
application of the precautionary principle in Community law are, from the Commission 
point of view; 
–        Once the existence of a risk is known, a scientific evaluation -risk assessment- 
(as complete as possible) has to be obtained in order to know the objective evidence, 
the gaps in knowledge and the scientific uncertainties; 
– Based on this evaluation, decision makers will determine whether to trigger 
action based on the precautionary principle balancing the potential consequences of 
inaction and of the uncertainties of the scientific evaluation. Transparency and societal 
involvement is fundamental as will assist policy makers in determining the risk 
management measures63  to  be  taken  and  society's desired  level  of  precaution  and 
59    The first legislative definition of the principle can be found in Regulation (EC) No 178/2002 of the European 
Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food 
law, establishing the European Food Safety Authority and laying down procedures in matters of food safety. O J L 
31/1 1.2.2002, where the Precautionary Principle is defined as a <<(...) mechanism for determining risk 
management measures or other actions in order to ensure the high level of health protection chosen in the 
Community>> (Recital 21). 
60    Communication from the Commission on the precautionary principle. COM (2000) 1 of 2.2.2000. 
61    Ibid. At. 10. The Communication has four aims: to outline the Commission's approach to using the precautionary 
principle, to establish Commission guidelines for applying it, to build a common understanding of how to assess, 
appraise, manage and communicate risks that science is not yet able to evaluate fully, and to avoid unwarranted 
recourse to the precautionary principle as a disguised form of trade protectionism. The Communication also 
sought to provide an input to the (then) ongoing debate on the issue, both within the Community and 
internationally. 
62   Recuerda, M. A., <<Dangerous interpretations of the Precautionary Principle and the foundational values of 
European Union Food Law: Risk versus Risk>>. At 29. Available at  http://ssrn.com/abstract=1305545. (Accessed 
March 2011). 
63    The application of the precautionary principle and risk management measures have to be based on a set of 
principles: proportionality, non-discrimination, consistency, cost-benefit analysis and examination of scientific 
development. Communication from the Commission on the precautionary principle. COM (2000) 1 of 2.2.2000. 
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protection. 
   
In the Communication on Regulatory Aspects of Nanomaterials (COM(2008)366final) 
the Commission specifically stated the applicability of the Precautionary Principle to 
nanomaterials64. 
 
 
Obviously, the Communication could not determine the application of the precautionary 
principle by the European Court and, in fact, their role has greatly contributed to the 
development  of  the  precautionary  principle,  not  only  on  a  definition  but  also 
determining when, how and by whom the principle may be relied upon in Community 
legal order. 
 
 
The European Court of Justice developed in the BSE judgement (Case 180/96) what it 
had become the general definition of the Precautionary Principle within the EC65 by 
holding that: 
  
<<99. Where there is uncertainty as to the existence or extent of risks to human health, the 
institutions may take protective measures without having to wait until the reality and seriousness 
of those risks become fully apparent.>> 
 
The above passage lays down three basic conditions for the application of the 
precautionary principle in Community law: uncertainty, risk, and lack of direct causal 
link66. 
 
 
In the Pfizer case (T-13/99)67, the Court defined the terms in which the principle can be 
 
At. 18. 
64    <<Where the full extent of a risk is unknown, but concerns are so high that risk management measures are 
considered necessary, as is currently the case for nanomaterials, measures must be based on the precautionary 
principle>>. 
65    Although giving shape to the precautionary principle, the BSE judgements did not refer to the principle as such. 
The first explicit reference in a curt ruling has been made in the Bergaderm case (Case C-353/98) at 52. 
66    Christoforou, T. (2001) <<The origins, content and role of the precautionary principle in European Community 
Law>> At. 25. Proceedings of the Conference <<The Role of Precaution in Chemical Policy>>. Diplomatic 
Academy Vienna. 15 and 16 November 2001. Federal Ministry of Agriculture, Forestry, Environment and Water 
Management. Freytag,E., Jakl, T., Loibl, G., Wittmann, M. Ed. 2001. 
67    Case T-13/99, Pfizer v. Council (2002) ECR p. II-3305, paras 143-144. Following Alemanno, we can consider the 
Courts statement as a procedural requirement for a valid application of the principle. This was repeated on the 
Case C-41/02 Commission v Netherlands para 53: <<a proper application of the precautionary principle 
presupposes, in the first place, the identification of the potentially negative consequences for health of the 
proposed addition of nutrients, and, secondly, a comprehensive assessment of the risk to health based on the most 
reliable scientific data available and the most recent results of international research>>. Alemanno, A. (2007) 
<<The shaping of the Precautionary Principle by European Courts: From Scientific Uncertainty to Legal 
Certainty>>. Bocconi Legal Studies Research Paper  No. 1007404. Cahiers Europèens, Halley.Valori 
Costituzionali    e    nuove    politiche     del     diritto.     L.    Cuocolo,     L.    Luparia,    eds.    Available    at 
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invoked: 
 
“ […] a preventive measure cannot properly be based on a purely hypothetical approach to the risk, 
founded on mere conjecture which has not been scientifically verified … Rather, it follows from the 
Community Courts’ interpretation of the precautionary principle that a preventive measure may be taken 
only if the risk, although the reality and extent thereof have not been ‘fully’ demonstrated by conclusive 
scientific evidence, appears nevertheless to be adequately backed up by the scientific data available at the 
time when the measure was taken”. 
  
 
This principle can therefore be validly applied only in situations in which; 
 
– There  is  a  risk,  notably  to  human  health,  that  have  not  been  scientifically 
confirmed (has not yet been fully proved), but it is not founded in mere 
hypotheses. 
– The precautionary principle’s invocation requires a prior objective evaluation of 
the existing scientific relevant studies68. 
  
Furthermore, an attempt at defining the threshold triggering the invocation of the 
precautionary principle, was done in Case C-41/02 Commission v The Netherlands 
(para 54) by stating: 
“when it proves to be impossible to determine with certainty [after having undertaken the prescribed 
comprehensive risk assessment] the existence or extent of the alleged risk because of the insufficiency, 
inconclusiveness or imprecision of the results of studies conducted, but the likelihood of real harm to 
public health persists should the risk materialize, the precautionary principle justifies the adoption of 
restrictive measures” 
 
 
That means that under EC law precautionary action may be taken if; 
 
a) precondition: undertaking risk assessment. 
b) scientific uncertainty. 
c) likelihood of real harm should the risk materialize. 
   
Once reached this point, and faced with the scientific uncertainties surrounding 
nanomaterials, it is important to reproduce the statement made by the European Court of 
Justice in “Alpharma” where a new attempt to set up a threshold trigger for the 
Precautionary Principle was adopted: 
 
173. Second, it is common ground between the parties that, when the precautionary principle is 
applied, it may prove impossible to carry out a full risk assessment, as defined at paragraph 169 
 
http://ssrn.com/abstract=1007404.At 11. (Accessed January 2011). 
68   However, even after the Pfizer judgement, the threshold of risk which must be established by a Member State in 
order to validly take precautionary action would seem to remain largely undefined. Only a negative condition has 
been laid down in the Court’s case law: it is insufficient to rely on hypothetical considerations to establish 
scientific uncertainty. That means that the main condition triggering the application of the principle, scientific 
uncertainty, can be shown only at the end of an assessment of risk Alemanno, A. (2007) At 11. 
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above, because of the inadequate nature of the available scientific data. A full risk assessment may 
require long and detailed scientific research. The case-law cited at paragraph 152 above shows that 
unless the precautionary principle is to be rendered nugatory, the fact that it is impossible to carry 
out a full scientific risk assessment does not prevent the competent public authority from taking 
preventive measures, at very short notice if necessary, when such measures appear essential given 
the level of risk to human health which the authority has deemed unacceptable for society. 
174. In such a situation, the competent public authority must therefore weigh up its obligations and 
decide either to wait until the results of more detailed scientific research become available or to act 
on the basis of the scientific information available. Where measures for the protection of human 
health are concerned, the outcome of that balancing exercise will depend, account being taken of 
the particular circumstances of each individual case, on the level of risk which the authority deems 
unacceptable for society. 
 
 
 
So it have to be concluded that if decision-makers considers that nanomaterials poses an 
unacceptable risk (on the bases of the limited scientific information available), they 
have to positively act to address it. Once reached this conclusion and before developing 
the consequences of it, we turn now specifically to REACH and the Precautionary 
Principle. 
 
 
Article 1,3 REACH establishes the application of the Precautionary Principle: 
 
<<3. This Regulation is based on the principle that it is for manufacturers, importers and 
downstream users to ensure that they manufacture, place on the market or use such substances that 
do not adversely affect human health or the environment. Its provisions are underpinned by the 
precautionary principle.>> 
  
And based on this article, and following the Commission, specific provisions can be 
found as practical applications of the principle like safety assessment, risk management 
measures, and in the authorization and restriction of substances69. 
 
It can also be interpreted that the overarching character of the Precautionary Principle 
covers three principles specific from REACH: “no data-no market principle”, 
“substitution principle” and “producer responsibility principle”70. 
 
69    - Safety assessment: If there is uncertainty over scientific evidence (e.g. conflicting data exist), the safety 
assessment should normally be based on the evidence that gives rise to highest concern. 
- Risk management measures: While a company is awaiting further test data on a particular hazard it should make 
sure that the risk management measures appropriate for the potential risk are in place and describe these measures 
in the safety assessment; in the case of PBTs and vPvBs, industry is requested to minimise exposure at all times. 
- Authorisation: Industry is required to seek authorisation for uses of substances of very high concern (SVHC, 
such as endocrine disruptors, PBTs, etc.), regardless of the measures taken to control the risks; in some cases, the 
authorisation is granted only if there are no alternatives, again regardless of the measures taken to control the 
risks. 
-  Restrictions:  Member  States  and  the  Commission  can  suggest  immediate  restrictions  in  case  there  are 
indications of severe risks associated with the use of a given chemical. In this way the PP could be implemented 
in cases where it would take too long to establish the data necessary for a scientific evaluation or where data does 
not allow the risk to be determined with sufficient certainty. 
Commission of the European Communities (2007) <<Questions and Answers on REACH>>. Available at 
http://ec.europe.eu/environment/chemicals/pdf/qa.pdf. (Accessed May 2011). 
70    The Producer Responsibility Principle implies a fundamental change of policy by which all major responsibilities 
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From the revision of the basic interpretation and triggering factors for the application of 
the Precautionary Principle by the Court and the consequences of its inclusion in art 1,3 
of REACH, we conclude that the conditions needed for the application of the 
Precautionary Principle appear to be met for engineered nanoparticles and the products 
incorporating them: Risk of serious and irreversible damage to health and the 
environment deemed unacceptable to society, supported by solid and objective scientific 
reasons, even if uncertain. 
 
 
Therefore, the European public authorities are not only allowed but compelled to take 
provisional measures to anticipate the potential occurrence of these risks, and that those 
measures must be based on general principles of risk management (and must be 
proportionate, non-discriminatory, consistent, based on an examination of benefits and 
costs of action or lack of action, and on an examination of scientific developments). 
 
 
When discussing on the specific legal consequences of the above conclusion, and 
regarding nanomaterials, the following measures71 can be envisaged: 
 
 
•    To act in order to avoid or minimize possible risks and not to be satisfied with 
 
(just) monitoring the development; 
 
• To  take  into  account  the  possible  effects  of  nanotechnology already in  the 
definition of EU policies72; 
• Provide funding for research on toxicology and ecotoxicology in order to allow 
complete scientific evaluation of the potential adverse effects, based on the 
available data, and carried out by independent authorities. 
• Organizing the collection of information about manufactured nanoparticles and 
nanomaterials, their properties, their manufacturers, their uses, and the people 
are placed  with firms rather  than  on  administrative bodies.  Companies marketing substances  falling under 
REACH must ensure that along the production chain dangers to health and environment will be mastered 
throughout all intermediate and final users of the substance or the product containing the substance. 
The responsibility shift affects principally manufacturers and importers but it extends to all parts of the supply 
chain and to the whole life cycle of the product. Commission of the European Communities (2001) <<White 
Paper. Strategy for a future Chemicals Policy>>. COM (2001) 88 final. 27.2.2001. At 8). 
71    When discussing the character of the measures to be taken, it is important to recall, as done by the Commission 
<<recourse to the precautionary principle does not necessarily mean adopting final instruments designed to 
produce legal effects. A wide range of activities or measures can be used, like legally binding measures, initiation 
of research projects or recommendations>>. Commission of the European Communities (2008) <<Regulatory 
Aspects of Nanomaterials>>. COM(2008)366final. 17.6.2008. 
72    Haselhaus, S. (2009) <<Nanomaterials and the Precautionary Principle in the EU.>>. J Consum Policy. 33: 91 – 
108. At. 96 – 97. 
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potentially exposed. This requirement can be met by the setting up of a 
compulsory inventory or reporting scheme that could be designed within 
REACH, but not necessarily73. 
  
  
 
  
 
  
 
  
 
  
 
  
 
                                       
73    REACH could help to collect the information needed (although limited by the regulatory gaps) but changes have 
to be done if an inventory has to be created. The need and design of a nanomaterials inventory is discussed in the 
Chronology section of this report. See Desmoulin, S. (2008) <<French and European Community Law on the 
Nanometric forms of Chemical substances: Questions About How the Law Handles Uncertain Risks>>. 
Nanotechnology Law & Business. 5 (3): 341 – 352. At 348. 
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2. EUROPEAN UNION REGULATION: THE QUEST 
  
 
In order to assess the European Union regulation strategy on Nanotechnology and 
 
Nanomaterials (N & N) we need to follow a three step process: 
 
– We   start   by   presenting   the   complex   set   of   applicable   legislation   for 
nanomaterials in the European Union; 
– Once presented, we will need to know how the European Union approaches 
N&N policy and regulation. For doing so, we have chosen a chronological 
approach that permits us, firstly, to be exhaustive on its presentation and, 
secondly, to present the different actors in the scene and their respective 
contribution to the making of the regulatory regime individually. 
– Finally,  we  will  be  presenting  the  foreseen  short  term  developments  for 
nanosubstances policy and regulation that will give us clues on the future 
developments on nanotechnology regulation design. 
 
 
With  all  these  data  in  mind,  we  will  be  able  to  propose,  in  the  final  section,  a 
preliminary assessment on the European Union quests for a regulatory regime. 
  
A) APPLICABLE LEGISLATION TO NANOMATERIALS IN THE EUROPEAN 
UNION. 
   
General Framework 
   
There are no specific regulations for nanotechnologies or nanomaterials at EU level. 
Instead, the manufacture, use and disposal of nanomaterials are covered, at least in 
principle, by a complex set of existing regulatory regimes. This situation will probably 
not change (in the near future at least) as the current and expected applications of 
nanotechnologies are so diverse that they can fall within such a broad field of industrial 
and commercial sectors (and in any of their life cycle stages), that the design of an 
overarching specific regulation seams an extremely complex and time consuming task74. 
    
74    In this sense, it is important to recall that the lack of a nano-specific legislation measures does not mean that 
nanotechnologies are an entirely unregulated enterprise. Their regulation falls to existing provisions designed to 
manage risks associated with conventional, bulk-sized materials. Van Calster, G. (2006). At 359. 
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A review of the applicable legislation to Nanotechnology and Nanomaterials (N & N) 
was presented by the Commission on its <<Communication on Regulatory aspects of 
nanomaterials>>, that was heavily criticized by the European Parliament afterwards. 
 
 
Following  the  Commission   Communication75   presentation,  it   can  be  said  that 
 
Nanomaterials are covered under current EU laws by; 
  
 
1.- Chemicals, namely REACH, that provides an over-arching legislation applying to 
the manufacture, placing on the market and use of substances on their own, in 
preparations or in articles. REACH also complements current product regulations (e.g. 
Cosmetics or general product safety). 
 
 
REACH does not cover explicitly nano materials. However, as REACH applies to 
substances on their own, in preparations or in articles, it covers areas in which 
nanomaterials are being used76. 
 
 
The general assessment was:77 
<<The Commission will carefully monitor the implementation of REACH with respect to nanomaterials. 
Based on information regarding production and marketing, or new knowledge, for instance regarding 
toxicological or physical-chemical properties, current provisions, including quantitative triggers and 
information requirements may have to be modified.>>. 
 
Basically it can be seen a policy of “wait and see” without rejecting the possibility of 
legal  modifications  if  needed  as  a  consequence  of  new  scientific  data,  or  if  the 
regulatory gaps are considered to be too inadequate (“based on information regarding 
production and marketing”). 
 
 
2.- Health and safety of workers; The general requirements in relation to occupational 
safety  and  health  of  workers  at  workplaces  are  presented  in  the  EU  Directive 
89/391/EEC78. The  aim  of  this  framework  directive  is  to  ensure  a  high  level  of 
protection of workers at work – including those exposed to nanomaterials - through the 
 
75    The Communication is backed by the Commission Staff Working Document where a summary of legislation can 
be found and where we remit. Commission of the European Communities (2008) <<Regulatory Aspects of 
Nanomaterials>>. Commission Staff Working Document. Summary of legislation in relation to health, safety and 
environment aspects of nanomaterials, regulatory research needs and related measures. SEC(2008)2036. 
COM(2008)366final. 17.6.2008. 
76    We remit to Part III of the present research paper. 
77     COM(2008) 366 final. At 2.1. 
78    Council Directive 89/391/EEC of 12 June 1989 on the introduction of measures to encourage improvements in 
the safety and health of workers at work, Official Journal of the European Communities L, 29.06.1989, pp. 1-8. 
http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31989L0391:EN:HTML 
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implementation of preventive measures to guard against exposure to risks, and through 
provision of information, consultation, balanced participation and training of workers 
and their representatives. 
 
 
The framework Directive foresees the possibility of adopting individual directives 
including more specific provisions in relation to particular aspects of safety and health 
and workplace exposures. Relevant directives thus adopted relate to risks related to 
exposure to carcinogens or mutagens at work79, risks related to chemical agents at 
work80, the use of work equipment by workers at work81, the use of personal protective 
equipment at the workplace82 and safety and health protection of workers potentially at 
risk from explosive atmospheres83. 
 
 
3.- Product requirements (for health and safety of workers, consumers and protection of 
 
79    Directive 2004/37/EC of the European Parliament and of the Council of 29 April 2004 on the protection of 
workers from the risks related to exposure to carcinogens or mutagens at work (Sixth individual Directive within 
the meaning of Article 16(1)  of Council Directive 89/391/EEC)  (codified version), Official Journal  of the 
European Communities L 158, 30.4.2004, pp. 50-76, 
http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:158:0050:0076:EN:PDF 
80    Council Directive 98/24/EC of 7 April 1998 on the protection of the health and safety of workers from the risks 
related to chemical agents at work (fourteenth individual Directive within the meaning of Article 16(1) of 
Directive 89/391/EEC), Official Journal of the European Communities L 131, 5.5.1998, pp. 11-23. 
http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:1998:131:0011:0023:EN:PDF 
Because Directive 98/24/EC presents minimum requirements, the European Trade Union Confederation (ETUC) 
demanded nano specific measures: <<6.- Occupational health and safety issues: Workers might be exposed to 
dispersive nanomaterials throughout the life cycle of nanomaterials (manufacture, production, use, maintenance 
and disposal). In the coming years millions of employees might be impacted. The ETUC demands the 
development of concrete measures at the workplace in order to know who is exposed, to what extent and to what 
type of nanomaterials, and which prevention measures to install to avoid exposure.>>. European Trade Union 
Confederation -ETUC- 2010 <<2nd resolution on nanotechnologies and nanomaterials. Adopted at the Executive 
Committee on  1-2  December  2010>>.  Available  at  http://www.etuc.org/. (Accessed April  2011);  See  also 
European Agency for Safety and Health at Work -EU OSHA- (2009) <<Workplace exposure to nanomaterials>> 
June   2009.  Available  at   http://osha.europa.eu/en/publications/literature_reviews/workplace_exposure_to_nanoparticles. 
(Accessed April 2011). 
81    Council Directive 89/655/EEC of 30 November 1989 concerning the minimum safety and health requirements for 
the use of work equipment by workers at work (second individual Directive within the meaning of Article 16 (1) 
of  Directive  89/391/EEC),  Official  Journal  of  the  European  Communities  L  393,  30.12.1989,  pp.  13-17. 
http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31989L0655:EN:HTML 
82    Council Directive 89/656/EEC of 30 November 1989 on the minimum health and safety requirements for the use 
by workers of personal protective equipment at the workplace (third individual directive within the meaning of 
Article 16 (1) of Directive 89/391/EEC), Official Journal of the European Communities L 393, 30.12.1989, pp. 
18-28, accessed on 13 November 2008. 
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31989L0656:EN:HTML 
83    Directive 1999/92/EC  of the European Parliament and  of the Council of 16 December 1999  on minimum 
requirements for  improving the  safety and  health  protection  of  workers potentially  at  risk from explosive 
atmospheres (15th individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC), Official 
Journal of the European Communities L 23, 28.1.2000, pp. 57- 64, accessed on 13 November 2008. 
http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2000:023:0057:0064:EN:PDF 
The general assessment of the Commission was that <<The Framework Directive and the above mentioned 
daughter Directives present a comprehensive package of legal requirements aiming at ensuring a high level of 
protection  of  workers  health  and  safety.  The  requirements,  whilst  they  do  not  make  explicit  mention  of 
nanomaterials and nanotechnologies, define a legislative framework that applies to most occupational risks 
including those arising from the presence of nanomaterials>> Commission of the European Communities (2008) 
<<Regulatory Aspects of Nanomaterials>>. Commission Staff Working Document.    SEC(2008)2036. 
COM(2008)366final. 17.6.2008. At. 11 
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the environment): 
 
• Groups of products: plant protection products84, biocides85, cosmetics, aerosol 
dispensers, medicinal products86, cars, etc.; 
• Food legislation: general food law, novel food87, food contact material, food 
additives, food supplements, feed legislation; 
• General Product Safety Directive on consumer products not covered by specific 
regulation88 and Product Liability Directive (related with defective products)89. 
 
 
4.- Environment: directives on Integrated Pollution Prevention and Control (IPPC), 
major accidents (Seveso II Directive), water, waste (mention has to be made to electric 
and  electronic  equipment  -EEE90),  air  quality,  soil  protection  and  environmental 
84    The general assessment of the Commission was that <<Directive 91/414/EEC concerning the placing of plant 
protection products on the market, lays down rules and procedures for approval of the active substances at EU- 
level. (…). Directive 91/414/EEC does cover nanomaterials adequately in its current form. However, current 
guidance documents (on data requirements, risk assessment and decision making) could need to be amended in 
order  to  properly  address  risks  to  nanomaterials>>.  Commission  of  the  European  Communities  (2008) 
<<Regulatory Aspects of Nanomaterials>>. Commission Staff Working Document.    SEC(2008)2036. 
COM(2008)366final. 17.6.2008. At. 11 
85    For an overview of the pesticides and biocides Directives and their regulatory regime for nanomaterials, see 
Haselhaus, S. (2010) <<Risk Management of Nanomaterials: Environmental and consumer protection under 
existing EC legislation on Chemicals, pesticides and biocides>>. Environmental Law Review. 12: 115 – 131. 
86    From a regulator´s point of view, nanotechnology applications in the pharmaceutical and medical device sector 
are not only spread across a number of sectors but, increasingly, products combine multiple modes of action, 
thereby making strict and clear categorization difficult (between medical products, medical divides and advanced 
therapies medicinal products) while current regulatory pathways from those sub-sectors are clearly differentiated. 
Another distinct characteristic is that pharmaceutical regulation has already the highest level of safety and 
environmental care standards as compared with other sectors. Chowdhury, N. (2010) <<Regulation of 
nanomedicines  in  the  EU:  destilling  lessons  from  the  advanced  therapy  medicinal  products  approach>>. 
Noanomedicine. 5 (1): 135 – 142; D'Silva, J., Van Calster, G. (2009) <<Taking Temperature – A Review of 
European Union Regulation in Nanomedicine>>. European Journal of Health Law 16: 249 – 269. 
87     On 29.03.2011 the final conciliation meeting on the Novel Foods Directive Recast failed and the legislative 
process will have to start again. Opinion of the Commission pursuant to Article 294, paragraph 7, point (c) of the 
Treaty on the Functioning of the European Union, on the European Parliament's amendments to the Council's 
position regarding the proposal for a Regulation of the European Parliament and of the Council on novel foods, 
amending Regulation (EC) N° 1331/2008 and repealing Regulation (EC) N° 258/97 and Commission Regulation 
(EC) N° 1852/2001.  COM(2010) 570 final 2008/0002  (COD). Brussels, 11.10.2010;  Bergeson, L.L. (2011) 
<<European   Parliament   and   EU   Council   Fail   to   Reach  Agreement  on   Novel   Foods   Regulation>>. 
Nanotechnology Law Blog. 31.03.2011. Available at  http://nanotech.lawbc.com/2011/03/ (Accessed June 2011); 
Nanotechnology Industries Association News -NIA- (2011) <<Clone Wars – End of the Novel Foods Regulation 
Recast>>. 4.4.2011. Available at http://www.nanotechnia.org. (Accessed May 2011) 
88    Directive 2001/95/EC of the European Parliament and of the Council of 3.12.2001 on general product safety. OJ 
L11 2002. 
89   Council Directive of 25 July 1985 on the approximation of the laws, regulations and administrative provisions of 
the Member States concerning liability for defective products 85/374/EEC. OJ L 210, 7.8.1985, p. 29; See Ware 
A., Kelly, B. (2009) <<Nanotechnology and the European Product Liability Directive>> RAJPharma. April 2009 
213 – 216. Available at  www.rajpharma.com. (Accessed May 2011). 
90    The European Parliament (EP) approved on 24.11.2010 the recast of the “Restriction of Hazardous Substances 
(RoHS) Directive”, which restricts the use of certain hazardous substances in electronic and electrical equipment 
(EEE). The final approved Directive do not include (previous EP proposed) restrictions on nanosilver and long 
multiwalled carbon nanotubs. 
The final adopted texts includes Recital 16 where nanomaterials are cited as due for further scientific scrutiny. 
The results from scientific scrutiny will be discussed in the review of the Directive that will take place three years 
after the Directive Publication. European Parliament Procedure file available at 
http://www.europarl.europa.eu/oeil/file.jsp?id=5723432 (Accessed May 2011). Ref. Code COD/2008/0240; 
European Parliament Press release ref. 20101124IPR99509. Available at 
http://www.europarl.europa.eu/es/pressroom/content/20101124IPR99509/html/Parliament-votes-for-safer- 
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liability. 
   
The main conclusions drawn by the Commission were91: 
 
1) Current legislation covers “in principle” risks in relation to nanomaterials and risk 
can be dealt with under the current legislative framework; 
2)  Current  legislation  may  have  to  be  modified  in  the  light  of  new  information 
becoming available; 
3) The regulatory problems have to be found on implementation and enforcement 
shortcomings  caused  by  the  knowledge gap:  For  the Administration  to  implement 
current legislation or administrative decision, and for the manufacturer or employer to 
comply with their obligations it is basic to rely on adequate guidance or standards (test 
methods and risk assessment methods). 
The problem arises when the scientific basis to fully understand all properties and risks 
of nanomaterials is not sufficiently available (knowledge gap92). 
Similarly, from the enforcement perspective, authorities and agencies will have to pay 
attention to risk in relation to nanomaterials where production and marketing are subject 
to pre-market control (for instance medical products). 
 
 
EU regulations explicitly referring to nanomaterials 
   
Regardless of the assessment that the Commission and other Institutions have done on 
the degree of adequacy of the legal framework, the fact is that since 2008 we have seen 
an increasing regulatory activity related with nanomaterials. Basically, nano specific 
Recommendations (horizontal measures) and sectoral Regulations (within the above 
explained framework of non specific nano regulation). Those are: 
  
electronic-and-electrical-products (Accessed May 2011); Nanotechnology Industries Association News -NIA- 
(2010) <<European Parliament approved Agreement on EEE-Legislation>>. 24.11.2010. Available at 
http://www.nanotechia.org/global-news/european-parliament-approves-agreement-on-eee-legislation (Accessed 
April 2011) and (2011) <<RoHS Recast: Nanomaterials Escape Explicit Regulation>>. Available at 
http://www.nanotechia.org/global-news/rohs-recast--nanomaterials-escape-explicit-regulation   7.1.2011. 
(Accessed April 2011). 
91    COM(2008)366  final.  At  4.  <<Current  legislation  covers  in  principle  the  potential  health,  safety  and 
environmental risks in relation to nanomaterials. The protection of health, safety and the environment needs 
mostly to be enhanced by improving implementation of current legislation. The Commission and EU Agencies 
will therefore in the first place review current documents that support implementation, such as implementing 
legislation, standards and technical guidance with regard to their applicability and appropriateness to 
nanomaterials>>. 
92    So the need for a rapid improvement of the knowledge basis to support the work of regulators is underlined in the 
Communication: Particularly in areas underpinning risk assessment and risk management, such as data on uses 
and exposures throughout the lifecycle of nanomaterials or products containing nanomaterials, data on toxic and 
eco-toxic effects (as well as test methods to generate such data) and characterisation of nanomaterials. 
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HORIZONTAL 
 
Commission  Recommendation  of  2  February  2008  on  a  Code  of  Conduct  for 
responsible nanosciences and nanotechnologies research C(2008) 424 (2008/345/CE) 
OJ L116/46 of 30.04.200893 
 
Commission Recommendation of 18 October 2011 on the definition of nanomaterials 
(2011/696/EU). OJ L275/38 of 20.10.201194 
 
CHEMICALS 
 
Commission Regulation (EC) No. 987/2008 of 8 October 2008 amending Regulation 
(EC) No. 1907/2006 of the European Parliament and of the Council on the Registration, 
Evaluation, Authorization and Restriction of Chemicals (REACH) as regards Annexes 
IV and V, OJ L268/14 of 09.10.2008 by which Carbon and Graphite were removed from 
the exemption list from Annex IV REACH95. 
 
FOOD SECTOR 
 
Regulation (EC) No. 1333/2008 of the European Parliament and of the Council of 16 
December 2008 on food additives OJ L345/16 of 31.12.2008(Art 12). 
 
Commission Regulation (EC) No 450/2009 of 29.05.2009 on active and intelligent 
materials and articles intended to come into contact with food OJ L135/3 of 30.05.2009. 
 
Commission  Regulation  (EU)  No.10/2011  of  14.01.2011  on  plastic  materials  and 
articles intended to come into contact with food. OJ L12/1 of 15.01.2011 (Arts 9, 13 and 
14). 
 
Regulation of the European Parliament and of the Council on the provisions of food 
information to consumers COM(2011) 475 final 2008/0028 (COD). Expected to be 
published in the OJ before the end of 2011. 
 
COSMETICS 
 
Regulation (EC) No. 1223/2009 of the European Parliament and of the Council of 
30.11.2009 on cosmetic products (recast). OJ L342/59 of 22.12.2009 (Arts 2 Definitions 
at (K), Art 2 Definitions at 3, Art 13 Notification at (F) Art 16 Nanomaterials and Art 19 
 
93    See Part II Section B.5). 
94    See Part II Section B.8). 
95    Carbon and Graphite were on the Annex IV REACH list until October 2008, when they were removed from the 
exemption list by Regulation 987/2008. The reason for this decision is related with the reported possible health 
risk of carbon nanotubs. 
REACH does not differentiate between nano and bulk forms inaccurately assuming that the risk of a substance is 
the same as whatever scale. In fact, if the nano substance would be regarded as a separate substance from the 
bulk, then, there will not be need for the withdrawal from the exemption. The identified gap on substances of 
Annex IV and V could be filled by a clear distinction between the bulk and the nano substances and this could be 
done by considering both as different substances (so giving a different EINECS number) or if the substance has 
been already recognized as phase-in substance by giving an additional code to the CAS number (Chemical 
Abstract Service). 
It is important for Companies when setting up their R&D programmes to take into consideration a precautionary 
approach in their decisions. In the case of carbon nanotubs, the existence of <<concern over potential harm>> 
and the decision to withdraw the exception is clearly guided by precaution. In aligning the investment decision 
with the policy principle will make private decisions safer from possible future legal obligations derived from 
new scientific findings. Lee, R.G., Vaughan, S. (2010) <<REACHing Down: Nanomaterials and Chemical Safety 
in the European Union>>. ESRC BRASS Research Centre. Cardiff University. At 8. 
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Labelling)96. 
 
RoHS ELECTRIC AND ELECTRONIC EQUIPMENT 
 
Directive 2011/65/EU of the European Parliament and of the Council of 08.06.2011 on 
the restriction of the use of certain hazardous substances in electrical and electronic 
equipment. OJ L174/88 of 01.07.2011. (Recital 16). 
 
 
Although the objectives of this research study only allow us to analyze the 
Recommendations , -given its horizontal character-, we could make the following 
general comments: 
 
 
a) Deepens in the "incremental approach startegy" as it chooses to insert explicit 
regulation on nanomaterials in the sectoral legislation. 
 
 
b) The regulation is done through Regulations and Recommendations. The Regulations 
 
-directly applicable in Member States- confirms the intention of creating a regulatory 
framework (fully) harmonized at EU level. 
 
 
c) The use of Recommendations can be explained by the combined effect of a general 
trend towards better and smarter regulation (including co-regulation and self-regulation) 
97, and the pressure for regulating nanotechnology. Regulatory failures (regulatory gaps) 
 
has lead regulators and industry to develop soft law mechanisms98. 
   
In fact, Soft Law mechanisms are considered “one of the most promising management 
  
96    From a regulator's point of view, cosmetics pose a special challenge as cosmetic materials are in direct contact 
with the body and it does already exist some evidence which points towards potential adverse effects of the use of 
nanoparticles and therefore the precautionary principle should be applied. 
The New cosmetic legislation (Regulation (EC) No, 1223/2009) on cosmetic products entered into force on 
January 11, 2010 is the first European Union (EU) and include a dedicated provision expressly designed to 
review the safety of nanometerials. It provides a definition for the kinds of nanomaterials that are intended to be 
subject to the regulation, and  establishes a pre-market notification or authorization and specific safety and 
labelling requirements applicable to cosmetic products containing nanomaterials in addition to registration (will 
come into force in July 2013 -art 40-). Guix, M., Carbonell, C., Comenge, J., García-Fernádez, L., Alarcón, A., 
Casals, E. (2008) <<Nanoparticles for cosmetics. How safe is safe?>>. Contributions to Science, 4(2): 213 217. 
97    See White Paper on European Governance. COM(2001)428; The Interinstitutional Agreement on better law- 
making between the European Parliament, The Council and the Commission Interinstitutional Agreement on 
better law-making Commission Communication on Smart Regulation COM(2010) 543 final. 
98    Following Senden, Soft Law mechanisms can be defined as <<rules of conduct that are laid down in instruments 
which have not been attributed legally binding force as such, but nevertheless may have certain (indirect) legal 
effects, and that are aimed at and may produce practical effects>>. Senden, L. <<Soft Law in European 
Community Law>>. Volume 1 Modern Studies in European Law. Hart Publishing. 2004. at 112. 
Overall, it can be said that voluntary measures share similar principles and actions (due respect for precaution; 
priority on safety; raise/consider stakeholder awareness; inclusive approach) and goals (built trust and confidence 
in the technology; promoting health and environmental safety; gathering information). Mantovani, E., (2011) 
<<The role of voluntary measures in the governance of nanotechnologies: the case of the European Code of 
Conduct>>. AIRI/Nanotec IT. Euronanoforum 2011. Budapest. 30.05.2011. 
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strategies for ensuring safety and risk control in the short term”99 and a complement 
 
(or/and a prelude) to existing mandatory regulatory approaches100. 
   
d) Concerns over possible health impacts from certain nanomaterials have prioritized 
works on food/food packaging sector and cosmetics. 
 
 
e) Cosmetics Regulation includes three key features in the specific field for 
nanomaterials that mark a guide to follow for future legal developments in other sectors 
(pre-market notification or authorization, specific safety and labelling requirements and 
compulsory registration). 
 
 
B) EUROPEAN UNION NANOMATERIALS POLICY AND REGULATION 
   
B.1) Communication on the European Union Strategy. 2004 
   
The European Commission formally announced its intention to develop an integrated 
nanotechnology strategy for Europe in May 2004 in its Communication <<Towards a 
European Strategy for Nanotechnology>>101. 
 
 
The Strategy defined for the first time, the European policy on nanotechnology. The 
final goal was (by the establishment of integrated and coherent set of measures) to 
strike the right balance between; 
a) creating a good climate and conditions for innovation and development of 
applications, contributing to economic growth, welfare and sustainable 
development and, 
b) ensuring that potential risks to environment and human health, as well as 
public and ethical concerns, are looked into and dealt with at the earliest possible 
stage. 
    
99   Renn, O., Roco, M <<White paper...>>. At 18. 
100 They are described as <<interim measures to fill the current risk management gap before our knowledge of the 
emerging technologies and the associated risk measures are developed>> Widmer, M. & Others <<The 
FramingNano...>>. At 81. 
101 European  Commission  (2004)  Communication  from  the  Commission:  Towards  a  European  Strategy  for 
Nanotechnology>>. COM(2004)338 final. The strategy was subsequently reviewed and supported by the 
Competitiveness Council and the European Economic and Social Committee. Conclusions of the Competitiveness 
Council 24.09.2004; Opinion of the European Economic and Social Committee of 15.12.2004. 
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The Communication defined the EU policy as a <<safe, integrated and responsible 
strategy>> and established the following set of interrelated factors (for each one of 
them specific actions were indicated): 
a)  European  Research  Area,  facilities  and  resources  that  provide  essential 
services to the research community, attract and retain researchers in Europe; 
b) Foster industrial innovation; 
 
c) Health, Safety and Environmental (HSE) factors; 
 
d) Ethic, Legal and Social (ELSA) aspects; 
 
e) International cooperation 
  
 
As we have seen, and from a regulatory point of view, the Communication was defined 
as an <<incremental approach strategy>>. 
  
B.2) European Union Action Plan. 2005 
   
In June 2005, and after an extensive open consultation102, the European Commission 
adopted the Communication <<Nanosciences and nanotechnologies: An Action Plan for 
Europe 2005 – 2009>>103. 
 
 
In relation to the European strategy Paper, the Action Plan specified actions for the 
 
<<immediate implementation of a safe, integrated and responsible strategy for 
Nanosciences and Nanotechnologies (N&N)>> and outlines a number of specific 
commitments related with the actions envisaged on the 2004 Communication104. 
 
 
In addition to public health, safety, consumer protection and environmental issues, 
employees were added to the list of subjects to be of concern with regard to possible 
  
102  Nanoforum Report. December 2004.  http://www.nanoforum.org . The public consultation was the largest of its 
kind in Europa and have to be underlined that the emphasis placed on public engagement and consultation was 
and has been a consistent characteristic in the development of the nanotechnology policy in the EU. 
103  Communication   from   the   Commission  to   the   Council,   the   European   Parliament   and   the   ECOSOC 
<<Nanosciencies and nanotechnologies: An action plan for Europe 2005 – 2009>> COM(2005)243 final 
104  The Action Plan  also called on the Scientific Committee on Emerging and Newly Identified Health Risks 
(SCENIHR) to provide an opinion on the ability of existing risk assessment methodologies to extend to 
nanotechnologies. The SCENIHR opinion, entitled <<The appropriateness of existing methodologies to asses the 
potential risks associated with engineered and adventitious products of nanotechnologies>> was adopted in 
September 2005. Following public consultation, this opinion was subsequently revised and the modified version 
adopted in March 2006. Adopted by the SCENIHR during the 10th plenary meeting of 10.03.2006. 
The Action Plan also called upon the European Group on Ethics in Science and New Technologies to examine the 
ethical aspects of nanomedicine, a commitment that was fulfilled in January 2007. EGE Opinion No. 21 from 
17.01.2007. 
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regulatory efforts, and specifically, the Commission endorser the compromise of: 
 
<< d) Examine and, where appropriate, propose adaptations of EU regulations in relevant sectors in light 
of the above paying particular, but not exclusive, attention to (i) toxicity thresholds, (ii) measurement and 
emission thresholds, (iii) labelling requirements, (iv) risk assessment and exposure thresholds and (v) 
production and import thresholds, below which a substance may be exempt from regulation, are typically 
based upon mass quantities.>>. 
 
On the Action Plan the Commission was taking a pro-active role on HSE related 
aspects: Although REACH was still under discussion, it looks like the Commission was 
adapting a stricter interpretation of the “no data – no market” principle from the one that 
was finally adopted in art. 5 of REACH. The Commission states: 
 
<<Appropriate ex ante  assessment should be carried out and risk management procedures elaborated 
before e.g. commencing with the mass production of engineered nanomaterials. Particular attention 
should be paid to products that are already or close to being on the market>>. 
 
Above statement shows a leading policy will, underpinned by the precautionary 
principle that, as we will see, was lost afterwards. 
 
B.3) European Union Action Plan: First Implementation Report. 2007 
   
A first implementation report on the EU Nanosciences and Nanotechnologies Action 
 
Plan was adopted in September 2007105. 
   
The  Commission   identified  public  health,  safety,  environmental  and  consumer 
protection as the main regulatory goals and acknowledged as a crucial problem the lack 
of data on health and environmental risks. 
 
 
Furthermore,  the  Commission  advanced  its  preliminary  opinion  on  the  regulatory 
review and concluded that: 
a) The existing legal framework was “in principle” addressing the regulatory 
issues related with nanomaterials106; 
b) Only in case of new scientific data or specific area regulatory needs, changes 
may be proposed; 
 
105  Communication   from   the   Commission  to   the   Council,   the   European   Parliament   and   the   ECOSOC 
<<Nanosciencies and nanotechnologies: An action plan for Europe 2005 – 2009. First Implementation Report 
2005 - 2007>> COM(2007) 505 final. 
106   COM(2007) 505 final. At 6.1: <<6.1. Regulatory review 
The Commission is finalising a review of current regulation, to establish whether new regulatory action is 
required to cover risks in relation to nanomaterials. Its initial finding is that current regulation addresses in 
principle concerns about health and environmental impacts. On the basis of scientific developments or regulatory 
needs in specific areas, regulatory changes may be proposed. In the course of this exercise, the EC will take 
account of reports on regulatory gaps produced in various Member States.>>. 
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c) Weakness were identified in the implementation of existing regulatory 
mechanisms. Updates of current texts could be envisaged (on implementing 
legislation,  standards  and  technical  guidance);  In  the  framework  of 
implementing legislation special attention should be placed to safeguard clauses 
or warning systems. 
 
 
Once this assessment was made, two conclusions were drawn by the Commission: 
 
1.- Up to the moment that the Commission and the Member States decide if 
regulatory changes and/or updates for improving implementation may be 
proposed, no further action has to be taken. 
 
<<In the meantime (...) existing methods will continue to be used (...) where necessary, existing 
regulatory mechanisms should be used>>. 
 
2.- The Commission knowledge that products on the marketplace containing 
nanomaterials can put consumers at risk. 
 
<<Particular attention must also be given to the various mechanisms that allow authorities and 
agencies in charge of implementing legislation to intervene, through measures such as safeguard 
clauses and warning systems, in case risk are identified for products already on the market>> 
   
B.4) Communication on Regulatory Aspects. 2008 
   
As announced on the Action Plan, the Commission undertook a regulatory review of the 
EU legislation in relevant sectors and was reflected on the <<Communication on 
Regulatory Aspects of Nanomaterials>>107. 
 
 
The Communication has been analysed in Part II, Section 2.A.1) where we remit in full. 
As stated there, the Commission presented the general framework of current legislation 
affecting nanomaterials and stated that it found the existing legislation in this field to be 
“in principle” sufficient. 
 
 
From this general conclusion, basically followed a three-tiered strategy on regulatory 
aspects: introducing minor changes to existing regulations if considered to be necessary, 
building up competence for risk evaluation and assessment (considered to be the basis 
for a proper implementation of current legislation, and of any administrative decision 
 
107 Communication from the Commission to the European Parliament and the ECOSOC “Regulatory aspects of 
nanomaterials”. C(2008)366 final. Also see the Commission Staff working document accompanying the 
Communication that includes a summary of legislation in relation to health, safety and environment aspects of 
nanomaterials, regulatory research needs and related measures; 
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and  manufacturer's  and  employer's  obligations)  while  engaging  in  a  transparent 
discourse with all stakeholders, including consumers and their organizations. 
  
B.5) EU Recommendation on a Code of Conduct. 2008 
  
 
On February 2008 the European Commission adopted (after public consultation108) a 
Code of Conduct for responsible research in nanosciences and nanotechnologies in a 
Recommendation (as such, not mandatory)109 and is one of the several initiatives which 
aim at regulating the field of nanomateriales on the basis of voluntary conduct110. 
 
 
The codes of conduct (in general) and the EU Code of Conduct in particular, it is not 
intended to supplant or delay regulation but to provide guidance on best practices 
during the transitional period in which the appropriate national and international 
regulatory frameworks are being evaluated and developed, and to complement existing 
regulation. 
 
 
The basic objective of the Commission was that universities, research institutes and 
companies in the EU signed up and undertake the promotions of an integrated, safe and 
responsible nanosciences and nanotechnologies research in Europe and to contribute to 
the coordination between Member States with a view to optimize synergies among 
research stakeholders. 
 
108  Towards a Code of Conduct for responsible nanosciences and nanotechnologies research consultation paper. 
Available at  http://ec.europa.eu/research/consultations/pdf/nano-consultation_en.pdf 
109 Commission Recommendation of 07.02.2008 on a code of conduct for responsible nanosciences and 
nanotechnologies research C(2008) 424 (2008/345/CE) OJ L116/46 of 30.04.2008; Nielsen, L. (2008) <<The 
Code of Conduct for responsible nanosciences>>. Available at http://ec.europa.eu/research/science- 
society/document_library/pdf_06/nielsen-l-presentation_en.pdf. (Accessed May 2011). 
110   In addition to the EU CoC there are other codes of conduct which directly or indirectly refer to nanotechnology. 
They differentiate themselves through their sectoral area of application as well as their target group: 
1) Responsible NanoCode (United Kingdom); 2) German NanoKommission; 3) The Swiss Retailers Association 
(IG DHS) Code of Conduct; 4) Other Industry codes of conduct/practices in line with the Corporate Social 
Responsibility (CRS): The ICCA (International Council of Chemical Associations) “Responsible Care Global 
Charter”,  the  BASF  “Code  of  Conduct  on  Nanotechnology”,  the  Bayer  “Code  of  Good  Practice  on  the 
Production and on-site-use of Nanomaterials”, and the DuPont “Nano Risk Framework, are telling examples of 
this type of initiatives. 
5) Certification systems: Closely related with Codes of Conduct it's interesting to mention the Certification 
systems, a further voluntary measure with regard to the regulation of nanotechnology: 1.- CENARIOS (first 
certificable risk management and monitoring system specifically adapted to nanotechnologies); 2.- Hohenstein 
Quality for Nanotechnology for the textile industry; 3.- Quality Seal Nano Inside (certifies that a certain product 
contains nano and that the applicant obliges itself to adhere to the Responsible Nanocode); 4.- Assured Nano 
(accredited scheme of best practice in HSE aspects and safe handling of nanomaterials). 
For further information:  http://www.responsiblenanocode.org/ ; Collinson, S.,  Alarcon, S., Park, B., Dorey, R., 
Rocks,  S.,  Friedrichs,  S.,Crossley,  R.,  Sutcliffe,  H.,  Grayson,  D.,  Pollard,  S.  (2010)  <<The  Responsible 
NanoCode>>.  International   Labmate.  35(6).  Available  at  http://www.labmate-online.com/. (Accessed  May 
2011). 
For the importance of soft law mechanisms and nanotechnology regulation see Part II, Section 2.A.2). 
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The   Code   of   Conduct   encompasses   seven   general   principles   (including   the 
Precautionary Principle)111, establishes a clear delimitation of research areas that should 
not be promoted112, and underline its concern with social and ethical implications of 
nanotechnologies in addition to risk issues. Perhaps the most practical result so far is 
that the EU Commission envisions applying the Code of Conduct itself as a guideline of 
its research policies in the area of nanotechnology113. 
 
 
It has been said that the principles underlying the European Code of Conduct are the 
ones to be underpinning a good governance of nanotechnologies114. 
 
 
In recognition of the fact that the CoC has received a very low interest among 
stakeholders,  it  was  launched  in  January  2010  a  two  years project  (FP7)  entitled 
<<NanoCode: a multistakeholder dialogue providing inputs to implement the European 
Code of Conduct for Nanosciences and Nanotechnologies Research>>, with the 
objective of improving and strengthening awareness of the CoC115. 
 
111  Namely: Sustainability, Precaution, Inclusiveness, Excellence, Innovation and Accountability. 
The Code does not contain any suggestion, guidelines, checklists, indicators or further ideas covering its 
operationalization or implementation. In addition, the principles are formulated in an open manner, leaving large 
discretion for interpretation. See note 117. 
The Commission considers that in parallel with the Code of Conduct the promotion of a balanced diffusion of 
legal information on nanosciences and nanotechnologies is fundamental: << 4.3.2 In addition to the existence of 
this Code of Conduct, N&N research funding bodies should make sure that N&N researchers are aware of all 
relevant legislation, as well as ethical and social frameworks>>. COM(2008) 424 final. 
112    <<Prohibition, restrictions or limitations 
4.1.15 N&N research funding bodies should not fund research in areas which could involve the violation of 
fundamental rights or fundamental ethical principles, at either the research or development stages (e.g. artificial 
viruses with pathogenic potentials). 
4.1.16 N&N research organisations should not undertake research aiming for non-therapeutic enhancement of 
human beings leading to addiction or solely for the illicit enhancement of the performance of the human body. 
4.1.17 As long as risk assessment studies on long-term safety is not available, research involving deliberate 
intrusion of nano-objects into the human body, their inclusion in food (especially in food for babies), feed, toys, 
cosmetics and other products that may lead to exposure to humans and the environment, should be avoided.>> 
COM(2008) 424 final. 
113   This is not stated in the Recommendation but indicated on the Consultation Paper from the Commission when 
opening the Consultation process prior to the adoption of the Recommendation: <<This Code of Conduct would 
take the form of a European Commission Recommendation and would invite the Member States, industry, 
universities (...) to follow its principles. The Commission itself would follow these principles in its own action 
under the Community research policy>>. Commission of the European Communities consultation paper (2008) 
<<Towards a Code of Conduct for responsible nano sciences and nanotechnologies research>>. Available at 
http://ec.europa.eu/research/consultations/pdf/nano-consultation_en.pdf At 1. (Accessed May 2011). 
114 Widmer, M., et Al. (2010). At 53. 
115  The  NanoCode  consortium  involves  partners  from  eight  European  countries  (Germany,  UK,  France,  The 
Netherlands, Italy, Spain, Switzerland, the Czech Republic) and two Associated Countries (South Africa and 
Angentina). 
On September 2010 the consortium published the <<Synthesis report on codes of conduct, voluntary measures 
and practices towards a responsible development of N&N>>. The report basic information is the individual 
country Reports covering the CoC in their own country. 
For Spain, the Country Report states: 
<<As resulted by the analysis made for the preparation of the Spanish Country Report, the EC CoC has not being 
implemented either at national or regional level. 
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The Code of Conduct is meant to be revised every two years116. Following this 
provision, the revision process is under way and is now waiting for the Commission 
final proposal. 
 
 
In October 2011 the NanoCode Consortium released the final report including 
recommendations for the further development and implementation of the CoC and 
stressing the need for a fundamental revision of the current Code117. 
 
 
B.6) European Parliament Resolution on Regulatory Aspects of Nanomaterials. 2009. 
  
 
On the 24th April 2009 the European Parliament issued a Resolution118 in response to 
 
However, some N&N centres and platforms have developed or are developing their own codes of conduct or 
practical guides, based on good practices in nanosafety. Most of these documents are confidential, still as drafts, 
or have not yet been implemented. 
Interestingly, standard procedures for R&D funding of public research organisations requires that projects 
involving research on humans, the use of their personal data or human biological samples, experiments on 
animals or the use of biological agents or genetically modified organisms not only have to comply with the 
requirements established for each case by law, but must also be specifically authorized by the Ethics Committee 
of the Centre where the research is carried out. No specific aspects of N&N are taken into account, unless the 
research involves any of the above mentioned cases. 
A considerable effort has been made in the last years in Spain to increase the level of knowledge, development 
and involvement in N&N, but still remains a lack of information and coordination between all interested parties 
working in this field>>. 
<<Among the institutions developing such measures can be cited the CIBER-BBN (http://www.ciber-bbn.es) , the 
Nanotechnology Platform at Parc Científic Barcelona (http://www.pcb.ub.es/homepcb/live/en/p905.asp/), the 
Institute for Bioengineering of Catalonia (IBEC) for nanomedicine applications (http://www.ibecbarcelona.eu), 
the Institute of Nanoscience of Aragon (http://ina.unizar.es/index.php), the Institut Català de Nanotecnologia 
(http://www.icn.cat), Tecnologia Navarra de Nanoproducts S.L. (TECNAN) (http://www.tecnan-nanomat.es), 
Grupo Antolín (http://www.grupoantolin.com), Fundación Leia (http://www.leia.es), INASMET-Tecnalia 
(http://www.inasmet.es)>>. 
NANOCODE Project (2010) <<Synthesis report on codes of conduct, voluntary measures and practices towards a 
responsible development of Nanotechnology and Nanomaterials>>. September 2010. At 40. Available at 
http:”www.nanocode.eu/. (Accessed Feb. 2011). 
116   The need for a revision is not only stated in the Recommendation itself but also instructed by the Competitive 
Council of 25.09.2008 (12853/1/08 REV 1 RECH264 COMPET 311) 13672/08 <<invited>> the Commission to 
<<review and, as appropriate, amend its Recommendation by February 2010 and regularly thereafter, in close 
consultation with Member States, while taking into account the above considerations as well as the state of 
European competitiveness in the nanosciences and nanotechnologies and developments in this sector at European 
and global level, and then report back regularly to the Council and the European Parliament>>. 
The revision process started with an open consultation. The final report from the consultation concludes that the 
basic trends are that a vast majority (about 88%) thought that the CoC needs a revision, with more than 60% 
suggesting adaptation or change in the principles, that one third only (32,65%) think that prohibition of research 
in terms of fields should be extended and slightly more than 50% wish that research be more appropriately 
regulated and that three quarter of the respondents think that the CoC should not be limited to research. 
From the public consultation on the revision it has to be pointed out that the total amount of contributions was of 
49 (against 64 from the first consultation in 2007) from research (19), industry (18), policy makers (6) and Civil 
Society Organisations (6). 
117 In summary, the negative aspects were: lack of legitimacy, lack of practicability, stumbling blocks, lack of 
pressure, lack of communication and lack of commitment. Meili, C., Markus, W., Schwarzkopf, S., Montovani, 
E., Porcari, A. (2011) <<Master Plan: Issues and Options on the Path Forward With the EC Code of Conduct for 
Responsible N&N Research>> Final Version. October 2011. Available at  www.nanocode.eu. (Accessed October 
2011). 
118  European           Parliament          resolution           of           24          April           2009           on           Regulatory 
Aspects of Nanomaterials (2008/2208(INI) (2010/C 184 E/18) P6_TA(2009)0328. OJ C184E/82 of 8.7.2010 
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the    Commission's    Communication    of    2008    on    <<Regulatory   Aspects    of 
 
Nanomaterials>>. 
   
The Resolution was jointly submitted by the five main groups in Parliament  and with a 
virtually unanimous support119. 
 
 
The European Parliament acknowledges that the use of nanomaterials and 
nanotechnologies promises important advances with multiple benefits in innumerable 
applications and can make an important contribution to the competitiveness of the 
European Union's economy and to the achievement of the Lisbon strategy but, on the 
other hand, was very critical with the Commission handling of the nanotechnology 
policy and with the Communication on Regulatory Aspects in particular. 
 
 
The position and opinion of the European Parliament can be summarized in a sentence 
quoted from CARL SCHLYTER -rapporteur of the European Parliament Resolution120: 
 
 
<<The Commission's paper on nanotechnology considers that the current rules are adequate despite the fact that none 
of them are geared to the specific effects of nanotechnology. The Commission's analysis is based on a one- 
dimensional, legalistic overview of the current rules but those rules are about as effective in addressing 
nanotechnology as trying to catch plankton with a cod fishing net>>. 
 
The key issues raised by the European Parliament were121 
 
• Address explicitly nanomaterials in the scope of regulation of chemicals, 
food, and relevant worker protection and environmental protection; 
• Review   legislation   and   to   ensure   that   legislative  provisions   and 
instruments of implementation reflect the particular features of 
nanomaterials to which workers, consumers and/or the environment may 
be exposed. In particular, to evaluate the need to review REACH, waste 
legislation, air and water legislation and workers protection legislation 
• A comprehensive, science based definition, harmonized at the global 
level; 
 
 
119  362 votes in favour, 4 votes against and 5 abstentions. 
120  On the explanatory statement from the Resolution. Available at 
http://www.europarl.europa.eu/oeil/FindByProcnum.do?lang=en&procnum=INI/2008/2208. (Accessed  February 
2011). 
121  Brekelmans, C. (2009) <<Regulatory developments>> Presentation at the Swedish Presidency Nanotechnology 
Event <<Nanotechnologies for Sustainable Development>>. 12.11.2009. 
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• An inventory of different types and uses of nanomaterials on the market; 
 
• Better   information   to   consumers   by   mandatory   indicating   “nano 
ingredients” in labelling, regardless of risk. 
 
The extensive and detailed European Parliament Resolution tackles all the basic 
regulatory problems encountered on the nanotechnology EU approach to regulation, and 
it is worthwhile, following SINGHOFEN122 (2010) to present in more details the 
European Parliament Resolution: 
 
1. Lack of knowledge and information 
 
•  “The current situation is characterized by a significant lack of knowledge and information, leading 
to disagreement starting at the level of definitions” (recital F) 
•  “No clear information about the actual use of nanomaterials in consumer products“ (recital H) 
 
 
2. Worrying mix of lack of scientific data, market reality and regulatory inaction 
 
• “The scientific committees and Agencies of the European Union points to major deficiencies not 
only in key data, but even in methods of obtaining such data;” (recital K) 
• “Whereas  SCENIHR  identified  some  specific  health  hazards  as  well  as  toxic  effects  on 
environmental organisms for some nanomaterials” (recital L) 
• “Nanomaterials are already on the market, particularly in sensitive applications with direct 
exposure of consumers” (paragraph 4) 
• “Knowledge  about   potential   health   and   environmental  impacts   of   nanomaterials   lags 
significantly behind the pace of market developments in light of the very rapid developments in 
the field of nanomaterials…” 
• “…Thus raising fundamental questions about the ability of the current regulations to deal with 
emerging technologies such as nanomaterials in ‘real time’“ (recital N) 
  
3. European Parliament base line: Need for clear and explicit regulatory framework 
 
• “Is convinced that the use of nanomaterials should respond to the real needs of citizens,” 
 
• “That their benefits should be realized in a safe and responsible manner within a clear regulatory 
and policy framework (legislative and other provisions)” 
• “That explicitly addresses existing and expected applications of nanomaterials as well as the 
very nature of potential health, environmental and safety problems” (paragraph 1) 
  
4. European Parliament position: Disagrees with the Commission approach 
 
• “Does not agree …with the Commission's conclusions that 
 
122  Singhofen, A. (2010)  <<Overview of European  Parliament's  position  on  how  to  regulate nanomaterials>>. 
Presentation at the Workshop <<Towards as effective governance of nanomaterials>>. Workshop of the Belgian 
Presidency. Bruxelles. 14 September 2010. 
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a) current legislation covers in principle the relevant risks relating to nanomaterials, and 
 
b)  that  the   protection   of   health,  safety  and   the  environment  needs  mostly  be  enhanced   by 
improving implementation of current legislation” 
• “When due to the lack of appropriate data and methods to assess the risks relating to nanomaterials it is 
effectively unable to address their risks;” (paragraph 3) 
  
5.  European  Parliament  concern:  “Safe,  responsible  and  integrated  approach”  is 
jeopardized 
• Considers  that  the  concept  of  the  “safe,  responsible  and  integrated  approach”  to  nanotechnologies 
advocated by the European Union is jeopardized 
- by the lack of information on the use and on the safety of nanomaterials that are already on the market, 
 
- particularly in “sensitive applications with direct exposure of consumers” (paragraph 4) 
 
 
6. Review of all relevant EC legislation within 2 years 
 
•     “Calls on the Commission to review all relevant legislation within two years 
 
- to ensure safety for all applications of nanomaterials in products with potential health, environmental or 
safety impacts over their life cycle, 
- and to ensure that legislative provisions and instruments of implementation reflect the particular features 
of nanomaterials to which workers, consumers and/or the environment may be exposed” (paragraph 5) 
•     “The review … should implement the principle “no data, no market” for nanomaterials” (recital AA)123 
 
 
7. Explicit provisions for nanomaterials, public inventory and labelling 
 
• Considers  it  particularly  important  to  address  nanomaterials  explicitly  within  the  scope  of  at  least 
legislation on chemicals (REACH, biocides), food (foodstuffs, food additives, food and feed products from 
genetically modified organisms), relevant legislation on worker protection, as well as legislation on air 
quality, water quality and waste (paragraph 9) 
• Calls on the Commission to compile before June 2011 an inventory of the different types and uses of 
nanomaterials on the European market, while respecting justified commercial secrets such as recipes, and to 
make this inventory publicly available; furthermore calls on the Commission to report on the safety of these 
nanomaterials at the same time (paragraph 16) 
• Reiterates its call for the provision of information to consumers on the use of nanomaterials in consumer 
products: all ingredients present in the form of nanomaterials in substances, mixtures or articles should be 
clearly indicated in the labelling of the product (paragraph 17) 
 
 
There  is  no  doubt  that  the  European  Parliament  has  influenced  greatly  on  the 
   
123  Article 5 REACH. Basically the “no data, no market” means that chemical substances shall only be manufactured 
and placed on the market upon prior registration and submission of the necessary health, environmental and 
safety data to prove that a substance cause no harm. 
The application of the “no data, no market” to nanomaterials was explicitly requested by the European Parliament 
(Recital AA)  although  watering  down  previous  request  from  the  European  Parliament  Committee  on  the 
Environment, Public Health and Food Safety (at 7) and ONG's probably because a strict implementation of the 
principle to nanomaterials would mean, in practice, a moratorium. See (2008/2208 (INI)) PE 418.270v 02-00. 
AG-0255/2009.  Available  at  http://www.europarl.europa.eu/sides/getDoc?pubRef=-//EP//text+report+ag-2009- 
0255+0+DOC+XML+VO//EN; EEB (2009) At.8. 
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development and configuration of the N&N regulation since the Resolution was 
approved. The European Parliament has consistently adopted a proactive role by 
systematically proposing specific nano-provisions into various laws still under revision 
or already reviewed. 
  
 
B.7) European Union Action Plan: second Implementation Report. 2009 
  
 
In autumn 2009, the Commission issued its second implementation report on the Action 
Plan124. Regarding regulation the Commission just maintained its original position of 
considering the current legislation as adequate “in principle”, that a bigger effort had to 
be done in implementing actual regulations and, in addition, was open to consider 
whether regulatory change on specific aspects was necessary. 
  
Also recalled that “at the request of the European Parliament, specific provisions in 
relation to nanomaterials have been introduced or are being considered for legislation 
on cosmetics, novel food and food additives” and “as planned, the Commission will 
present an updated regulatory review in 2011, paying particular attention to the points 
raised by the European Parliament”. 
 
 
Besides the recognition that specific provisions has been approved “at the request” of 
the European Parliament, the Commission itself gave the lowest possible rating (“1- 
relatively little progress”) for its performance in launching initiatives, in promoting 
measures and/or issue recommendations to minimize worker, consumer and 
environmental exposure to nanoparticles. 
 
 
B.8) Commission recommendation of 18.10.2011 on the definition of nanomaterial 
   
At EU level, the efforts by the European Commission to release a legal definition of 
“nanomaterial” for regulatory purposes, started in 2009 with the European Parliament 
request   “for   the   introduction   of   a   comprehensive   science-based   definition   of 
     
 
124  COM(2009)607 final. and  Commision Staff Working Document SEC(2009)1468. 29.10.2009. 
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nanomaterials”125, that was followed in September 2010 by a draft Recommendation126, 
and, after long discussions127, finally crystallised in the Recommendation of 18.10.2011 
on the definition of nanomaterial128 that “should be used as a reference for determining 
whether a material should be considered as a “nanomaterial” for legislative and policy 
purposes in the Union”129. 
  
The Recommendation states: 
 
 
125  PA_T6(2009) 0328. The EP called for the introduction of a comprehensive science-based definition as part of 
nano-specific amendments to relevant horizontal and sectoral legislation. Also the Belgian Presidency of the 
Council called for the adoption of a definition. See Part II B.6) and C.2) of this research paper. 
126 In September 2010 the Commission released a draft Recommendation that for the first time defined the term 
“nanomaterial” with the objective of becoming an “overarching, broadly applicable reference term for any Union 
communication or legislation addressing nanomaterials” (at 12). 
Article 2 of that Recommendation stated: 
1. Nanomaterial: means a material(8) that meets at least one of the following criteria: 
- consists of particles, with one or more external dimensions in the size range 1 nm – 100 nm for more than 
1% of their number size distribution; 
- has internal or surface structures in one or more dimensions in the size range 1 nm – 100 nm; 
- has a specific surface are by volume greater than 60 m²/cm³, excluding materials consisting of particles 
with a size lower than 1 nm. 
2. Particle: means a minute piece of matter with defined physical boundaries (ISO 146446:2007) 
(8) The term “material” is replaceable with other terms for an object used in the specific legal context.>> 
Commission Recommendation of […] on the definition of the term “nanomaterial” C(20..) yyy final. Available at 
http://ec.europa.eu/environment/consultations/nanomaterials.htm (Accessed Nov. 2010). 
The long discussions leading to the adoption of the Recommendation project of September 2010 included a 
public consultation and the Commission's request of reports to the JRC (Lövestam et Al. 2010) and SCENIHR 
(2010) <<Opinion on the Scientific Basis for the Definition of the Term “nanomaterials”>> Adopted by The 
Scientific Committee on Emerging and Newly Identified Health Risks. Approved by written procedure on 
8.12.2010     Available     at     http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_032.pdf 
(Accessed January 2011). 
For a detailed analysis of the Recommendation project Juet, E. (2010) <<L'émergence d'une définition juridique 
de référence des nanomatériaux>> Available at http://www.nanonorma.org. (Accessed November 2011).   See 
also, Dana, D. A. (2010) <<Can the Law Track Scientific Risk and Technological Innovation?: The Problem of 
Regulatory  Definitions  and  Nanotechnology>>.  Northwestern  Public   Law  Research  Paper   No.  10-83. 
Northwestern    University    -    School    of    Law.    Available    at    http://papers.ssrn.com/sol3/papers.cfm? 
abstract_id=1710928. (Accessed January 2011). 
127  It can be said that the discussions focused on two areas: firstly, the very need to arrive at a definition and, 
secondly, on its content. 
As for the first question, the reasons backing the adoption of a definition (following Stamm, could be synthesized 
in the following: 
- Increasing social demand for regulating nanomaterials; 
- Political requirements from the European Institutions; 
- Principles of European Regulation: need to define what has to be regulated; 
- Removing uncertainties for industry and regulators on how to deal with nanomaterials; 
- Assuring equal treatment of nanomaterials in different types of legislation; 
- Enforceability of legislation. 
On the other hand, the arguments against a definition were: 
- Many attributes of possible significance (size, surface area, etc); 
- Large variety of nanomaterials; 
- No scientific evidence for strict limits regarding physico-chemical properties; 
- Experimental difficulties (lack of validated methods); 
- Size distribution/mixture; 
- False positive/false negative; 
- Scientific basis to reconcile with policy needs regarding enforceability; 
- Nanomaterials are not (intrinsically) harmful substances. 
Stamm,  H.   (2011)   <<The   Needs   to   Define   Nanomaterials   for   Regulatory  Purposes>>.  Available  at 
http://www.fooddrinkeurope.eu/uploads/events_documents/11._Hermann_Stamm_- 
_Nanomaterial_Definition.pdf (Accessed November 2011). 
The different positions were presented by Stamm and Maynard respectively, in two articles in Nature: Maynard, 
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1.   Member  States,  the  Union  agencies  and  economic operators  are  invited  to  use  the  following 
definition of the term "nanomaterial" in the adoption and implementation of legislation and policy 
and research programmes concerning products of nanotechnologies. 
2.   "Nanomaterial" means a natural, incidental or manufactured material containing particles, in an 
unbound state or as an aggregate or as an agglomerate and where, for 50 % or more of the particles 
in the number size distribution, one or more external dimensions is in the size range 1 nm - 100 nm. 
In specific cases and where warranted by concerns for the environment, health, safety or 
competitiveness the number size distribution threshold of 50 % may be replaced by a threshold 
between 1 and 50 %. 
3.   By derogation from point 2, fullerenes, graphene flakes and single wall carbon nanotubes with one 
or more external dimensions below 1 nm should be considered as nanomaterials. 
4.   For the purposes of point (2), "particle", "agglomerate" and "aggregate" are defined as follows: 
(a)    "Particle"    means   a    minute    piece    of    matter   with    defined    physical   boundaries; 
(b) "Agglomerate" means a collection of weakly bound particles or aggregates where the resulting 
external surface area is similar to the sum of the surface areas of the individual components; 
(c) "Aggregate" means a particle comprising of strongly bound or fused particles. 
5.   Where technically feasible and requested in specific legislation, compliance with the definition in 
point (2) may be determined on the basis of the specific surface area by volume. A material should 
be considered as falling under the definition in point (2) where the specific surface area by volume 
of the material is greater than 60 m2 / cm3. However, a material which, based on its number size 
distribution, is a nanomaterial should be considered as complying with the definition in point (2) 
even if the material has a specific surface area lower than 60m2/cm3. 
6.  By December 2014, the definition set out in points (1) to (5) will be reviewed in the light of 
experience and of scientific and technological developments. The review should particularly focus 
on whether the number size distribution threshold of 50 % should be increased or decreased. 
7.   This Recommendation is addressed to the Member States, Union agencies and economic operators. 
 
Synthetically, it can be said that the definition of nanomaterial is; 
 
a) Based only on the size130 without regard of hazard or risk: 
 
 
A. (2011) <<Don't define nanomaterials>>. Nature 475, 31; Stamm, H. (2011) <<Risk factors: Nanomaterials 
should be defined>>. Nature 476, 399. 
As for the second question, this is, the discussions surrounding with the different stakeholders positions, a general 
overview  can  be  found  at  http://www.euractiv.com/innovation/comissions-nano-policy-lost  definition-news- 
503665 and http://www.sciences-et-democratie.net/blog/2011/04/16/blocages-a-la-commission-europeenne- 
autour-de-la-definition-tant-attendue-des-nanoma. 
128  Recommendation 2011/696/UE OJ L275/38 of 20.10.2011 
Following Juet, we also consider that choosing a Recommendation is not a neutral election: “En premier lieu, il 
sera aisé pour la Commission de réformer sa définition sans passer par un processus législatif complexe. En 
second lieu, même si la recommandation ne lie pas, J-P. Jacqué rappelle que la CJUE a estimé “que les 
jurisdictions nationales devaient les utiliser comme instruments d'interprétation de mesures nationales adoptées 
pour leur mise en oeuvre ou lorsqu'elles viennent à l'appui d'autres mesures communautaires de caractère 
contraignant>>. Juet, E. (2010) <<L'émergence...>>. 
Previous to this Recommendation, at EU level we could only find a definition of “nanomaterial” in the specific 
context of the Cosmetic Products Regulation: Regulation (EC) No 1223/2009 on cosmetic products. OJ L 342, 
22.12.2009.  P.  59.  Article  2  provides  a  definition  of  nanomaterial  <<An  insoluble  or  biopersistent  and 
intentionally manufactured material with one or more external dimensions, or an internal structure, on the scale 
from 1 to 100 nm>>. 
129  Recital 4 of the Recommendation. 
130  The Commission has chosen to base the definition “solely on the size of the constituent particles of a material” 
(Recital 4) and not on nano-specific properties because it considers that “size” is the “only universally applicable, 
clear and measurable criterion”, for legal clarity and in order to avoid “circular reasoning” (as only would be 
possible  to  identify  whether  a  material  is  a  nanomaterial  after  the  testing  for  those  properties”).  See 
<<Nanomaterials. Questions and Answers on the Commission Recommendation on the definition of 
Nanomaterial>> http://ec.europa.eu/environment/chemicals/nanotech/questions_answers.htm#2. At 7. (Accessed 
October 2011). 
But, at the same time, the Recommendation underlines (Recital 6), that harmonised measurement methods for 
size (of the constituent particles) and for number size distribution (number of nanoparticles to total number of 
particles) has to be developed and that until harmonization is reached, “best available alternative methods should 
be applied”, without further clarification on which alternatives have to be considered as the “best available”. As 
stated on the Q & A document “The Commission intends to start work to provide practical guidance on 
measurement methods. This issue is also likely to be one of the subjects to be studied in further detail as part of 
the review planned for 2014” See <<Nanomaterials. Q & A>> At 9. See also at 14. 
For a very critical view on the size related criteria see Jasper, N. (2010) <<Nanomaterial Safety: The Regulator's 
Dilemma>>. European Journal of Risk Regulation. 3/2010. 270 – 274. 
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<<2. “Nanomaterial” means a (…) material containing particles (…) where (…) one or more 
external dimensions is in the size range 1nm – 100nm>>131. 
  
In addition, fullerenes, graphene flakes and single wall carbon nanotubes below 1 
nm have to be classified as nanomaterials: 
<<3. By derogation from point 2, fullerenes, graphene flakes and single wall carbon nanotubes with one 
or more external dimensions below 1nm should be considered as nanomaterials>>. 
  
b) Particle size distribution based in the number of particles (understood as number of 
nanoparticles to total number of particles)132. 
 
Alternatively, “where technically feasible and requested in specific legislaton”, particle 
size distribution may be determined on the basis of the specific surface area by volume 
133.  
In case of discrepancy between the measurement of the specific surface area and the 
number size distribution, the latter will prevail and it should not be possible to use 
specific surface area to demonstrate that a material is not a nanomaterial. 
 
131  As stated by the Commission, “There is no clear scientific justification for setting the thresholds at 1 nm and 100 
nm, as specific effects may also occur at a lower and higher size range. On the other hand, there may also be no 
specific effects of particles within the size range of 1 to 100 nm. Nevertheless, many of the described specific 
properties of nanomaterials are actually within that range. Therefore, in the absence of better arguments for other 
thresholds, the Commission decided to follow the most commonly applied approach, i.e. a size range between 1 
and 100 nm. This is also in line with the advice from SCENIHR and other scientific bodies, as well as with the 
size range used in the ISO term “nanomaterial” See <<Nanomaterials. Q & A>> At 8. See also Recital 8. 
Several CSOs (Citizents and  Social Organizations) -ANEC, BEUC and  Friend  of the Earth- denounce  the 
adoption of the upper limit of 100 nm that they consider too restrictive and points out that SCENHIR´s report 
already indicated the existence of toxicology studies on toxicity of submicron particles over 100 nm. For a 
general overview on the first reactions from civil society and chemical industry see Nanowerk News <<Adoption 
of the new definition of nanomaterials by the European Commission: first reactions and analyses>>. Available at 
http://www.nanowerk.com/news/newsid=23122.php. (Accessed October 2011). 
Juet E., analysing the draft Recommendation of September 2010 states that “la limite haute de 100 nm a été 
choisie en raison de la capacité, notamment rappelée par l'AFSSET dans son rapport de 2006 sur les 
nanomatériaux, des particules de dimension inférieure à 100 nm à franchir les barrières biologiques protégeant 
habituellement les tissus et organes” while the 1 nm limit “est justifiée par le CCR (JRC), dans son rapport de 
2010, par la nécessité de distinguer les nanomatériaux des atomes et molécules qui sont les constituants des 
substances qui à leur tour constituent en phase condensée les (nano) matériaux. Le CCR (JRC) rappelle que 
l'atome le plus large, le cesium, à un diamètre de 0,6 nm et que la plupart del molécules ont une taille inférieure 
au nanomètre” Juet, E. (2010) <<L'émergence...>> At. 2. 
132  The  Commission  considered  number  size  distribution  as  a  more  relevant  metric  for  possible  effects  of 
nanoparticles than mass concentration, following in this point the SCHENIR argument that "a low mass 
concentration of nanoparticles in a product may still represent a high number of particles and a mass based 
distribution  can  be  skewed  by  the  presence  of  relatively  few  large  and  thus  heavy  particles".  See 
<<Nanomaterials. Q & A>> At 9 and Recital 10. 
The chemical industry supported using weight concentration rather than particle number distribution to determine 
the cut-off criteria for nanomaterials. The consequences of having been chosen the metrics for measuring number 
size distribution is that “there are no validated testing methodologies which enable test to be reproducible and 
consistent. It will result in materials which have been on the market for a long time, such as pigments, fillers and 
certain contruction materials, being identified as nanomaterials”. See CEFIC <<Practical nanomaterials definition 
needed to push forward next great innovation breakthoughs>> htpp://www.cefic.org. (Accessed November 2011); 
RSC <<EU proposes nanomaterial definition>> http://www.rsc.org/chemistryworld/News/2011/October/21101101.asp. 
133  Recital 13: <<Ar present it is possible to measure the specific surface area by volume for dry solid materials or 
powders with the nitrogen adsorption method (“BET-method). In those cases the specific surface area can be used 
as a proxy to identify a potential nanomaterial. New scientific knowledge may expand the possibility to use this 
and other methods to other types of materials in the future>>. 
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c) Number size distribution general threshold of 50% for the proportion of particles 
within a material that have to be within the 1nm - 100nm range (for a material to be 
considered a nanomaterial). 
 
 
In specific cases and where warranted by concerns for the environment, health, safety or 
competitiveness the number size distribution threshold of 50 % may be replaced by a 
threshold between 1 and 50 %. 
 
 
If the particle size distribution is determined by specific surface area by volume, the 
threshold is set at 60m²/cm³. 
  
This has been, by far, the most surprising part of the Recommendation, as the 
Commission  has  largely  raised  the  proportion  of  nano-sized  materials  required  to 
qualify as nanomaterials: 50% or more of the particles in the number size distribution is 
50 times higher that the September 2010 draft Recommendation proposal (1%), 333 
times greater than the recommended by SCENIHR (0,15%) and even 5 times greater 
than the threshold proposed by the German industry134. 
 
 
The Commission justifies the 50% threshold “for practical consideration” and based “on 
the attempt of distinguish nanomaterials which may exhibit specific novel properties 
from conventional chemical substances”135. 
  
134 CIEL <<CIEL welcomes new EU definition of nanomaterials as a necessary step towards assuring safety>> 
http://ciel.org/CIEL/Chemicals_Program/Nano_EU_definitions_18Oct11.html.  (Accessed  October   2011). 
Possible the most critical view has been expressed by Friends of the Earth Australia: “If this definition were 
applied to regulation, it would mean that where 45% of particles are 95nm in size and 55% particles are 105nm in 
size, substances would not be regulated as nano. To put that another way, (…) even if nearly half a sample is in 
nano-form, it will trigger no new safety assessment or labelling. (…) In the workplace, there would be no 
expectation  that  Material  Safety  Data  Sheets  would  give  nano-specific  information. The  'loophole'  in  the 
European Commission definition that sayd “where warranted by concerns (…) below 50% may be set” will be 
ineffective in practice. It puts a huge burden of proof on to the community to demonstrate not only that certain 
nanomaterials can cause harm but that certain nanomaterials can cause harm as specific proportion of particles in 
a sample.” FRIENDS OF THE EARTH <<European Commission caves to industry pressure on nano definition, 
leave people and environment at risk>>  http://nano.foe.org.au (Accessed October 2011). 
135  As nanoparticles are present in low quantities in most solid  materials (for instance powders) and  a lower 
percentage could include too broad a range of materials within the definition. See <<Nanomaterials. Q & A>> At 
5 and Recital 11. 
Maynard considers that “this is a laudable attempt to handle materials comprised of different sizes. But it is 
unclear where the scientific basis for the 50% threshold lies, how this applies to aggregates and agglomerates, and 
how diameter is defined (there is no absolute measure of particle diameter – it depends on how it is defined and 
measured)”. On the contrary, some authors considers that the 50% benchmark appears not to be arbitrary. See 
Maynard, A. (2011) <<EC adopts cross-cutting definition of nanomaterials to be used for all regulatory 
purposes>> http://2020science.org/2011/10/18 (Accessed October 2011). 
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In addition, it is not clear who and how will be decided that the threshold might be 
reduced, neither is explained what “competitiveness” concerns means. 
  
d) Inclusion: 
 
–        incidental, natural and manufactured materials136; 
 
–        unbound particles, aggregates and agglomerates137; 
 
–        substances and mixtures 
   
e) Exclusions: 
 
– materials with internal structure or surface structure in the nanoscale (such as 
complex nano-components nanomaterials including nano-porous and nano-composite 
materials that are used in some sectors)138; 
–        final products139. 
 
–        Pharmaceutical and medical devices140. 
   
Given the broad scope of the definition, NIA considers that “a vast number of 
materials will be regarded as nanomaterials, for which manufacturers until today 
  
136 The focus on nanotechnology debate is on applications and products using “engineered” or “manufactured” 
nanoparticles. Engineered nanomaterials have to be distinguished from “natural” nanoparticles (those that occur 
in the environment -volcanic dust, lunar dust, mineral composites) and “incidental” nanoparticles (those that 
occur as the result of man made industrial processes -diesel exhaust, could combustion, welding fumes). Natural 
and incidental nanoparticles may have irregular or regular shape, while engineered nanoparticles most often have 
regular shapes, such as tubes, spheres or rings. Bell, T.E. (2006). 
Because the Recommendation only identifies a nanomaterial on the basis of its particle size regardless of hazard 
and risk and the “properties or risks posed by a nano-sized material are not determined by the intention of the 
manufacturer and do not differ depending on whether the nanomaterial is natural, produced incidentally, or the 
result of a manufacturing process with or without the explicit intention to produce a nanomaterial”, the 
Commission concludes that it would be “therefore not logical to omit certain types of materials on the basis of 
their genesis”. Having said that, it seams also logical that if “a specific piece of legislation only addresses 
manufactured materials, the same limitation would also apply to nanomaterials” (See <<Nanomaterials. Q & A>> 
At 6.) 
137  The reason for including agglomerated or aggregated particles is that they may exhibit the same properties as 
unbound particles and, additionally, there can be cases during the life-cycle of a nanomaterial where the particles 
are released from weakly bound  agglomerates or under certain conditions  even from more strongly bound 
aggregates. See <<Nanomaterials. Q & A>> At 10. 
138 Recital 14. The Commission did not include other types of nanostructured materials (materials with internal 
structure or surface structure in the nanoscale) such as nanoporous or nanocomposite. The reason being that there 
is not sufficient evidence to guide what materials should be included. See <<Nanomaterials. Q & A>> At 12. 
Maynard stresses that this king of complex nanostructured materials may present “unusual health and 
environmental  risks  -such  as  materials  with  biologically  active  structures  that  are  not  based  on  unbound 
nanoparticles (patterned surfaces, porous materials and nano-engineered micrometer-sized structures)”Maynard, 
A. (2011) <<EC adopts...>>. 
139 The Recommnedation's scope covers nanomaterials when they are substances or mixtures, but implicitly not 
when they are final products. This means that if a nanomaterial is used amongst other ingredients in a formulation 
the entire product will not become a nanomaterial. See <<Nanomaterials. Q & A>> At 13. 
140  Recital 17: <<Given the special circumstances prevailing in the pharmaceutical sector and the specalised nano- 
structured systems already in use, the definition in this Recommendation should not prejudice the use of the term 
“nano” when defining certain pharmaceutical and medical devices>>. 
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are not aware of, are not prepared to react and have not even started to collect 
information yet. (…) All companies working with material need to re-think 
whether and which of their materials are concerned, in order to be best prepared 
for sustainable exploitation of technology and guarantee access to market 
segments>>141. 
 
f) Revision of the definition by December 2014 with special focus on the number 
size distribution threshold and the inclusion of material with internal or surface 
structure in the nanoscale. 
  
When the EP requested, back in 2009, the introduction of a comprehensive science 
based definition of nanomaterials in the EU, it was with the intention of setting up one 
of the basic pillars for a sound regulatory framework that would permit a robust 
assessment to be made about the safety of nanomaterials and the measures to be taken to 
control risk. 
 
In fact, it could be said that the European Commission has been delaying the 
development of the regulatory framework until an “applicable”142 definition for 
nanotechnology would be released but, once the Recommendation has been published, 
the first reactions points to the fact that, instead of a “sound science” based definition, 
we have a definition that has been considered a “trade-off between the expectations of 
the various stakeholders”143, where materials with nano properties and possible toxicity, 
will fall outside the definition. 
 
This implies that the regulatory focus on solving the issues related with Health, Safety 
and Environmental issues, as by nature (protecting human health and environment) are 
the most compelling ones has not been tackled. On the contrary, the Commission states 
  
141 NIA    <<Europan    Commission    issues    regulatory    Definition    of    Nanomaterial>>    Available    at 
http://www.nanotechia.org/. (Accessed November 2011). 
142 Henrik Laursen, coordinator of the nano team in the Commission's environmental department, said that the 
Commission would not be rushed into making a decision because, once made, it would not be a working model 
but would immediately have a significant binding effect. http://www.euractive.com/innovation/comissions-nano- 
policy-lost-definition-news-503665 
143 Basically DG Enterprise defending industrial interest, and on the other DGSanco and DGEnvironment defending 
positions of environmental and consumer organizations.  http://www.nanowerk.com/newsid=23122.php 
It also have to be pointed out that, from the Commission perpective, it seemed that arriving at a definition for 
nanomaterials was as much about public relations as about creating good regulatory policy. It seams logical to 
think that working with conflicting objectives may lead to unclear results. Dexter, J (2011) <<Definitions for 
Nanotechnology Inform EU Citizens as mush as Regulatory Framework>> 
http://spectrum.ieee.org/nanoclast/semiconductors/nanotechnology/definitions-for-nanotechnology-inform-eu- 
citizens-as-much-as-regulatory-framework. (Accessed November 2011). 
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that144: 
  
The definition will primarily be used to identify materials for which special provisions 
(concerning for example risk assessment or ingredient labelling) might apply. Those special 
provisions are not part of the definition but of specific legislation in which the definition 
will be used. 
Nanomaterials are not intrinsically hazardous but there may be a need to take into account 
specific considerations in their risk assessment. Therefore one purpose of the definition is to 
provide clear and unambiguous criteria to identify materials for which such considerations 
apply. It is only the results of the risk assessment that will determine whether the 
nanomaterial is hazardous and whether or not further action is justified. 
  
So, as Johnson states, “(...) they have created a class of materials that at the moment are 
not known to be intrinsically hazardous; but if some day they are, there is now a 
separate class for them. While some may see this as making some sense, the sense of it 
eludes me”145. 
 
 
In addition, the fact that the basis for determining whether a material or product is 
regulated as a nanomaterial is not based on “sound science” but a “policy decision” may 
have the consequences of shifting the focus from hazard and risk (evidence-based 
regulation) to a formal regulation of a theoretical class of materials146. 
 
 
From our point of view, some of the critics received can not be disputed, being the most 
worrying one that some materials at the nanoscale about which there is already concern 
have fallen out of the definition. 
 
 
But once the Recommendation has been published in the Official Journal and knowing 
that a revision is going to be done by December 2014, we understand that a pragmatic 
position has to be taken: it is time now to properly review all sectoral legislation and 
  
144  See <<Nanomaterials. Q & A>> At 1. 
145 Johnson,        D.       (2011)        <<The       EC       Defines       a       Nanomaterial:       Now       What?>> 
http://spectrum.ieee.org/nanoclast/semiconductors/nanotechnology/the-ec-defines-a-nanomaterial-now-what (Accessed 
November 2011). Probably, a confirmation of this conclusion is that calls already has been made for starting 
analysis to “verify that the adopted size range captures materials about which there is already concern”, so 
initiating (already!) the revision process scheduled for 2014. See David Azoulay (Head of CIEL's nanotechnology 
project) statement at  http://ciel.org/CIEL/Chemicals_Program/Nano_EU_definitions_18Oct11.html. 
In this same line of thinking Duprez (EEB nanotechnology policy officer) states “Definition is an important first 
step but does nothing to allow a robust assessment to be made about their safety, let alone take measures to 
control risks” http://www.eeb.org/EEB/index.cfm/news-events/news/nano-definition-too-narrow-says-eeb/ 
146 Maynard,      a.      (2011)      <<Don't      define      nanomaterials      –      the      evolution      of      an      idea>> 
http://umrscblogs.org/2011/07/06/dont-define-nanomaterials-the-evolution-of-an-idea/.    (Accessed    November 
2011). This is one of the main reasons way Maynard considers that “it is time to move away from dogma-driven 
definitions and towards science-informed guidelines that identify materials and products that raise plausible and 
specific concerns – irrespective of what they are called. In this way, frameworks can be developed that support 
resposive and adaptive regulations that are truly based on science”. 
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identify the “special provisions” to be applied -being the fundamental ones a robust risk 
assessment and  additional risk  control  measures  guided  by an  “exposure focused” 
and/or “commercial relevance” approach- and in the understanding that a modulation of 
the overarching concept might be necessary (additional qualifiers, specific physico- 
chemical properties or even to include certain nanomaterials that may fall outside the 
general definition)147. 
 
C) EUROPEAN UNION FUTURE DEVELOPMENTS IN 
NANOMATERIALS POLICY AND REGULATION 
  
 
The short term agenda for future developments on the nanotechnology policy and 
regulatory is tight. In this section we will focus on the following (expected) 
developments: 
 
 
1.- Strategic Action Plan; 
 
2.- Revision of the general legal framework applicable to nanomaterials; 
 
3.- REACH revision; 
 
4.- Nanomaterials Compulsory Register. 
   
C.1) Strategic Action Plan (SNAP) 2010-2015. 
   
The European Union Action Plan for Nanosciences and Nanotechnologies 2005-2009 
came to an end in December 2009 and the European Commission was planning to 
develop a new action plan for the time period 2010-2015. In this context, the 
Commission launched a public consultation148. The Strategic Action Plan is scheduled 
 
147  Recital 16  <<The definition  set  out  in  this  recommendation should  not  prejudge  nor  reflect the  scope  of 
application of any piece of Union legislation or of any provisions potentially establishing additional requirements 
for those materials, including those relating to risk management. It may in some cases be necessary to exclude 
certain materials from the scope of application of specific legislation or legislative provisions even if they fall 
within the definition. It may likewise be necessary to include additional materials, such as some materials with a 
size smaller than 1 nm or greater than 100 nm in the scope of application of specific legislation or legislative 
provisions suited for a nanomaterial>>. 
In this sense, it will be interesting to see how the new definition will affect article 2 of Regulation (EC) No 
1223/2009  on  cosmetics  products.  The  Regulation  affects  only  manufactured  nanomaterials  while  the 
Commission Recommendation applies to natural, incidental or manufactured. On the other hand, the Regulation 
includes nanomaterials with internal structure and nanomaterials with external dimensions in the range of 1 nm to 
100 nm without any threshold.  The final resolution of those discrepancies will show us how much the regulator 
is ready to deviate from a formal definition in order to focus in risk management. 
148  Public Consultation took the form of an online questionnaire in order to gather stakeholders opinions and ideas for 
the new action plan. The public consultation process ended at the 19th February 2010 and the results of this public 
consultation process were summarized and published: Report on the European Commission's Public Online 
Consultation     “Towards     a     Strategic     Nanotechnology     Action     Plan     2010-2015”.     Available     at 
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to be presented in 2011. 
 
 
The main conclusions from the public consultation process on regulatory issues were149: 
 
- The major concerns regarding policy centre on the safety of nanomaterials and their 
regulation. Generally, more action is expected to ensure safety. 
-  There  is  overwhelming  demand  for  an  inventory  of  the  types  and  uses  of 
nanomaterials that would include safety aspects. Demand is also high for requirements 
to ensure that adequate information is provided on consumer products. 
 
 
Specifically, the respondents were asked to express their opinions on new EU policy 
actions. Strong support for the following actions were reported150: 
1.- establishment of an inventory of types and uses of nanomaterials, including 
safety aspects; 
2.-  requirement to  adequate information on  consumer  products  (e.g. Claims 
verification, labelling of nano-content of consumer products); 
3.- development of new, specifically targeted regulation for nanotechnologies, 
especially related to nano-bio-cogno-applications (e.g. Human enhancement). 
  
It seams clear that those are the basic elements on which we will see specific proposals 
from  the  Commission  on  the  SNAP  proposal  and  also  on  the  “revision  on  the 
Regulatory Aspect”. 
 
 
C.2) Revision on Regulatory aspects of nanomaterials (2011) and REACH revision 
 
(2012) 
   
The Commission has repeatedly taken the compromise to undergone a review of the 
regulatory aspect by 2011 and the first revision of REACH is scheduled for 2012151. 
http://ec.europa.eu/research/consultations/snap/report_en.pdf/. (Accessed January 2011). 
149    SNAP Online Consultation Report. At 4. 
150  SNAP Online Consultation Report. At 17. 
151  To ensure that the provisions of the REACH Regulation are properly applied in the case of nanomaterials, the 
European Commission launched the REACH Implementation Projects on Nanomaterials (RIPoN) in June 2009. 
The projects included stakeholders from industry, environmental organizations and trade unions. The objective 
was to provide scientific and technical advice on three key areas: 1) substance identification (SI) RIPoN1; 2) 
information requirements (IR) RIPoN2; 3) chemical safety assessment (CSA) RIPoN3. These recommendations 
could result in amendments to the ECHA Guidance documents, but could also include proposals for amendments 
to the text of REACH or its Annexes. 
The final reports has been released in November 2011. 
It is now for ECHA to decide whether and when to recommend changes to the REACH Guidance Documents on 
the basis of the findings of the RIPs and for the Commission on the proposed changes to REACH. 
Documents available at  http://ec.europa.eu/environment/chemicals/nanotech. (Accessed October 2011). 
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The  Commission  has  already advanced  that  the  review  will  specifically deal with 
 
REACH regulatory gaps and basically152; 
 
• To set up a simplified registration for nanomaterials < 1 ton/a153; 
 
• Consideration of all nanomaterials as new substances; 
 
• A chemical safety report with exposure  assessment for all registered 
nanomaterials; 
• Notification requirements for all nanomaterials placed on the market on 
their own, in preparations or in articles; 
 
 
The Belgian Presidency (ended in December 2010) considered that the review has to 
address the following regulatory issues154: 
• Clarify the various issues to adapt REACH to the nanomaterials and to 
include effective modifications to REACH into its 2012 review: 1.- lower 
the tonnage triggers; 2.- modifications to data requirements in REACH 
annexes;  3.-  consideration  of  nanomaterials  as  new  substances;  4.- 
review Annex V exemptions155; 5.- Review Annex XIII (PBT, vPvB); 6.- 
include definition of nanomaterials and articles containing nanomaterials 
in REACH. 
Especial attention to all this regulatory gaps will be given on Part III of 
the present Report. 
• To “urgently” approve a nanomaterial definition for regulatory 
    
152  Laursen, H., Puolamaa, M., (2010) <<REACH and Nanomaterials>> Belgian Presidency Workshop “Towards a 
regulatory framework for the paper traceability of nanomaterials”.14 September 2010, Brussels. Available at 
http://www.health.belgium.be/eportal/Aboutus/eutrio/environment/Nanomaterials/index.htm?fodnlang=en. 
(Accessed February 2011). 
153  The simplified registration stated by the Commission have to be received with caution as the specific content of 
data requested has not been explained and there is concern that “simplified” could lead to more bureaucracy 
without real effectiveness. The level of data to be requested for being useful is: toxicological and ecotoxicological 
tests and properties, degradation and bioaccumulation. Hansen, S.F. (2010b) At 445. 
It may be sensible to prioritize which data is requested and which ones could register with a “simplified 
registration”. In this sense, an “exposure focused approach” and the “commercial relevance approach” may help 
to this prioritization. Widmer, M., et Al. (2010). At 62. 
154  Belgian Presidency Conclusions from the Belgian Presidency Workshop “Towards a regulatory framework for 
the paper traceability of nanomaterials”. Brussels. 14 September 2010. Available at 
http://www.health.belgium.be/eportal/Aboutus/eutrio/environment/Nanomaterials/index.htm?fodnlang=en. 
(Accessed February 2011). 
155  Several members of the German Nanokommission, for instance, considers that a matter of principle, Annexes IV 
and V Exemptions from the obligation to register, should not include substances in the nanoform. 
Nanokommission (2010) <<Review of nanomaterials and nanoproduct regulation Working Group 3 of the 
Nanokommission>> 18.09.2010. Available at 
http://www.bmu.de/files/english/pdf/application/pdf/nano_abschlussbericht3_en_bf.pdf. (Accessed June 2011). 
60 
purposes156; 
 
• Better regulate labelling of products containing nanomaterials. 
  
 
C.3) Harmonized Mandatory Register 
  
 
C.3.1) Reasons for a Reporting Scheme 
  
 
As we have seen in Part I of this paper, consumer products containing nanomaterials are 
already on the market and many more are under way at the research stage or near 
market access. 
 
 
In order to assess the risk of nanomaterials (in toxicology and exposure) -that is a first 
step towards achieving regulation- it is basic to collect data on manufactured 
nanomaterials and their fields of application, but there is no institution within Europe 
which  can provide  information on  nanomaterials used  commercially or  on 
nanomaterials being produced or used for research purposes. 
 
 
A reporting scheme is aimed to gather data on nanomaterials with the objective of; 
 
• Promote collaboration between government and industry; 
 
• Ensure  that  nanomaterials  and  nano-related  products  are  introduced 
without risk into the market; 
• Provide  governments with  the  information they  require  to  determine 
whether current legislation is adequate and at informing debate on 
whether additional legislation is required. 
• It could be understood as a practical application of the provisions of the 
 
Aarhus Convention157. 
   
The reporting schemes are generally related to specific provisions (for instance 
chemicals) and they can be voluntary158 or enforced by legislation. On the remaining of 
156  Already approved by Recommendation of 18.10.2011. See Part II, section B.8) of this researcher paper. 
157  D'Silva, J., van Calster, G. (2010) "For Me to Know and You to Find Out? Participatory Mechanisms, The Aarhus 
Convention and New Technologies," Studies in Ethics, Law, and Technology: 4(2) Article 3. Available at: 
http://www.bepress.com/selt/vol4/iss2/art3. (Accessed February 2011). 
158  In 2006, the UK's DEFRA (British Department for Environment, Food and Rural Affairs) ran between September 
2006 and September 2008 a two-year trial Voluntary Reporting Scheme (VRS). 
It was aimed at collecting data concerning free engineered nanomaterials from manufacturers, commercial users, 
research and waste industry and focused on engineered nanoscale materials that are free at any stage of product's 
life-cycle. 
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this section we will focus on the French compulsory reporting scheme and the Belgian 
 
Presidency proposal. 
   
C.3.2) France: compulsory reporting scheme 
   
The French Environment Code was modified in July 2010 in order to include a new 
chapter  “Prévention  des  risques  pour  la  santé  et  l'environnement  résultant  de 
l'exposition aux substances à l'état nanoparticulaire” including several articles (523-1 to 
523-5) establishing a mandatory159 reporting scheme160. 
   
The main features of the system are; 
 
• Addressed   to   manufacturers,   importers   and   distributors   placing 
nanomaterials and nanomaterials-containing products on the French 
market; 
• Obligation of reporting the identity of nanomaterials, quantities on the 
market, uses, identity of downstream users (confidentiality clause) and 
available data on hazards and exposures; 
• Creation  of  a  unique  database  for  products  categories  (chemicals, 
 
Information requested include any data on: uses, benefits and exposure pathways, physico-chemical properties, 
toxicology, ecotoxicology and risk management practices. 
The VRS was initially set up as a 2-years trial initiative and only 13 submissions were received at the end of the 
programme (11 from industry and 2 from academia). 
The large amount of information requested, confidentiality issues and also the resources needed to participate (in 
particular with respect to SME's) are amongst the reasons identified by DEFRA for low participation in the VRS. 
At his moment the scheme is under revision but remain open to further data submission. See UK Voluntary 
Reporting Scheme for engineered nanoscale materials. 
UK Department for Environment, Food and Rural Affairs (DEFRA). 2006. Available at 
http://www.defra.gov.uk/environment/quality/nanotech/policy.htm and 
http://www.defra.gov.uk/environment/quality/nanotech/documents/vrs-nanoscale.pdf.; <<Note of the 11th Meeting 
of the Nanotechnologies Staheholder Forum. DEFRA 26.09.2008. Available at 
http://www.defra.gov.uk/environment/quality/nanotech/documents/080926-meeting-note.pdf.   Accessed January 
2010. 
159  The reasons for being a mandatory scheme were: a) More information on manufactured nanomaterials on the 
market since their uses are already or expected widespread (better knowledge on exposure of consumers and 
workers  and  traceability  to  be  able  to  take  targeted  measures if  necessary);  b) Awareness raising  among 
stakeholders and improvement of the risk management; c) Voluntary reporting scheme already experience d in 
2007 by AFSSET -Agence Française de Sécurité Sanitaire de l'Evironement et du Travail- that yield a very low 
response (16%). 
160  Legislative process background: In 2007 it was organized a national brainstorming in favour of a sustainable 
development called “Le Grenelle de l'environnement”, conducted by the ministry for sustainable development 
and initiated by President Sarkozy. 
It was a wide and open process involving all kinds of stakeholders (state and regional administration, industry, 
employees, NGO's, elected representative, scientific experts) and general public (consultations via internet and 
public meetings). 
The legal framework is the Grenelle Law nr.1  (Programmation law which lays down the main objectives. 
Promulgation on the 3rd  of August 2009. Art. 42) and Grenelle Law nr.2 (Implementation law 2010-788 which 
lays down the concrete measures to implement the commitment. Promulgation 12.07.2010. OJ du 13.07.2010. Art 
185). Art. 185 inserts in: Code environement 523-1 to 523-5; Code santé publique 5161-1; Code rural et de la 
pêche maritime 253-8. 
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biocides, pesticides, cosmetics, food, etc.); 
 
• Information   available   to   the   public   about   identity and   uses   of 
nanomaterials. 
  
More detailed requirements will be covered by an implementing decree that has been 
drafted and open to public consultation161, and is now waiting for final approval. It has 
been said that the French mandatory scheme is meant to be a help on the REACH 
implementation162 and that is not infringing EU law163 (opinion that is not shared by the 
author of this research paper). 
 
 
C.4.3) Belgian Presidency proposal for a harmonized mandatory register 
   
The Belgian Presidency of the Council of the EU (that ended in December 2010) 
 
161  Nanonorma Project (2011) <<Rapport et avis sur le décret relatif à la déclaration annuelle des substances à l'etat 
nanoparticulaire mises sur le marché tel que soumis à consultation publique le 5 jauvier 2011>> Available at 
http://www.nanonorma.org. (Accessed March 2011). 
162  It has been said that the mandatory reporting scheme will anticipate and be complementary to the REACH 
requirements because; 
- knowledge of the market (quicker available and more explicit); 
- knowledge covers manufacture, import and placing on the market sold below 1 tonne/year.; 
- input to the REACH/nano subgroup of the competent authorities (assessment of the need to review REACH in 
2012); 
- awareness of industry about the need to care for its registration dossiers; 
- help to prioritise registration dossiers and substances according to Title VI of REACH; 
- help the authorities in charge of public  health and  environment to take action through REACH (SVHC, 
restrictions, etc...) to better manage the risk. Mir, C. (2010) <<The French initiatives regarding nanomaterials>>. 
Belgian Presidency Workshop “Towards a regulatory framework for the paper traceability of nanomaterials”. 
Brussels. 14 September 2010. (Accessed February 2011). At 9. Available at 
http://www.health.belgium.be/eportal/Aboutus/eutrio/environment/Nanomaterials/index.htm?fodnlang=en. 
163  The compatibility of this measure with EU law is an open debate. While the Commission considers  that REACH 
does fully harmonize the conditions related to the manufacturing, placing on the market and use of substances, 
either on their own, in preparations or in articles, so leaving no room for Member States to maintain or introduce 
national provisions  (based on the provisions of Art. 128 REACH). 
This   interpretation   is   disputed   by   the   French   authorities   who   put   forward   art.   128,2   of   REACH: 
REACH does not include substances produced below 1 tonne per year and the specific properties of nanoparticle 
state,        except        if        they        are        considered        substances        of        very        high        concern. 
Furthermore, the French Government considers that nanomaterials represent specific chemicals which control 
(objective assigned to REACH) is not ensured by the general rules (including registration) as contained in 
REACH. Then, setting up a national mandatory reporting mechanism to nanosubstances could be considered as 
an       intervention       in       a       field       not       harmonized       by       REACH.       The       legality       of 
National measures should then be assessed under sections 34 and 36 TFEU. 
REACH Article 128: 
<<Free movement 
1.Subject to paragraph 2, Member States shall not prohibit, restrict or impede the manufacturing, import, placing 
on the market or use of a substance, on its own, in a mixture or in an article, falling within the scope of this 
Regulation, which complies with this Regulation and,  where appropriate, with Community acts adopted  in 
implementation of this Regulation. 
2.Nothing in this Regulation shall prevent Member States from maintaining or laying down national rules to 
protect workers, human health and the environment applying in cases where this Regulation does not harmonize 
the requirements on manufacture, placing on the market or use.>> 
Juet E., (2010) <<Réflexions sur la légalité du mécanisme français de déclaration obligatoire au regard du droit de 
l’Union européenne>> September 2010. Available at http://www.nanonorma.org/ressources/articles/Reflexions 
%20sur%20la%20legalite%20du%20mecanisme%20francais%20de%20declaration%20obligatoire.pdf/view. 
(Accessed March 2011). 
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catalysing and consolidating several Member State regulatory projects164, judging 
critically the current regulatory regime165 and as a reply to the passive attitude from the 
Commission regarding the regulation of nanomaterials166, formally proposed167 to draw 
up coordinated and integrated national strategies and concrete measures in favour of 
risk management, information and monitoring, including the development of a 
harmonized compulsory databases of nanomaterials and products containing 
nanomaterial168. 
 
 
The  Presidency Conclusions  underlines the  need  for  “taking responsibilities at  the 
 
Member States level (...) during the transitory period”169 with the objective of; 
  
164  Basically were France, Italy, Belgium, Germany and The Netherlands. 
For instance Italy, (in response to the EU Parliament Resolution of 24.04.2009 or Regulatory aspects of 
nanomaterial where the need for a notification requirement was underlined) is drafting a ministerial decree 
creating a national database on nanomaterials manufactured, imported and used on their own, in mixture and in 
articles. See Polci, M., L., <<A project of ministerial decree concerning the establishment of a National Database 
on Nanomaterials>> Belgian Presidency Workshop “Towards a regulatory framework for the paper traceability of 
nanomaterials”. Brussels. 14 September 2010. Available at 
http://www.health.belgium.be/eportal/Aboutus/eutrio/environment/Nanomaterials/index.htm?fodnlang=en. 
(Accessed February 2011). 
The Netherlands (that is undergoing a study on the possibilities of national measures) clearly stated the position 
that additional legal measures on European level are needed and that <<If the Commission is not able to come up 
with a definition, information requirements in REACH and to initiate legal measures on traceability on short 
term, the Netherlands will explore the use of art. 129>>. Reference to actual Art 169 (and former art. 153 TEC 
and  129A  SEA)  At  4.  Bosman,  M.T.M.,  <<Dutch  policy  on  risks  of  nanomaterials:  precaution  and 
transparency>> Belgian Presidency Workshop “Towards a regulatory framework for the paper traceability of 
nanomaterials”. Brussels. 14 September 2010. Available at 
http://www.health.belgium.be/eportal/Aboutus/eutrio/environment/Nanomaterials/index.htm?fodnlang=en. 
(Accessed February 2011). 
165  The critical view towards current regulatory regime was summarized by the Presidency on the following three 
main aspects: 
a) The current legislation does not provide sufficient information to offer a response in case of an incident and to 
guarantee nanomaterials risk management. 
b) Due to persistent doubts, it is not presently possible to guarantee sufficient protection of public health and 
environment. 
c) There is a considerable dearth of information all along the supply chain, whereas it is essential to have this 
information for traceability reasons. 
166 In this sense, Mr. Maguette, minister in charge of consumer protection and environment, and speaking on behalf 
of the Belgian Presidency explained that although there was <<no need to be alarmed (...) it is our duty to apply 
due minimum of care and caution>> and that <<the current development approach for nanomaterials without 
prior notification of their presence or labelling of their characteristics or potential toxicity is not acceptable>>. 
Available at http://www.euractive.com/en/food/reach-register-ensure-traceability-nanomaterials-news-497781 
Accessed Feb 2011. 
167  The Belgian Presidency formally presented the proposal at the CASG-nano meeting of 16/12/2010. 
168 Belgian Presidency  Conclusions  (2010)  <<A regulatory framework for  nanomaterials?>> Published  by  the 
Belgian Presidency of the Council of the European Union 16.09.2010. Belgian Presidency Workshop “Towards a 
regulatory framework for the paper traceability of nanomaterials”. Brussels. 14 September 2010. Available at 
http://www.health.belgium.be/eportal/Aboutus/eutrio/environment/Nanomaterials/index.htm?fodnlang=en. 
(Accessed February 2011). 
169 It is not clearly explained what is meant for “transitory period” but it can be understood that, the time frame 
envisaged by the Commission (second legislative nanomaterials review by 2011 following the request of the 
European  Parliament  of  2009  and  entering  the  regulatory  changes  by  the  2012  REACH  review) is  being 
considered too long. SO the present strategy would be designed for setting up (basically) the Member States 
action plans (for those Member States that do not have them) and the compulsory databases before the 
Commission calendar, what represents a really tight agenda. Backing this interpretation, <<Just like the 
Presidency, certain stakeholders were of the opinion that the proposed time scale for making improvements to the 
current  legislation  is  unacceptable.  Transient  measures  are  therefore  required.  (...)  a  certain  number  of 
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• ensuring nanomaterials traceability; 
 
• market surveillance; 
 
• gaining knowledge for better risk prevention; 
 
• gaining knowledge for the improvement of the legislative framework. 
 
It is also stressed that the data obtained have to be made accessible to stakeholders, 
consumers and general public, while taking into consideration industrial data protection. 
  
The Commission would be also involved in the design process through the European 
 
Commission Joint Research Centre (JRC)170. 
 
stakeholders  believes  that  a  harmonised  register  of  nanomaterials  constitutes  an  effective  and  immediate 
response>> Belgian Presidency Conclusions (2010). 
170 The JRC will be supporting the initiative giving conceptual design and technical implementation help to provide 
a harmonized European approach making use of already technology and knowledge tools at the JRC as far as 
possible. Basically the JRC will be collaborating with the so called NanoPortal (newly planned suite of database 
services, containing the NAPIRAhub Database), a comprehensive IT platform dedicated to the management of 
information on nanomaterials, relevant for safety/risk assessment in which all data for the OECD WPMN 
Sponsorship  Programme  is  collated  and  built  on  IUCLID  5  (the  IT  platform  currently  used  for  REACH 
registration purposes). Klein, Ch. <<What could a nanomaterial characterisation dataset look like>>. Belgian 
Presidency Workshop “Towards a regulatory framework for the paper traceability of nanomaterials”. Brussels. 14 
September 2010. Available at 
http://www.health.belgium.be/eportal/Aboutus/eutrio/environment/Nanomaterials/index.htm? 
fodnlang=en. (Accessed February 2011). 
In February 2010, ECHA presented IUCLID 5.2 which enables the information “nanomaterial” to be included in 
the database. This version is used for first phase registration and CLP notification. A new nano fields has been 
created, allowing the entry of nanomaterials: Le Goff, F. <<IUCLID5. Project overview>>. REACH-IT/IUCLID 
Stakeholder Webinar. 21.06.2010. 
In the process of setting up this mandatory registry it will be of great help the recent launching by the JRC (Joint 
Research Center) of the first European repository of nanomaterials. It contains most types of nanomaterials that 
are currently assumed to be used in significant volumes in consumer products. These materials will be used as a 
reference point by laboratories that carry out safety assessments on nanomaterials, to make sure that their results 
are comparable to those of other laboratories. This responds to a need expressed by experts in international 
standardisation organisations. Available at  http://www.jrc.ec.europa.eu (Accessed May 2011). 
Additionally, it has to be pointed out that the Commission was already scheduling a compulsory registry to be set 
up. The background from the Commission project was the proposal for an EU Reporting System for 
Nanomaterials as presented in Miliue/RPA Final Report (2010) <<Information from Industry and Applied 
Nanomaterials and their safety>>. Contract NV.D.1/SER/2008/00105r for the European Commission. May 2010. 
The report advocates for a mandatory nanomaterial-specific reporting under REACH based on the following 
three main elements: 
–      designation of nanomaterials as “new” substances, 
–      a lower threshold for registration, and 
–      a deadline of 2013 for submission of registration dossiers 
The study concluded ‘that current reporting under REACH-CLP is unlikely to provide the complete range of 
information  needed  by  regulators  to  assess  the  potential  risks  to  public  health  and  the  environment  from 
nanomaterials. An additional EU-level reporting system for nanomaterials on the market appears necessary.’ 
The report highlighted possible information gaps for nanomaterials properties under REACH, including; 
–      the current tonnage thresholds; 
–      the limitations of current guidelines for the testing of nanomaterials; 
–      communication issues with downstream users; 
–      exemptions of nanomaterials under REACH, and 
–      time-lags when registering lower tonnage substances 
The  framework  of  REACH  should  be  the  basis,  with  the  European  Chemicals Agency  (ECHA)  as  the 
implementing agency. A two-stage approach is suggested: 
1. The first stage should focus on gathering information concerning any and all nanomaterials placed on the 
market           and           their           uses,           i.e.,           a           nanomaterials           product           register. 
2.The second stage of an EU-level nanomaterials reporting scheme should focus on the gathering of the 
toxicological and other information needed to accurately assess the potential risks of specific nanomaterials and 
their uses, and to manage those risks, including specific testing of all nanomaterials intended for placement on the 
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The Belgian Presidency strategy was successful and on the 20th  December 2010, the 
Council of the European Union, during its 3061st  Environment Council meeting adopted 
a conclusion to provide a mandate to the European Commission to review the risk- 
assessment of nanomaterials and to develop a harmonized database for nanomaterials: 
 
 
<<5. INVITES the Commission to further promote health through environment policy through the 
preparation as soon as possible of a second Environment and Health Action Plan (EHAP) in order to: 
- (...) 
 
- evaluate the need for the development of specific measures for nanomaterials relating to risk assessment 
and management, information and monitoring, including the further development of a harmonized 
database for nanomaterials, while considering potential impacts>> 
 
D) ASSESSMENT ON THE EUROPEAN UNION 
NANOMATERIALS POLICY AND REGULATION. 
   
The Commission, that took a leading role when issuing the European Nanotechnology 
Strategy  has  been  changing  toward  a  “wait  and  see”  attitude171  and,  instead  of 
proposing initiatives, has sent request for opinion to the different scientific committees 
or just accepted the insertion of nano specific provisions on the legislative (recast) 
process. 
 
 
From the Commission's Strategy (Communication on the European Union Strategy. 
 
2004) it was clear that the objective was to strike the right balance between innovation 
and development of applications and ensuring that health and environmental risks were 
looked into and dealt with at the earliest possible stage, but in practical terms, from 
2004 to 2011 the Commission has released: 
   
i. Communications  (Strategy  2004;  Action  Plan  2005;  First  and  Second 
 
Implementation Reports 2007 and 2009; Regulatory Aspects 2008); 
 
 
market. 
It is proposed that nanomaterials be considered as “non-phase-in” (i.e., “new”) substances under REACH. 
The current OECD Test Guidelines and the preliminary guidance available from the OECD Working Party on 
Manufactured Nanomaterials (WPNM) on sample preparation and dosimetry, testing, exposure measurements 
and mitigation of nanomaterials should be used. 
171 As graphically expressed by the ETC group, from “no data – no market” to “no data – no regulation”. ETC Group 
(2010) <<The Big Downturn? Nanogeopolitics>>. ETC Group Communiqué # 105. December 2010. Available at 
http://www.etcgroup.org. At 14. (Accessed May 2011). 
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ii.  Recommendation on a Code of Conduct (soft law). With guidelines over 
 
Nanotechnology and Nanomaterials Research in the Community. 
 
iii. Regulation 987/2008 removing carbon and graphite from REACH Annex IV. 
iv.  Regulation 10/2011 on plastic materials and articles intended to come into 
contact with food. 
 
v.   Agreed on the content of Regulation 1333/2008 of the European Parliament 
and the Council on food additives following the European Parliament 
pressure. 
vi. Agreed on the content of Regulation 1223/2009 of the European Parliament 
and the Council on the cosmetic product recast. 
vii. Regarding supplementary policy we have to mention the 7th Framework 
Programme where a considerable increase of the budget is foreseen for 
nanotechnology but that was assessed by the European Parliament as being 
too low in terms of funding and too restrictive in terms of evaluation criteria 
for  granting  research  projects  to  assess  the  safety  of  nanomaterials 
(European Union Communication on Regulatory Aspects at M). 
viii.Organization of experts meetings and the request for expert opinions from 
the different aspects of nanomaterials health, environment, safety and 
regulation of nanomaterials. 
ix.  Recommendation of 18.10.2011 on the definition of nanomateriales. It is too 
early  to  assess  the  importance  that  the  definition  will  have  in  the 
development of the regulatory framework because it will be its application in 
sectoral rules which will tell us if it has helped the implementation of the 
precautionary principle or if it will be just a formal definition that will not 
help to identify risk. 
 
 
The global assessment points to the conclusion that the Commission has not reached its 
objectives in a timely manner172 for a balanced development of nanotechnology by 
tackling health and environmental concerns at the earliest possible stage, because the 
actions taken can not be labelled as proactive (excluding the “Action Plan” and the 
“Strategy” at the beginning of the process, and the Code of Conduct -basically 
concerned with laboratory practices), and clearly departing from their own policy goals 
  
172  For the importance of a timely regulation see Ludlow, K., Bowman, D.M., Kirk, D.D. (2009) <<Hitting the mark 
or falling short with nanotechnology regulation?>>. Trends in Biotechnology. 27(11): 615 – 620. 
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and objectives regarding regulation173. 
   
In addition, it is also important to underline that the free movement of nanosubstances 
is being placed in jeopardize due to the Commission's inactivity, being the France 
compulsory registry the clearest evidence. 
 
 
We consider that the same conclusion has been reached by the European Parliament 
(being the European Parliament Resolution on Regulatory Aspects a stunning wake-up 
call), by the Member States (being France the most active one), by the European 
Presidency and finally, by the Environmental Council. 
 
 
This patchy and non proactive approach towards regulation makes that the “Incremental 
Approach Strategy”174 has not been implemented, in other words, we have not seen the 
deployment  of  strategy  so  that  a  comparison  with  the  Differentiated  Approach 
regulatory option can not be really made. 
 
 
In  this  final  assessment  we  also  have  to  underline  the  leading  role  taken  by  the 
European Parliament, based on clear policy and regulatory objectives underpinned by 
the Precautionary Principle. We consider that the fact that the European Parliament 
Resolution on Regulatory Aspects of Nanomaterials (2009) was adopted practically by 
unanimity, express a general consensus on regulatory matters for nanomaterials, that has 
to be not only taken into consideration, but adopted as a basic framework (or draft 
roadmap), for developing a proper and balanced regulatory regime for nanomaterials. 
 
 
We also consider that some Member States have also taken a proactive role (specially 
France for being the first one to approve a compulsory register for nanomaterials) 
requesting a harmonized mandatory register as a first step for tackling HSE issues from 
a regulatory perspective. 
    
173  It could be illustrative to state the Commission Action Plan 2005 and to compare it with the above list of practical 
realizations: <<Appropriate ex ante assessment should be carried out and risk management procedures elaborated 
before e.g. commencing with the mass production of engineered nanomaterials. Particular attention should be 
paid to products that are already or close to being on the market>>. COM(2005)243 final. 
174  As we have seen, the Community Strategy was based in four main elements: a) Appropriate, consistent and 
timely  regulation;  b)  Maximum  use  of  existing  regulation;  c)  Proactive  approach  by  re-examination  and 
reviewing legislation due to the special characteristics of nanomaterials and the updated scientific information; d) 
Ensure free movement of goods by regulatory harmonization. COM(2004)338 final. At 3.4.4. 
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Finally, and talking about the future, it seams logical to expect (in the next two years) 
that we will witness major changes in the regulation of nanomaterials. Among them, 
and most notably, the setting up of a compulsory register and the review of the REACH 
Regulation, specifically addressing the nanomaterials regulatory gaps, that will be the 
focus of our Case Study. 
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PART III. CASE STUDY: REACH AND NANOMATERIALS 
 
  
We have seen in PART II a permanent discussion between those advocating that the 
actual legislative framework has to be considered (in principle) to cover risks associated 
with nanomaterials, that changes (if needed) would follow new scientific data and that 
the regulatory problem was on the implementation of the different provisions, and on 
the other hand, those considering that the actual regulatory framework is not designed 
for nanomaterials (and, as a consequence, it is logic to expect regulatory gaps), that 
proactive and timely decisions has to be taken and that the Precautionary Principle has 
to underpin every legislative proposal. 
 
 
The objective of PART III is to asses whether actual legislative framework does cover 
adequately risks associated with the use of nanomaterials, so taking position on the 
above mentioned discussion. As the scope and objective of our research work has not 
allowed us to enter on each one of the regulatory regimes presented in PART II we have 
opted, instead, for selecting REACH as a Case Study in order to assess whether current 
chemical substances Regulation adequately covers risks associated with nanomaterials. 
 
To select REACH is based on the following basic reasons; 
 
1) Because <<chemicals regulation, and in particular REACH, constitutes a cornerstone 
for addressing health, safety and environmental risks in relation with nanomaterials>> 
175; 
 
2) REACH legislative process implied extensive consultation to stakeholders and may 
be a model to follow if the European Union finally decides that there is a need for an 
overarching regulatory regime specific for nanomaterials. This is also the reason for 
entering a brief explanation on the making of REACH. 
3) REACH can be seen as a new step on European legal integration and European legal 
culture. 
  
The present Case Study is structured in two Sections. The first is a general introduction 
to REACH while the second presents a set of nanomaterials regulatory gaps. 
    
175 Commission of the European Communities (2008) <<Regulatory Aspects of Nanomaterials>>. Commission Staff 
Working Document. COM(2008)366final. 17.6.2008. 
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1) INTRODUCTION TO REACH 
  
A) THE MAKING OF REACH 
  
 
At the end of 2006, the European Union (EU) adopted a comprehensive new system for 
the regulation of industrial chemicals throughout Europe, which is known by its 
acronym, REACH176, for Registration, Evaluation, and Authorisation of Chemicals. 
 
 
Chronologically, the REACH process officially started with the Commission's <<White 
paper strategy for a future chemical policy>>177 that set out the core objectives and 
structure  of  the  new  chemical  policy  in  the  EU.  On  May  2003  the  Commission 
published the Draft Regulation, presenting the regulatory details of the strategy to the 
public and stakeholders for comments and in October 2003 the final regulatory proposal 
on REACH that was finally agreed by the European Parliament on 13 December 2006 
178 and unanimously adopted by the Environmental Council on 18 December 2006, 
 
ending an extensive open debate179 and major political, media and lobbying battle in the 
 
EU180. 
 
176  Regulation (EC) No. 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning 
the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European 
Chemical Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No. 793/93 and 
Commission Regulation (EC) No. 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 
91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. OJ L 396, 30.12.2006. 
For a consolidated version 
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:2006R1907:20090627:EN:HTML 
177  COM (2001) 88 final. On the white paper, the commission identified seven political objectives that had to be met 
<<in order to achieve sustainable development in the chemicals industry within the framework of the Single 
Market>>. Among these objectives (that at are least partly antagonistic), it can be found environmental demand 
such as the protection of human health and the environment, increasing transparency or promotion of non-animal 
testing and, on the other hand, objectives stressing the maintenance and enhancement of the competitiveness of 
the EU Chemicals industry, preventing fragmentation of the internal market, integration with international efforts 
and conformity with international obligations under the WTO (World Trade Organization). 
178  In the European Parliament (EP), the REACH second reading (codecision procedure) deal was passed by 529 
votes in favour, 98 against and 24 abstentions. Infopress <<Parliament adopts REACH -new EU chemical 
legislation and new chemical agency>> (2006 13 December) < 
http://www.europarl.europa.eu/news/expert/infopress-page/064-1496-345-12.50-911-20061213IPR01493-11- 
122006-2006-true/default_en.htm >. This voting ended a 3 years period of formal negotiations (including a first 
reading  opinion  in  the  European  Parliament  on  the  17  November  2005  (PG_TA-PROV/(2005)0434,17 
November2005), A Council Common Position adopted on June 2006 (7524/8/06REV8, 27 June 2006) and the 
Commission Communication on REACH and forwarded to the European Parliament on 12 July 2006. SEC and 
Regions Committee also released their Opinion during the process. 
179  The reported open debate was canalized by two stakeholders conferences, internet consultations and working 
groups of experts giving opportunities for input to stakeholders in the decision making process including two 
stakeholders conferences, internet consultations and working groups of experts. This open governance model do 
not necessarily results in a better regulation and permits key stakeholders to influence decision makers in novel 
ways without a real enhancement of public participation. In this sense Pesendorfer, D., (2006) <<EU 
Environmental Policy under Pressure: Chemicals Policy Change between Antagonistic Goals?>> Environmental 
Politics, 15 (1): 95-114. At 111. 
180   For an in depth presentation on the REACH political process see Schöling, I. (2004) <<REACH:  The Only 
Planet  Guide  to  the  Secrets  of  Chemicals  Policy  in  the  EU.  What  Happened  and  why? >>.   Brussels. 
Greens/European Free Alliance in the European Parliament. Available at  www.mp.se. I. Schörling (member of the 
Green /European Free Alliance in the EP and Rapporteur for the <<White Paper – Strategy for a future Chemicals 
71 
The final text of the REACH Regulation was published in the Official Journal of the 
 
European Community on 30 December 2006. REACH entered into force on 1 June 
 
2007181. The European Union also approved the CLP Regulation (for Classification, 
Labelling and Packaging) that complements REACH182. 
  
Article 114 of the TFEU (harmonization of laws – ex art. 95) is the explicit legal basis 
of European legislation on chemicals. This means that the fundamental objective of 
REACH is the establishing of the internal market by ensuring the free movement of 
chemical substances183. In addition, art. 144 paragraph 3 provides that the Commission 
will take as a base of its proposals a high level of protection, “taking account in 
particular of any new development based on scientific facts”184. 
 
Policy>>) states : <<The same   governments that had supported REACH and requested even tighter provisions 
in the European Council meeting in 2001, were during 2002 and 2003 convinced to turn around and oppose the 
regulation. The US chemicals industry joined the battle, eagerly supported by the Bush administration. Under the 
vicious attacks from one of the largest industrial sectors and four of the most powerful governments in the world, 
the Commission backed down. The Proposal is undoubtedly a watered down version of the initial ambitions and 
drafts>>. 
181   From its entry into force, REACH has undergone several amendments: 
a) Council regulation (EC) No 1354/2007 of 15 November 2007 L304 22.11.2007; 
b) Commission Regulation (EC) No 987/2008 of 8 October 2008 L268 9.10.2008; 
c) Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 L353 
31.12.2008; 
d) Commission Regulation (EC) No 134/2009 of 16 February 2009 L46 17.2.2009; 
e) Commission Regulation (EC) No 552/2009 of 22 June 2009 L164 26.6.2009. 
and corrections; 
f) Corrigendum OJ L 136 29.5.2007 p3 (1907/06); 
g) Corrigendum OJ L 141 31.5.2008 p22  (1907/06); 
h)  Corrigendum OJ L 036 5.2.2009 p84  (1907/06); 
i) Commission Regulation (EC) No 494/2011 of 20 May 2011. L134 21.5.2011 
For comments on amendments and corrections see Blainey M. (2009) <<REACH, still being developed>> 
JEEPL 6(1): 51-73. 
182  CLP Regulation replace the current system contained in the Dangerous Preparations Directive (1999/45/EC), and 
aligns the European Union system of classification, labelling and packaging chemical substance and mixtures to 
the Globally Harmonised System (GHS). Regulation (EC) No 1272/2008 of the European Parliament and of the 
Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending 
and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006. 
The CLP Regulation entered into force the 20th January 2009 and has repealed Directive 67/548/CEE on the 1st of 
December 2010 and will repeal Directive 1999/45 on June 2015. 
The United Nations Globally Harmonised System of Classification and Labelling of Chemicals (UN GHS) 
provided a basis for globally uniform physical, environmental, health and safety information on hazardous 
chemicals through the harmonisation of the criteria for their classification and labelling. It was developed at UN 
level with the aim of overcoming differing labelling information requirements on physical, health and 
environmental hazards for the chemicals around the world. Moreover, it also aim to lower barriers to trade caused 
by the fact that every time a product was exported, it mostly has to be classified and labelled differently because 
of differing criteria. 
183  This has to be taken in consideration when confronted with competing principles included in REACH 
184  Following Moreno Molina, it has to be considered that this principle (as stated in article 114 TFUE) has no 
legally binding content beyond compelling the Commission to “take as a base a high level of protection” in its 
proposals. Moreno Molina, A.M., <<El régimen jurídico de los productos químicos en la Unión Europea>>. 
Iustel. 2010. At 67. 
In the context of nanomaterials and in the light of scientific advances in the understanding of the implications for 
health and the environment from the use of nanomaterials, an open question is whether actual legislation is 
ensuring a “high” level of protection or if it should be adapted “to technical progress“ (Council Resolution 
15.07.1975). OJ C 168.23.07.1975). In this sense, there is no doubt that Regulation 987/2008 removing from the 
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The  immediate  consequence  of  REACH  was  the  replacement  of  most  of  the 
complicated and confusing system of over forty different Directives and Regulations 
with a single (but complex) regulatory regime185. 
 
 
From a decision-making point of view, REACH has been considered “a hybrid model of 
governance” as it mixes direct mandate to companies (first generation regulation) with a 
combination of incentives directed to shape industrial behaviour (second generation 
regulation)186. 
 
 
From a legal perspective, FISHER (2008) highlights three different, independent but 
interdependent regulatory aspects of the regime: First, REACH privatizes information 
collection, provisions and assessment. Second, REACH represents a significant 
application of sustainable development and, in so doing, redefines the conditions on 
which the EU chemicals market operates. Third, REACH will inevitably have 
international jurisdictional impacts for both supranational and national legal cultures 
including trade law implications187 
  
From the Member States perspective, the consequences of REACH will be, in the short 
term  (especially  when  all  the  provisions  will  be  enforced)  the  almost  virtual 
 
 
exemption list in Annex IV Carbon and Graphite can be seen as an “adaptation” of REACH to the “technical 
progress”.  Commission Regulation  (EC)  No  987/2008  of  8  October  2008  amending  Regulation  (EC)  No 
1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and 
Restriction of Chemicals (REACH) as regards Annexes IV and V. 
Following this line of thinking, it seams clear that (without assessing the pace) the Commission is aware of the 
need to revise the regulations to better suit the special characteristics of nanomaterials in the light of new 
scientific advances in their characterization. As we have seen elsewhere on this report, the Commission has 
formally scheduled a revision on the regulatory aspects of nanomaterials by 2011 and a revision of REACH by 
2012. It has to be expected that both revisions will incorporate proposals for legal modifications that will have to 
be based on the principle of high level of protection. 
185 For a clear general view of (at that time) existing Chemical legislation see COM(2001) 88 final. 2.2.2001 
186  Hey, C., Klaus J., Volkery, A. <<Better regulation by new governance hybrid? Governance models and the reform 
of European Chemical policy>>. FFU-report 02-2006. Environmental Policy Research Centre. Freie Universität 
Berlin. SSRN – id 926980. 
REACH is clearly within the framework of the “new governance approach” as presented by Commission White 
Paper on European Governance COM (2001) 428 final 25.7.2001. The new governance approach includes 
elements of self regulation (non-legislative solutions - soft law) and participation of main stakeholders and 
general public, so strengthening the power and responsibility of Member States and private actors in policy 
formulation and implementation. The approached rely more on networks and voluntary action than on hierarchy, 
more on national responsibility than on EU harmonization, more on non governmental participation and 
responsibility than on state action. 
187  Fisher, E., (2008) <<The “perfect storm” of REACH: charting regulatory controversy in the age of information, 
sustainable development, and globalization>>. Journal of Risk Research 11:541-563; Benedetto, C., (2010) <<is 
the European Laboratory Over-Reach-ing? the experimentation, reaction and product yielded by the European 
Union's Registration, Evaluation, and Authorization of Chemicals>>. 21 Villanova Environmental Law Journal 
75. 
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disappearance of internal norms regulating the commercialization of chemicals products 
 
188 and in the long term, and due to the European regulatory centralisation that REACH 
 
represents, a change towards a European legal culture189. 
B) REACH OVERVIEW 
Possibly, the most radical change brought by REACH to the EU Chemical Law is the 
transfer of responsibility for carrying out the risk assessment to the producers and 
importers of a chemical substance, that are also requested to develop risk minimisation 
strategies190, in application of the principle of producer responsibility. 
Scope and exemptions: 
 
REACH applies to substances manufactured or imported into the EU in quantities of 1 
tonne or more per year. Generally, it applies to all individual chemical substances on 
their own, in preparations or in articles191 (if the substance is intended to be released 
  
188  <<El  sistema  de  fuentes  ha  sido,  pues,  plenamente  “europeizado”,  con  la  consiguiente  ablación  del 
correspondiente  espacio  de  conformación  normativa  de  la  realidad  del  que  disponía  los  poderes  públicos 
españoles en este sector>>. Moreno Molina A..M. (2010).At 51. 
The only fields left to Member States regulation are: 
1.- Penalties applicable for infringement of the provisions of the REACH Regulation (Art. 126 REACH). See 
Milieu Environmental Law & Policy (2009) <<Report on penalties applicable for infringement of the provisions 
of the REACH Regulation in the Member States. Final Report>> 17.12.2009. EC DG Environment (Study 
contract No. 07.307/2008(520090/ETU/D1). 
2.- Configuration of the internal administrative organization needed to exercise the powers and developing 
activities that Member States must carry out as part of the REACH implementation. 
189  Hyevaert states that the regulatory network can be affected in the long run because REACH represents an 
exercise in regulatory centralisation (basic functions are exercised by ECHA and the Commission), that requires a 
direct dialogue between EU institutions and regulatory addressees, that can change the regulatory practice and 
authority from the national to the European level. Hyevaert, V. <<The EU Chemical Policy: Towards Inclusive 
Governance?>> LSE Law, Society and Economic Working Papers  7/2008. London School of Economics and 
Political Science. Law Department. At 10. 
In this sense, a fundamental impact and direct consequence of REACH total harmonization is that Member State 
courts intervention is limited to those areas where the MMSS competences has not been restricted. As Moreno 
Molina states, << la Administración europea (la Comisión y la Agencia) se convierte en la ejecutora-aplicadora 
de la ley, por lo que los tribunales “naturales” de la normativa química pasan a ser los europeos, pues ellos son 
los únicos que pueden controlar a las organizaciones administrativas (europeas) y ” gestionan” el sistema legal. 
La intervención de los tribunales nacionales queda de ese modo limitada a los pocos ámbitos en los que se sigue 
reconociendo competencias a las administraciones internas, prencipalmente la acción de inspección, vigilancia y 
sanción>> Moreno Molina , A..M. (2010) At 51 
190  REACH in brief. European Commission DG Environment. October 2007. At 4. This major change is assessed by 
Führ as follows: <<The REACh proposal is bringing about a paradigm shift towards self-responsibility of agents 
and responsive regulation. The shift accepts the difficult situation of regulatory agencies in a highly complex 
environment with limited information about substances and their risks. REACh is highly demanding in requiring 
basic toxic information and explicit risk minimisation strategies along the production chain. At the moment, the 
regulation nonetheless falls short  in changing the incentives for all relevant agents to act according to the 
objectives of REACh.>> Führ, M. Bizer, K. (2007) <<REACh as a paradigm shift in chemical policy – responsive 
regulation and behavioural models>>. Journal of Cleaner Production 15: 327-334. 
191 Substance: A chemical element and its compounds in the natural state or obtained by any manufacturing process, 
including any additive necessary to preserve its stability and any impurity deriving from the process used, but 
excluding any solvent which may be separated without affecting the stability of the substance or changing its 
composition. REACH does not cover explicitly nano materials. However, as REACH applies to substances on 
their own, in preparations or in articles, it covers areas in which nanomaterials are being used. 
Preparation: A mixture or solution composed of two or more substances. 
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during normal and reasonably foreseeable conditions of use from an article). 
 
REACH does not mention explicitly nanomaterials, however, as REACH applies to 
substances on their own, in preparation or in articles, it covers areas in which 
nanomaterials are being used. 
 
Some substances are specifically excluded192, or have specific tailored provisions 
outside193 REACH or inside194 it. 
 
Registration: 
 
A major part of REACH is the requirement for manufacturers or importers of substances 
to register them with a central European Chemical Agency (ECHA). Registration 
involves a number of steps (looking for existing data, sharing data where it exists, 
creation of the electronic registration dossier) that finish with the sending of the 
registration package to ECHA195. 
 
 
The registration package is being supported by a standard set of data on that substance 
and the amount of data required is proportionate to the amount of substance 
manufactured or supplied196. Joint registration and data sharing are important aspects 
when setting up the registration package197, and, specifically for nanomaterials, the joint 
Article: An object which during production is given a special shape, surface or design, which determines its 
function to a greater degree than does its chemical composition. Examples of articles are a car, a battery and a 
telephone. 
192 Radioactive substances; Substances under customs supervision; The transport of substances; Non-isolated 
intermediates; Waste; Some naturally occurring low-hazard substances. 
193  Human and veterinary medicines; Food and foodstuff additives; Plant protection products and biocides. 
194  Isolated intermediates; Substances used for research and development. 
195  Data-sharing: One of the key objectives in REACH is to obtain and share information about the properties of 
substances being manufactured, supplied and used in the EU. This ensures that registrations use existing data 
rather than commissioning new studies. REACH prohibits the duplication of animal testing. Data sharing is 
achieved using one of two mechanisms, SIEF or the Article 26 Inquiry. The SIEF is the data sharing forum used 
for phase-in substances that have been pre-registered. For non-phase-in (new) substances, the main data sharing 
process is the Article 26 Inquiry, This process allows prospective registrants to be put in touch with any existing 
registrants so that data sharing can be organised. In some cases, data can be made freely available for registration 
purposes. 
Dossiers are created using the IUCLID software system, that helps applicants to create the file that will be sent to 
ECHA  using  their   REACH-IT  system.  For  nanomaterials  ECHA  has   issued  the  guidance  document 
<<Nanomaterials in IUCLID 5.2>>. IUCLID 5.2 Guidance and Support. June 2010 v1.0. First version. 
196  Basically: 
a) Common information for all registrations: Annex VI 
b) Depending on the tonnage threshold: 
- > 1t/yr Annex VII 
- > 10 t/yr As above + Annex VIII 
- > 100 t/yr As above + Proposal for Annex IX 
- > 1000 t/yr As above + Proposals for Annex X 
197   Joint registration and data sharing: 
This is the principle that for anyone substance, a single set of information on its intrinsic properties is produced 
that is shared by all those companies that manufacture or supply that substance. Business specific (e.g. company 
name) and business sensitive (e.g. how it is used) information is submitted separately by each company. The 
Companies will work together to get an agreement on information sharing through a Substance Information 
Exchange Forum (SIEF: A Substance Information Exchange Forum (SIEF) will be formed automatically within 
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registration links with the concept of “sameness” between bulk substance and 
nanosubstance that will be reviewed in the following section. 
  
If a particular substance needs to be registered (basically because it is produced in 
quantities greater than 1 Tonne/year or is a Substance of Very High Concert -SVHC- 
and is not exempted or excluded) but no registration is submitted, then the data will not 
be available and as a result, the manufacturer or supplier will no longer be able to 
manufacture or supply them legally, (“no data, no market” principle). In the 
nanotechnology debate, the application of the “no data - no market principle” has been 
requested by the European Parliament. 
 
 
The time line for registration depends on the possibility (for the substance) to be “pre- 
registered” or not. If the substance can be “pre-registered” it can benefit for an extended 
registration period Basically, the substances that can be “pre-registered” are those 
considered by REACH as “phase-in substances”198. The registration of those substances 
already being manufactured or supplied (phase-in substances) is being taken place in 
three phases (if the substances had been pre-registered from 1st June to 1st December 
2008199) up to 1 June 2018. 
   
This extended registration period has important consequences for nanomaterials: Those 
nanomaterials  that  has  been  pre-registered  -so  phase-in  substances-  (due  to  be 
considered  as  the  same  substance  than  their  bulk  substance)  will  not  have  to  be 
registered  until  2018  (depending  on  the  total  yearly  tonnage)  provided  that  the 
substance is supplied at ≥ 1 tpa. For those nanomaterials, the information that will be 
 
REACH-IT, comprising all the relevant stakeholders for each substance. You can view all the members of the 
SIEF through the REACH-IT system where you made your pre-registration. There is no option to opt out of a 
SIEF, but you can decide how active you wish to be within it. The fact of pre-registering nanosubstances based on 
the seamness principle/option to the bulk substance can also create problems once the SIEF is automatically 
assigned  to  the  stakeholder.  Scheidmann,  H.,  Roselfeld,  A.,  (2005)  <<Forming  Consortia  for  REACH 
Registration: Contractual and Competition Law Issues>>. JEEPL. 3: 173 – 183. 
198  Non-phase-in substances: those not produced or marketed prior to the entry into force of REACH: 
Phase-in substances: a) Substances listed on EINECS. b) Substances manufactured in the EU (including the 
newer member states) at least once in the 15 years before REACH became law, but were not placed on the 
market by the manufacturer (provided the manufacturer has documentary evidence of this). Substances that are so 
called 'No Longer Polymers' of Directive 67/548. 
EINECS: European Inventory of Existing Commercial Chemical Substances, it is a list of all the so called 
“existing substances”. 
199   As the 1st of December 2008 deadline for general pre-registration has already passed, the only pre-registration 
function now available is for the so called “late pre-registration”: If you manufacture or import (into the EU) a 
phase-in substance at one tonne or more per annum for the first time after 1 December 2008, you will be entitled 
to submit a pre-registration for that substance to the European Chemicals Agency (ECHA). The facility to pre- 
register after 1st  December 2008 is sometimes referred to as “late-registration”. If not pre-registered, then the 
applicant have to follow the registration procedure. 
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know up to 2018 is the limited information required on the pre-registration of a 
substance that is: a) Name of the chemical, including an identifying number (e.g 
EINECS number); b) Company’s name and address and a contact name; c) An 
Envisaged deadline for registration and tonnage band; d) Date of first supply; e) 
Identifier information of any structurally similar chemical (useful evidence on hazards 
as part of the registration package). 
 
 
Evaluation: 
 
Dossiers submitted in support of registration will be subject to different degrees of 
evaluation200. 
  
Substances of Very High Concern: 
 
Some substances have hazards that have serious consequences, e.g. they cause cancer 
(carcinogenic), or they have other harmful properties and remain in the environment for 
a long time (persistent) and gradually build up in animals (bioaccumulative). These are 
substances of very high concern201. One of the aims of REACH is to control the use of 
such substances via authorisation and encourage industry to substitute these substances 
for safer ones (substitution principle). 
 
Authorisation: 
 
In order to place on the market or use substances with properties that are deemed to be 
 
200  A) Compliance checking: This is a check of the quality of the information submitted by industry. It will be 
undertaken by the European Chemicals Agency (ECHA) in Helsinki and will be on a sample (at least 5%) of 
dossiers submitted at each tonnage level. 
B) Dossier Evaluation: For substances registered at the highest tonnage levels (≥100 tonnes/annum) a proposal is 
made by the registrant detailing those animal tests they consider are required from the list of standard tests in 
Annexes IX and X of REACH. The ECHA will evaluate these testing proposals to prevent unnecessary animal 
testing. 
C) Substance evaluation: This is undertaken by national Competent Authorities on substances that have been 
prioritised for potential regulatory action because of concerns about their hazardous properties. A key regulatory 
outcome of evaluation could be the imposition of restrictions on the manufacture, supply or use of a substance. 
Substance evaluation may also lead to a substance being added to the priority list for authorisation or a proposal 
to change the classification and labelling. 
All dossiers will undergo an automated completeness check to ensure that all the relevant pieces of information 
are present. This completeness check will not assess the quality or suitability of the information. 
201  Article 57 REACH 
Substances meeting these criteria may be placed on one or both of two lists that are defined in the REACH 
Regulation: the so called ‘Candidate List’ and the ‘Annex XIV List’. 
A potential SVHC may be prioritised by national REACH Competent Authorities, or by the European Chemicals 
Agency (ECHA) at the request of the European Commission (EC), and a dossier prepared for nomination of the 
substance for inclusion on the Candidate List. The list of proposed substances is then published on the ECHA 
website and interested parties are invited to submit comments within a set time frame. If no comments are 
received, the substance will be automatically included on the Candidate List. However, if comments are received, 
ECHA will refer the dossier to its Member State Committee where agreement will be sought as to whether the 
substance meets the Article 57 criteria. If there is failure to reach a unanimous agreement at the Member State 
Committee then the EC will prepare a draft proposal on the identification of the substance and a final decision 
subsequently taken in accordance with the comitology procedure laid out in Article 133. 
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of “very high concern” industry must apply for an authorisation202. 
   
The Authorisation procedure under REACH is relevant to nanomaterials as restriction of 
substances can apply regardless of quantities manufactured or placed on the market and 
even regardless of the fact of being registered or not. 
 
 
Being this the case, it could be though that REACH could perfectly deal with 
nanosubstances of very high concern, but there are several elements that blur this 
preliminary opinion creating another regulatory gap or miss functioning that we will 
review on the following section. 
 
 
Restrictions: 
 
Any substance that poses a particular threat that is deemed to require Community-wide 
action can be restricted. Restrictions take many forms, for example, from a total ban to 
not being allowed to supply it to the general public. Restrictions can be applied to any 
substance, including those that do not require registration. 
    
2) INVENTORY OF REACH REGULATORY GAPS 
RELATED WITH NANOMATERIALS 
   
Before entering to present the different regulatory gaps let me just summarize the 
outcome, because our conclusion is clear; REACH was designed with the bulk 
substances in mind and when faced with nanomaterials, important regulatory gaps has 
been found and identified. 
 
 
From the analysis of the Precautionary Principle and the interpretation given by the 
European Court, we have reached the conclusion that the European regulator comes 
bounded to take those measures tending to minimize the possible risks. The existence of 
  
202  Substances of very high concern will be gradually included in Annex XIV of the REACH Regulation. Once 
included in that Annex, they cannot be placed on the market or used after a date to be set (the so-called “sunset 
date”) unless the company is granted an Authorisation. 
Decisions on authorisation are made by the European Commission, taking advice from the ECHA and Member 
States. Applicants will have to demonstrate that risks associated with uses of these substances are adequately 
controlled or that the socio-economic benefits of their use outweigh the risks. Applicants must also analyse 
whether there are safer suitable alternatives or technologies. If there are then they must prepare substitution plans 
and if not then they should provide information on research and development activities if appropriate. 
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regulatory gaps generates these risks. So it can be understood that eliminating them 
during the REACH review (or at least to critically discuss them in the review process) 
can be consider as an obligation of the European legislator. By not doing so, the 
Commission could be in breach of Community Law. In any case, that breach can only 
by judged by the Court if requested to do so. 
 
 
2.1) Lack of explicit mention of “nanosubstance” under REACH 
   
There are no provisions in REACH referring specifically to nanomaterials but there is 
no doubt that their provisions apply to them. 
  
As stated in art.5, REACH applies to <<substances on their own, in preparations or in 
articles>>, and art. 3 (1) REACH defines <<substance>> as <<a chemical element and 
its compounds in the natural state or obtained by any manufacturing process>>. Given 
this broad scope, it is accepted that REACH apply to the bulk substance as well as to the 
nanoform of the bulk substance203, and the fact that REACH does not differentiate 
between nanoscale and bulk materials can not challenge the application of REACH to 
nanosubstances204. 
 
 
As stated by the Commission, as <<REACH addresses substances, on their own, in 
preparations or in articles>> and <<it deals with all substances, in whatever size, shape 
or  physical  state>>  then  <<substances  at  the  nanoscale  are  therefore  covered  by 
REACH and its provisions apply. It thus follows that under REACH manufacturers, 
importers  and  downstream  users  have  to  ensure  that  their  nanomaterials  do  not 
   
203  The  Committee  on  Environmental Affairs  of  the  European  Parliament  explicitly  called  for  not  including 
substances in the nanoscale in the Registration of the substance concerned on the conventional scale. The 
proposal was dropped in the legislative process, clearly showing that REACH covered the substances at the 
nanoscale   but   does   not   regard   nanomaterials   as   a   substance   of   their   own.   European   Parliament 
<<Recommendation For Second Reading on the Council Common Position.>> A6-0352/2006. 13 OCT 2006; 
Proposal for Amendment No 217 to Article 56 REACH by Carl Schlyter, Caroline Lucas and Hiltrud Beyer; 
Commission of the European  Communities (2008)  <<Follow-up to the 6th   Meeting of REACH Competent 
Authorities for the Implementation of Regulation (EC) 1907/2006 (REACH). Nanomaterials in REACH>>. 16 
Dec 2008. CA/59/2008 Rev. 1 At 4-5. 
204  As  Haselhaus  explains,  the  wording  of Art.  5  places  the  chemical  element  in  centre  field  and  does  not 
differentiate between applications on the nanoscale and the bulk material. This is based in the assumption that 
risks arising from the behaviour of a certain chemical are attributable to a substance and not to its different 
physicochemical properties. Because of this assumption, the system is not able to provide fon an effective risk 
assessment with regard to nanomaterials. But this regulatory failure can not change the legal definition of 
“substance” neither the inclusion of “nanomaterials” in it (in any case, only the European Court of Justice can 
interpret differently the “substance” concept and consider nanomaterials to be excluded from the REACH 
definition of substance). Haselhaus, S. (2010) At 122. 
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adversely affect human health or the environment>>205. 
   
The importance of explicitly mentioning <<nanomaterials>> on REACH scope (or even 
in the <<substance>> definition), is generally accepted and although will not report 
legal consequences will give certainty206. 
 
 
2.2) Exemptions and exclusions 
   
Art.2 REACH details various substances to which certain of the provisions of the 
 
Regulation do not apply. Not applicability in the form of exemptions or exclusions. 
  
 
1.- Substances included in Annex V. Those which occur in nature, including minerals 
and ores. 
The reason for excluding those substances is that the risk from base elements are well 
known already (art 2(7)(b) REACH). This may not be the case for the nanoforms of 
these substances (for instance, gold is unreactive and stable at bulk level, but highly 
volatile in certain of its nano forms)207. 
 
 
2.- Substances included in Annex IV. The reason for excluding those substances is that 
they are considered to be of minimum risk. Also in this case, what could be logical 
when dealing with bulk substances it is not when faced with the nanoform. 
 
 
REACH does not differentiate between nano and bulk forms of substances in Annex IV 
and V, so inaccurately assuming that the risk of a substance is the same as whatever 
scale. In fact, if the “nanosubstance” would be regarded as a separate substance from 
the bulk, then, there will not be need for the withdrawal from the exemption as has been 
the case with Carbon and Graphite in the European Union208. 
205 Commission of the European Communities (2008) <<Follow-up ...>>. At 4-5. 
206  As Fürh states <<in order to provide those affected with a clearly perceptible indications  that nanomaterials are 
also covered by REACH, reference to them in the definition of substance would be advisable, even if it were 
merely in a declaratory manner>> Führ, M., Hermann, A., Merenyi, S., Moch, K., Möller, M. (2006) <<Legal 
appraisal of nano technologies. Existing legal framework, the need for regulation and regulative options at a 
European and national level>>. Final Report . ÖKO-Institut e.V. & Sofia. FKZ 363 01 108. At 42. 
207 Lee, R.G., Vaughan,  S.  (2010)  <<REACHing Down: Nanomaterials and  Chemical Safety in the European 
Union>>. ESRC BRASS Research Centre. Cardiff University. At. 14. 
208  Carbon and Graphite were on the Annex IV list until October 2008, when they were removed from the exemption 
list by Regulation 987/2008 (Commission Regulation (EC) No 987/2008 of 8 October 2008 amending Regulation 
(EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation 
and Restriction of Chemicals (REACH) as regards Annexes IV and V). 
The reason for this decision is related with the reported possible health risk of carbon nanotubs (<<(3) The review 
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The  identified  gap  on  substances  of Annex  IV and  V  could  be  filled  by  a  clear 
distinction between the “bulk” and the “nano” substances and this could be done by 
considering both as different “substances” (so giving a different EINECS number) or if 
the substance has been already recognized as phase-in substance by giving an additional 
code to the CAS number (Chemical Abstract Service)209. 
 
 
2.3) Thresholds 
  
 
Art. 6 REACH states the registration obligation under REACH. Schematically, the 
following classification is envisaged: 
i)         If > 1T/year: Registration (without a Chemical Safety Assessment) 
 
ii)        If  >  10T/year:  Registration  (with  Chemical  Safety  Assessment  through  a 
 
Chemical Safety Report -CSR- Data content will depend on T/year). 
 
iii)       Without thresholds: substances of very high concern included in Annex XIV of 
REACH or substances of equivalent concern210 have to be registered and the following 
information have to be presented: 
• Chemical Safety Assessment through a Chemical Safety Report -CSR-.); 
 
• Exposure Scenarios; 
 
• Risk Characterisation. 
   
So, if the substance is not of special concern (iii), the general requirement for 
Registration laid down in Article 6(1) REACH applies from a production volume of one 
tonne per year and manufacturer211. 
 
carried out by the Commission pursuant to Article 138(4) has revealed that three substances listed in Annex IV 
should be removed from that Annex, as insufficient information is known about these substances for them to be 
considered as causing minimum risk because of their intrinsic properties. This is the case with vitamin A, as that 
substance may present significant risks of reproductive toxicity. This is also the case with carbon and graphite, in 
particular due to the fact that the concerned EINECS and/or CAS numbers are used to identify forms of carbon or 
graphite at the nano-scale, which do not meet the criteria for inclusion in this Annex>>.  Regulation (EC) No 
987/2008. 
209 It is important for Companies when setting up their R&D programmes to take into consideration a precautionary 
approach in their decisions. In the case of carbon nanotubs, the existence of <<concern over potential harm>> 
and the decision to withdraw the exception is clearly guided by precaution. In aligning the investment decision 
with the policy principle will make private decisions safer from possible future legal obligations derived from 
new scientific findings. Lee, R.G., Vaughan, S. (2010) At 8. 
210  Substances subject to authorisation are: a) CMRs (carcinogenic, mutagenic or toxic) category 1 and 2; b) PBTs 
(persistent, bioaccumulating and toxic) and vPvB (very persistent and very bioaccumulating); c) substances with 
probable serious effects to humans or the environment which give rise to an equivalent level of concern as CMRs 
and   PBTs/vPvBs.  This  is  for  instance  the  case  for  substances  with  endocrine   disrupting  properties. 
COM(2008)366final. At 7. 
211  On  the  framework of  the  discussion  on  the  thresholds,  the  REACH  competent Authorities  Sub-Group  on 
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The threshold gap is, as said by the Royal Commission on environmental Pollution <<the 
most significant potential limitation affecting the application of REACH to nanomaterials is the one tone 
threshold for registration. Because of the very large number of (often highly interactive) particles present 
even in tiny quantities of a nanomaterial (...) one tonne may be too high a threshold to capture potentially 
problematic effects>>212. 
 
 
There is a general concern that, as per today, an important amount of nanomaterials 
currently on the market will not reach this volume213, and as a consequence, products 
including nanosubstances are being released in the marketplace without being registered 
214. 
   
It is commonly agreed that based on the potential health problems reported by the 
scientific community a reduction in the quantitative threshold for nanomaterials, at 
which mandatory registration applies, <<does not appears to be unreasonable>>215, with 
reference to the principle of precaution (art 174 TFUE and Article 1(3) REACH) and 
the “no data no market” principle. Some institutions are starting to consider the need of 
solving the threshold issue as urgent216. 
Nanomaterials (CARACAL) stated: <<The tonnage trigger for registration apply to the total volume of a 
substance manufactured or imported by a registrant. Thus, for substances which exist both in a bulk form and in a 
nanoform, the total volume determines the need and the timing for registration and the information 
requirements>>. 
Trying to understand the CARACAL statement, Lee & Vaughan indicates that it would seem that if a 
manufacturer of carbon (who produce for instance – 1000 tonnes of carbon per year) also produce an amount of 
carbon nanotubes (CNTs), these CNT's would be registered along with the (bulk form) carbon whatever their 
volume of manufacture.  Although not indicated by CARACAL, this combination of volume for registration 
purposes should only apply where the substances, in their different forms, are considered the “same”. 
Commission of the European Communities (2008) <<Follow-up...>>; Lee & Vaughan (2010) At 17. 
In addition, CARACAL also states that <<REACH also does not prevent companies from registering on a 
voluntary basis their substances if they are below the one tonne threshold>> 
CARACAL is an expert group which advises the European Commission and ECHA on questions related to 
REACH and CLP. It is composed by representatives of Member States Competent Authorities for REACH and 
CLP, representatives from Competent Authorities of EEA-EFTA countries as well as a number of observers from 
non-EU countries, international organisations and stakeholders. For further information on CARACAL see 
http//:ec.europe.eu/enterprise/sectors/chemicals/reach/caracal/index_en.htm 
212  Royal Commission on Environmental Pollution (RCEP) (2008) At 4.37. 
213  <<The regulation of products containing nanoparticles based on tonnage, as proposed for existing chemicals 
under REACH, needs to be considered further because there are many more nanoparticles to the tonne than is the 
case for larger particles, and their behaviour in the body and in the environment may be different>>. Scientific 
Committee on Emerging and Newly Identified Health Risks -SCENIHR- (2006) <<The appropriateness of 
existing methodologies to assess the potential risks associated with engineered and adventitious products of 
nanotechnologies>>.. Modified Opinion (after public consultation). 10th plenary meeting of 10 March 2006. 
SCENIHR/002/05. At 3.10.9. 
214 The concern arising from this regulatory gap is one of the main arguments on behalf of the adoption of a 
compulsory registry for nanomaterials approved by France. 
215  Führ, M., et Al. (2006) At 43. 
216  <<We commend the Government's commitment to address the issue of the one-tonne threshold for considering 
the potential toxic effects of a substance under REACH Regulation. We ask the Government to update the 
Committee  in  the  progress  they  made  towards  meeting  the  urgent  need>>  in  House  of  Lords  (2009) 
<<Nanotechnologies and Food>>. Science and Technology Committee 1st Report of Session 2009-10. House of 
Lords. Vol. I Report. HL Paper 22-I. At 54. 
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In addition, it also would be advisable to deviate from the “weight/year” logic and to 
give preferences to other parameters more fitted to nanomaterials characterisation217 
 
 
2.4) Classification difficulties 
  
 
2.4.1) Nanosubstance as phase-in substance 
  
 
Art. 3(20)218 of REACH establish the basic concept that substances which have been 
listed on the European Inventory of Existing Commercial Chemicals Substances 
(EINECS) and thus were “existing” substances prior to the entry into force of REACH 
can be considered as phase-in substances for REACH purposes219. 
 
 
The importance of the distinction is basically the possibility (if considered phase-in 
substances) of opting for the deadlines established in art. 23220 of REACH, which meant 
 
217  The  UK  Government  states  <<2.  The  Government  agrees  with  the  Royal  Commission  that  the  REACH 
Regulation provides the most sensible legislative framework for the regulation of nanomaterials, in tandem with 
more specific legislation where this exists (for example on biocidal products). Likewise, the Government 
recognises that functionality, rather than size, should be given particular attention>> <<5. The Government agrees 
that some changes may be necessary to the current framework to more effectively manage the use of 
nanomaterials. In particular, the Government recognises the limitations of the annual one tonne threshold for 
registration and that the test guidelines may need to be extended to cover risks specific to nanoparticles>>. United 
Kingdom Government (2009) <<Response to the Royal Commission on Environmental Pollution (RCEP) Report 
"Novel Materials in the Environment: The Case Of Nanotechnology>>. June 2009. 
Available at  http://www.official-documents.gov.uk/document/cm76/7620/7620.pdf (Accessed May 2011). 
218 <<Article 3 Definitions 
20. phase-in substance: means a substance which meets at least one of the following criteria: 
(a) it is listed in the European Inventory of Existing Commercial Chemical Substances (EINECS); 
(b) it was manufactured in the Community, or in the countries acceding to the European Union on 1 January 
1995, on 1 May 2004 or on 1 January 2007, but not placed on the market by the manufacturer or importer, at least 
once in the 15 years before the entry into force of this Regulation, provided the manufacturer or importer has 
documentary evidence of this; 
(c) it was placed on the market in the Community, or in the countries acceding to the European Union on 1 
January 1995, on 1 May 2004 or on 1 January 2007, by the manufacturer or importer before the entry into force 
of this Regulation and it was considered as having been notified in accordance with the first indent of Article 8(1) 
of Directive 67/548/EEC in the version of Article 8(1) resulting from the amendment effected by Directive 
79/831/EEC, but it does not meet the definition of a polymer as set out in this Regulation, provided the 
manufacturer or importer has documentary evidence of this, including proof that the substance was placed on the 
market by any manufacturer or importer between 18 September 1981 and 31 October 1993 inclusive.>> 
219 CARACAL: <<A phase-in substance is defined by a substance meeting the criteria of Article 3(20) of REACH. 
Unless the substance is a no-longer polymer or has not been placed on the market in line with Article 3(20)(b), 
this means that the substance must have been listed in the European Inventory of Existing Commercial Chemical 
Substances (EINECS). The intention behind this provision is to give phase-in status to substances which have 
been listed in EINECS in the past and which therefore were considered as existing substances before the entry 
into force of REACH. In interpreting whether a concrete material is covered by a particular EINECS entry, 
therefore historical criteria need to be applied. In other words, whenever the material was considered to be 
covered by a  particular EINECS entry in  the  past, it  should  be  considered  to  have phase-in  status under 
REACH>> Commission of the European Communities (2008) <<Follow-up ...>> At 2.1. Following Lee & 
Vaughan (2010) the statement is not helpful as, for instance, Carbon is registered on EINECS with the number 
7440-44-0, but this listing does not distinguish, for example, between carbon in a conventional form and carbon 
nanotubes. Lee & Vaughan (2010) At. 22 
220  For  a  graphic explanation of  REACH registration  deadlines  established in  art.  3.  Environment Directorate 
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the option of getting extended registration periods221. 
   
Regardless of being manufactured or placed in the EU market as nano or bulk form, the 
only requisite for opting to a phase-in classification is the fact of being or not listed on 
the EINECS. 
 
 
So, if a substance (in bulk) was listed on the EINECS prior to the entry into force of 
REACH, then the nanoform will also be phase-in substance (as nanosubstance is 
considered the same substance). The final consequence is that nanomaterials like CNTs 
(carbon nanotubs) may not be registered with safety data until 2018 (or possible not 
even be registered because they do not exceed the REACH registration threshold of 1 
tonne or more of annual output or imports -as we have seen above-). The fundamental 
reason of this gap is (again) because REACH does not differentiate substance identity 
on the basis of physicochemical characteristics. 
 
 
Faced with this problem, Fürh propose (even to) accept that nanomaterials are not 
considered to be a substance on their own under REACH provided that (for registration 
purposes) REACH assign nanomaterials a different CAS (Chemical Abstract Service) 
number or (like both red and white phosphorous) to be listed under EINECS number 
with a different index number222. 
 
 
The German NanoKommission advices that the long transitional deadlines for 
registration of phase-in substances (art. 23 REACH) should not apply to substances on 
the nanoscale because otherwise <<this would not be compatible with the precautionary 
principle. In order to ensure continuity of manufacturing, importation and marketing, 
however, a deadline should be set by which all substances in the nanoscale already on 
   
General European Commission (2007) <<REACH in brief>>. 2007. At. 9. 
221   Substances considered “non-phase-in” (and which were manufactured or imported in quantities greater than one 
tonne per year) needed to be registered prior to 1 June 2008 and prior to commercialization or import could 
continue. 
222  Führ, M., et Al. (2006)  At 44; SCENIHR reach a similar conclusion: <<If the nanoparticle form of a chemical 
does have distinctly different properties in biological systems from other physical forms of the same chemical, it 
will be necessary to readily identify the nanoparticle form of each chemical for the purposes of hazard warning 
labels etc. One approach to ensure that the effects of the nanoparticle form of a chemical is properly assessed 
would be to have a unique identification for it, either assigning different CAS numbers to the nanoparticle form, 
or adding a code (CAS-NP50) to existing CAS numbers leaving the CAS number for identifying similar chemical 
compounds>>. Scientific Committee on Emerging and Newly Identified Health Risks -SCENIHR- (2006) At 
3.10.9. 
CAS Registry: database of organic and inorganic substances maintained by the American Chemical Society. 
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the market must be registered>>223. 
   
2.4.2) Sameness of substances 
   
When identifying a substance, it must be clarified whether a given nanomaterial is to be 
regarded; a) as a substance in its own right or b) as a specific physical form of a 
substance. 
 
 
Under REACH, the analysis of “sameness” has to be done by the Registrant224 after 
undergoing a sameness analysis that should indicate whether the substance at nanoscale 
can be considered as a specific physical form of the bulk substance (ie both are covered 
by the same EINECS entry), or is a different substance than the bulk substance (ie 
separate EINECS entries). 
 
 
When deciding this, the registrant must take into account the provisions of Art. 3 and 
 
Annex VI (2) of REACH, in conjunction with the ECHA Guidance documents. 
 
Neither REACH, nor the ECHA Guidance documents lay down binding requirements 
specifically for substances in the nanoform basically due to the lack of proper scientific 
knowledge when deciding what information is needed for a “sameness” analysis with 
nano material. 
 
 
In this sense, REACH does not define “sameness” and it does not foresee any formal 
step to confirm the establishment of sameness225 and ECHA has not yet released 
guidelines on the identification of substances in the nanoscale226 with the consequent 
  
223  NanoKommission (2010) <<Review....>>. At 23. 
224   <<Under REACH, this “sameness” analysis has to be done by potential registrants. Nevertheless, the outcome of 
this analysis is not at the discretion of potential registrants but must be in line with the substance definition, 
information related to molecular and structural formula, composition and other relevant provisions of REACH. 
Any decisions taken by SIEFs may therefore also be challenged, e.g. by ECHA during the compliance check.>> 
Commission of the European Communities (2008) <<Follow-up ...>>. At 2.3. 
225 <<Article 29 of the REACH Regulation provides that all Potential Registrants and Data Holders for the “same” 
phase-in substance shall be participants in a SIEF. However, the REACH Regulation does not define “sameness” 
and it does not foresee any formal step to confirm the establishment of sameness and the formation of a SIEF>>. 
ECHA (2007) <<Guidance on data sharing>>. September 2007. At. 34. Available at 
http://guidance.echa.europa.eu/docs/guidance_document/data_sharing_en.pdf. (Accessed January 2011). 
226   <<The current developments in nano-technology and insights in related hazard effects may cause the need for 
additional information on size of the substances in the future. The current state of development is not mature 
enough to include guidance on the identification of substances in the nanoform in this TGD>>. ECHA (2007b) 
<<Guidance for identification and naming of substances under REACH>>. June 2007.   At 28. Available at 
http://guidance.echa.europa.eu/docs/guidance_document/substance_id_en.pdf. (Accessed January 
2011). 
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confusion in the registration process227. 
   
The issue of substance identity was being debated at EU level within RIPoN 1, but the 
final published report is not conclusive as the experts could not reach a consensus, 
therefore no recommendations will be send to ECHA228. 
  
2.5) Methodological gap 
  
 
Under REACH the safety of a substance is determined by volume in which it is 
produced, failing to account for particle size and surface area as key determinants of 
toxicity. 
 
 
For this reason, there has been no substance-specific legal duty to perform studies 
specially for nanomaterials229, meaning that ecotoxicology tests performed on the 
nanoscale  form  may,  from  a  legal  point  of  view,  need  to  be  accepted  for  both 
macroscale and nanoscale forms by regulatory authorities. 
 
 
The Commission launched the REACH Implementation Report on Nanomaterials, 
RIPoN2 on information requirements and RIPoN3 on Chemical safety assessment. The 
reports has just been published and is now for the ECHA to decide whether and when to 
include changes on the Technical Guidance Documents based on those 
recommendations230. 
 
 
2.6) Registration updates (art 22 REACH) 
   
Article 22 REACH establish the registrants' obligation to update his registration in cases 
  
227  The confusion over classification of nanomaterials under REACH has led to two groups of companies using 
different criteria to submit data on carbon nanotube to ECHA, and are forming separate data-gathering bodies 
(SIEFs) to deal with carbon nanotubes. One group is setting up its own SIEF for carbon nanotubs to register them 
as distinct chemicals with their own safety profile while another planned to register the nanomaterials as a form 
of bulk graphite so that they will not require their own registration dossier. RSC – Advancing the Chemical 
Sciences. Available at http://www.rsc.org/chemistryworld/News/2009/June/16060901.asp 
228  DG Environment & JRC <<REACH Implementation Project Substance Identification of Nanomaterials -RIPoN1- 
>> AA N. 070307/2009/D1534733.Advisory Report March 2011. Available at 
http://ec.europa.eu/environment/chemicals/nanotech/pdf/report_ripon1_pdf 
229  Fullerenes represents an exception since they are not an EINEC substance, has received specific CAS number and 
(once reached the 1 Tonne/year threshold) are subject to Registration. Orthen, B. (2007) <<Nanotechnology: 
Health and environmental risks of nanomaterials – Research Strategy>>. BauA (German Federal Institute for 
Occupational Health and Safety). 2007. At 12. Available at  www.baua.de/en/Topics-from-A-to-Z/Hazardous- 
Substances/Nanotechnology/Nanotechnology.html. (Accessed February 2011). 
230  Reports are available at http://ec.europa.eu/environment/chemicals/nanotech 
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like change in the composition, new knowledge of the risk of the substance and others. 
   
The updating obligation is “following registration”, so the duty applies only to phase-in 
substances (new substances) and not to non-phase-in-substances (old substances) until 
registration is accomplished, which will be in 2018 at the latest231. The gap could be 
closed by a wide interpretation which also comprises “pre-registration”232. 
 
 
2.7) Nanosubstances ban 
  
 
The Substances of Very High Concern (SVHC) listed in Annex XIV of REACH will 
have to be subject to authorisation for each individual use (art. 57 REACH), if it wants 
to be placed on the EU market. The application for authorisation has to include a 
chemical safety report -CSR- and an analysis of possible alternative substances233 
 
 
If the analysis of alternatives reveals that there is a suitable alternative, the applicant 
must submit a substitution plan. When the applicant can not demonstrate adequate 
control on risk and where no suitable alternative exists, he needs to include a socio- 
economic analysis in his application (SEA)234. 
 
 
The Authorisation procedure under REACH is relevant to nanomaterials as restriction of 
substances can apply regardless of quantities manufactured or placed on the market and 
even regardless of the fact of being registered or not. 
 
 
Being this the case, it could be though that REACH could perfectly deal with 
nanosubstances of very high concern, but there are several elements that blur this 
preliminary opinion creating another regulatory gap or missfunctioning. Those are: 
 
 
a) There must be an evidence that the substance poses unacceptable risks. As we have 
seen earlier, risk assessment methodology is not fully adapted to nanomaterials, so the 
“evidence” will not be possible to prove; 
b) The procedural arrangement for the inclusion of substances in Annex XIV (Art. 58 
 
231  Haselhaus, S. (2010) At. 123. 
232  Obviously this wide interpretation if followed by the Commission or ECHA could be challenged. At the end it 
would be for the European Court of Justice to interpret. 
233  See http://guidance.echa.europa.eu/authorisation_en.htm 
234  See http://guidance.echa.europa.eu/socio_economic_en.htm 
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REACH) states a short list of priority substance where nanomaterials are not mention235. 
   
In order to properly take into consideration the special characteristics of (certain) 
nanomaterials it could be advisable to consider them priority substances at the same 
level of concern, at least, as the substances “normally” considered to be prioritized236. 
 
 
c) The analysis of alternatives could be a complex issue with nanomaterials: The bulk 
substance can be considered as alternative ? The applicant has to limit the possible 
alternatives to  nanomaterials? A similar  question  could  arise  from  the  SEA as  its 
purpose is to evaluate what costs and benefits an action will create for society by 
comparing what will happen if this action is implemented as compared to the situation 
where the action is not implemented. 
                                       
235  <<3. Prior to a decision to include substances in Annex XIV, the Agency shall, taking into account the opinion of 
the Member State Committee, recommend priority substances to be included specifying for each substance the 
items set out in paragraph 1. Priority shall normally be given to substances with: 
(a) PBT or vPvB properties; or (b) wide dispersive use; or (c) high volumes.>> 
236  Desmoulin considers that ECHA does not seam to consider some nanoforms as substances “raising an equivalent 
level of concern” Desmoulin, S. (2008). At 347. 
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PART IV. CONCLUSIONS 
  
 
It is commonly stated that nanotechnologies will bring societal benefits, innovation and 
competitiveness. On the other hand, we only have a limited understanding of potential 
risks from nanomaterials, although a growing body of scientific data suggest that certain 
nanomaterials may have a negative impact on human health and the environment. 
 
 
This is the base of our regulatory dilemma: if we regulate “too much”, we may hinder 
(nano)technology development (or force a certain number of companies to move their 
activities to less regulated countries or regions) but, if we do not regulate as a priority 
(and in a timely manner) all aspects related with Health, Safety and Environmental 
issues (HSE) or under-regulate nanotechnologies, we can face unexpected damaging 
effects and (over) reaction from public opinion that may also jeopardize nanotechnology 
development. 
 
 
In the nanotechnology field this dilemma is further complicated by different levels of 
uncertainty (over terminology, methodologies, HSE risks, risk assessment, future 
nanomaterials developments, etc.). 
 
 
Is within this complex framework (risk, benefits and uncertainties) that regulators have 
to decide, firstly, witch regulatory option is considered to be appropriate and, secondly, 
on the time line, level and intensity to be applied. Our research paper focus on analysing 
how the European Union has replied to above questions. 
 
 
From the first Part of our research paper, we conclude that the legislator needs to 
regulate risks associated with nanomaterials based on inconclusive and preliminary 
scientific evaluation indicating that particular nanomaterials might lead to potential 
risks and consequently damaging effects on human health and the environment. In this 
context, the Precautionary Principle has to be invoked. 
 
 
An added problem from nanomaterials regulation is that uncertainty is not limited to the 
availability of scientific conclusive data related with health, safety and environmental 
issues  (HSE),  but  it  also  reaches  issues  like  terminology,  methodologies,  risk 
assessment, quantity and quality of products in the marketplace and future technology 
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developments. 
   
We have identified four main regulatory options, namely: “wait and see”, differentiated 
approach, nano-specific regulation and “moratorium”. 
  
The two extreme options are considered inadequate for regulating nanotechnologies. To 
wait until scientific certainty is reached could mean to stop regulatory intervention for a 
long time and makes (next to) impossible to promote public involvement in the 
technology development or to address public concerns at the earliest possible stage. 
 
 
To over-react and generalize a moratorium until the risk of nanomaterials are identified 
would hinder research and development and international competitiveness as it seams 
fairly  difficult  an  international  agreement  on  nanomaterials  ban. Additionally,  this 
option implies that all nanomaterials may be hazardous and provoke risk. This is not the 
case with nanomaterials. 
 
 
The Differentiated Approach is the pragmatic option that we consider to be adequate, at 
least in the short term, because is based on the recognition that all regulatory systems 
are badly equipped to respond to new technologies, as regulatory regimes are designed 
for handling regulatory concerns at the time of promulgation. So we part from the 
assumption that is logical to expect that the emergence of nanotechnology creates or 
exacerbates regulatory gaps. In this sense, rejecting the actual regulatory regime just 
because is inadequate do nor seams reasonable. 
 
 
Based on this recognition, the Differentiated Approach regulatory strategy is to use 
existing legislative structures to the maximum together with the need of reviewing and 
amending (when appropriate, on a case by case basis and for specific nanomaterials and 
their applications) existing regulation (including the development of a specific guidance 
and standards to support existing regulation) and the introduction of supplementary 
policy. 
 
 
All this set of measures (hard law, soft law and supplementary policy) must be seen as a 
comprehensive regulatory regime, timely and proactive, and based on a proper 
assessment of the Precautionary Principle (as regard intensity/modulation). 
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Conceptually, we consider that the European Union regulatory strategy, the so called 
“Incremental Approach” strategy, is within the framework of the Differentiated 
Approach, although it can not be considered proactive, neither timely and only partially 
following the legal requirements under the Precautionary Principle. 
 
 
Conscious of the different interpretations given to the Precautionary Principle (that 
could justify nearly any kind of regulatory intensity), we have chosen a pragmatic 
approach: to present the content given to the Precautionary Principle by the European 
Courts because represents, in legal terms, the minimum level of precaution that the 
European Union has to aim for in the design and implementation of regulation. 
 
 
The fourth regulatory option identified is the “Nano-specific regulatory approach”. We 
consider that in the medium to long term the recourse to this strategy can not be 
discarded. Depending on the technology development (among other possible factors) a 
specific regulation may bring a more comprehensive, authoritative and clear legislative 
framework. In any case, the design of a brand new overarching regulatory regime is a 
complex task, time consuming and requiring a well organized and thoroughly planned 
legislative process open to public consultation, difficult to conduct if urgent answers are 
expected. 
 
 
The European Union Chemical Policy process, that started with the “White Paper on 
Chemical Policy” to the REACH approval (with an extensive public consultation) may 
be a model to consider for nanotechnology regulatory development. 
 
 
Any regulatory option design has to incorporate the Precautionary Principle as 
interpreted by the European Courts. The Courts are placing to the European public 
authorities a mandate to take provisional measures to anticipate the occurrence of a risk 
(of serious and irreversible damage to health and the environment deemed unacceptable 
to society, supported by solid and objective scientific reasons, even if uncertain), and 
that those measures must be based on general principles of risk management (and must 
be proportionate, non-discriminatory, consistent, based on an examination of benefits 
and costs of action or lack of action, and on an examination of scientific developments). 
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From there, and trying to avoid loose interpretations over the meaning of the Courts 
ruling, we have listed what we consider are specific legal obligation addressed to the 
regulator: 
• To act in order to avoid or minimize possible risks and not to be satisfied with 
 
(just) monitoring the development; 
 
• To  take  into  account  the  possible  effects  of  nanotechnology already in  the 
definition of EU policies; 
• Provide funding for research on toxicology and ecotoxicology in order to allow 
complete scientific evaluation of the potential adverse effects, based on the 
available data, and carried out by independent authorities. 
• Organizing the collection of information about manufactured nanoparticles and 
nanomaterials, their properties, their manufacturers, their uses, and the people 
potentially exposed. This requirement can be met by the setting up of a 
compulsory inventory or reporting scheme that could be designed within 
REACH, but not necessarily. 
 
 
Entering to the applicable legislation to nanomaterials in the European Union we have 
concluded that there are no specific regulations for nanomaterials at European Union 
level. Instead, the manufacture, use and disposal of nanomaterials are covered, by a 
complex set of existing regulatory regimes: Chemicals (REACH), Health and Safety of 
workers, product requirements -for health and safety of workers, consumers and 
protection of the environment- and legislation related with general environmental 
protection. In addition, we have identified specific nano-regulation included in non 
specific regulations. 
 
 
The scope and objective of our research work has not allowed us to enter on each one of 
those regulatory regimes and have opted, instead, for selecting REACH as a Case Study, 
in order to assess if it does cover adequately risks associated with the use of 
nanomaterials. 
 
 
Although the Commission considers, basically, that the current legislation covers “in 
principle” risk in relation to nanomaterials, that current legislation may have to be 
modified in the light of new scientific data and that regulatory problems have to be 
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found on implementation and enforcement shortcomings, caused by the knowledge gap, 
we understand that current legislation framework is designed to cover risk associated 
with bulk forms of substances and fails to cover some of the new risks associated with 
nanomaterials. 
 
 
The Commission that took a leading role when issuing the European nanotechnology 
strategy has been changing towards a “wait and see” attitude and, instead of proposing 
initiatives, has sent request for opinion to the different scientific committees, or just 
accepted the insertion of nano specific provisions on the legislative (recast) process 
requested by the European Parliament. 
 
 
On the other hand, we have to mention the positive contributions made by the 
Commission's “Recommendation on a code of conduct for responsible nanosciences and 
nantechnologies research” [C(2008)424final] (although not very successful among 
stakeholders we think that it is a good example of soft law applicable to nanotechnology 
regulation and hope that the ongoing revision and the necessary modifications will 
reinforce its role) and the funding increase on the 7th Framework Programme. 
 
 
In relation to the recent Recommendation of 18.10.2011 ot the definition of 
nanomaterial, we also consider that a pragmatic position has to be taken. Once we have 
a legal definition, it is time now to properly review all sectoral legislation and identify 
the “special provisions” to be applied -being the fundamental ones a robust risk 
assessment and  additional risk  control  measures  guided  by an  “exposure focused” 
and/or “commercial relevance” approach- and in the understanding that a modulation of 
the overarching concept might be necessary (additional qualifiers, specific physico- 
chemical properties or even to include certain nanomaterials that may fall outside the 
general definition). 
 
 
The European Parliament in a Resolution (that was jointly submitted by the five main 
groups in Parliament and with a virtually unanimous support) was very critical with the 
Commission handling of the nanotechnology policy in general and with the 
Commission's Communication on Regulatory Aspects in particular. We consider that the 
European Parliament Resolution may be considered as the first intent to set up a clear 
(draft) roadmap for a nanotechnology regulatory regime in the European Union. 
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France has approved a compulsory reporting scheme in response to the passive attitude 
from the Commission. The compatibility of this measure with the free movement of 
goods within the European Union is an open debate. We consider very difficult to put 
forward legal arguments backing its compatibility. In any case, the French initiative has 
accelerated the decision making process within the European Union. 
 
 
The Belgian Council Presidency, catalysing the critical opinion of several Member 
States regarding the Commission's regulatory framework, proposed to draw up 
coordinated national strategies including the development of a harmonized compulsory 
database of nanomaterials and products containing nanomaterials. 
 
 
From our point of view, it would be advisable to create a European register, including 
all nanomaterials instead of sectoral databases (because the same nanomaterial may be 
used in different sectors). Whether the register is centralized at European level or a 
Member States coordinated databases, we consider that the decision must be based on 
efficiency, reduced costs and simplicity. 
 
 
We have taken REACH as a Case Study in order to assess whether current chemical 
substances Regulation adequately covers risks associated with nanomaterials. Our 
conclusion is clear; REACH was designed with the bulk substances in mind and when 
faced with nanomaterials, important regulatory gaps has been found and identified. 
 
 
From our point of view, the European quest for a European regulatory regime for 
nanomaterials could be summarized as follows: 
1.   Need for clear and explicit regulatory framework; 
 
2. Current legislation does not cover the relevant risks relating to 
nanomaterials. The revision of all applicable legislation -that is under 
way- needs to identify all regulatory gaps and avoid just (another) formal 
review. 
3.   In the short term to address nanomaterials explicitly within the scope of 
at least legislation on Chemicals (REACH, biocides), food (food stuffs, 
additives, packaging) relevant legislation on worker protection, as well as 
legislation on air quality, water quality and waste. 
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4.   Setting up a compulsory reporting scheme where the level of information 
to be requested may be guided by an “exposure focused” approach or/and 
the “commercial relevance” approach. Having in mind this tiered 
information content, a strict interpretation of the “no data – no market” 
principle to be implemented. All nanomaterials will have to be registered 
and the information requested might be modulated as previously 
explained. 
5.   In all sectoral legislation, nanomaterials have to be considered as new 
substances. 
6.   The pre-market approval mechanisms (implemented in the cosmetic and 
food related regulations) must be analysed in order to conclude if it can 
be extended to new sectors. 
7.   Labelling regardless of risk (as far as possible). 
 
8.  In the medium term, to initiate a debate on a specific nano regulation 
embracing ELSI issues above the regulatory response to HSE issues; 
 
 
Finally, I would like to point to the need to carry out a debate on the role of legal 
science in the field of nanoscience and nanotechnology (N&N) at the UAB: While the 
UAB has opted to become a leading European Centre for nanotechnology sciences 
(being  at  the  forefront  the  ICN  -Catalan  Institute  of  Nanotechnology-, the  CIN2 
-Research Centre on Nanoscience and Nanotechnology and the BCN-b -Barcelona 
Nanotechnology Cluster Bellaterra-), the role played by legal science in this challenging 
project is, to say the least, minor. 
 
 
In this sense, I totally agree with the importance given by the European Commission to 
the integration of legal aspects in to scientific research, as stated on the 
“Recommendation on a code of conduct for responsible nanosciences and 
nantechnologies research” [C(2008)424final]: 
  
<<4.2.7. N&N research funding bodies should launch and coordinate specific research activities 
in order to gain a better understanding of ethical, legal and societal impacts of the new fields 
opened by N&N. 
4.3.2.     In addition to the existence of this Code of Conduct, N&N research funding bodies 
should make sure that N&N researchers are aware of the relevant legislation, as well as ethical 
and social frameworks>>. 
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